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Hess, David A. Ph D., Purdue University, December 2013. Establishing the role of the 
transcription factor MIST1 in XBP1-mediated maintenance of pancreatic acinar cell 
homeostasis. Major Professor: Stephen F. Konieczny. 
 
Pancreatic acinar cells (PACs) continuously produce more protein than any other cell 
type in the human body. As a result, PACs and other specialized secretory cells have a 
constant demand placed on their protein synthetic and packaging machinery. When 
demand for secreted products exceeds the capacity of the cell’s basal protein production 
facilities, dangerous accumulations of misfolded proteins can build up, resulting in a 
condition known as ER stress. To ameliorate this stress, secretory cells activate a 
coordinated, three-part compensatory network collectively known as the unfolded protein 
response (UPR) to both expand the capacity of the ER and directly assist in refolding or 
degradation of aberrant peptides. Interestingly, others have hypothesized that the UPR 
branches largely overlap in their functions and targets, prompting us to investigate 
whether loss of the IRE1/XBP1 branch via conditional ablation of XBP1 in mature mouse 
PACs could be compensated for by the remaining UPR pathways. We show that survival 
and homeostasis of PACs is wholly dependent on the IRE1/XBP1 axis of the UPR. 
Specifically, ablation of Xbp1 in mouse PACs results in a gradual but cumulative onset of 
irreversible ER stress. This results in abrogation of normal digestive enzyme synthesis, 
onset of extensive signs of pancreatic distress, and eventual apoptosis via ER stress-
induced death pathways. Remarkably, we also show that the pancreas initiates a robust 
regenerative response via cell cycle reentry and proliferation of multiple adult cell types. 
This regenerative mechanism rapidly restores a functioning exocrine compartment and 
provides a novel means to study pancreatic damage and recovery from intrinsic stress 
events. Finally, we investigated the role of the acinar cell-specific transcription factor 
MIST1 as a downstream effector of XBP1. We verify that MIST1 is a direct target of 
XBP1, and a number of MIST1 target genes directly participate in facilitating cell 
recovery and survival during ER stress. Together, these data indicate that XBP1 and 
xiv 
 
MIST1 cooperate to sustain pancreatic acinar cells during times of high protein demand. 
Future disease research exploiting stress induction via modulation of the XBP1/MIST1 
transcriptional network may be used to generate novel therapeutics for treatment of 










CHAPTER 1. INTRODUCTION 
1.1 Regulated secretion is a necessary component of metazoan survival  
The generation and distribution of secreted cell products in higher eukaryotes occurs 
through regulated cellular pathways that ensure proper homeostatic maintenance. 
Internal- and externalization machinery is present in all multicellular organisms, and it 
facilitates cellular environmental responses and survival via its role in trafficking of 
signaling molecules to and from the cell surface, recycling and acquisition of necessary 
cell components, and transport of synthesized products to extracellular spaces. For 
many multicellular species including humans, specialized secretory cells are responsible 
for synthesis, packaging, and secretion of proteins necessary for regulation of life 
processes. In secretory cells, proteins destined for export are differentially processed 
and packaged to allow for expulsion from the cell and subsequent action upon a target 
tissue. At an organism level these secreted products often serve as vital components of 
maintenance and regulatory mechanisms including essential processes such as 
immunity and digestion. Due to the necessity of secreted products for survival, secretory 
cells have evolved unique mechanisms to regulate the synthesis and release of proteins. 
  
Secretory cells possess extensive protein production and secretion capabilities, thus 
requiring a more developed regulatory system for ensuring proper protein production. 
Examples of secretory cells include plasma B cells that secrete antibodies as a 
component of the adaptive immune response, gastric chief cells that generate proteases 
and hydrolases in the stomach, and pancreatic acinar cells that synthesize and secrete 
inactive digestive enzyme precursors (zymogens) for eventual transport to the 
duodenum. Each of these cell types share common phenotypic and molecular 
characteristics including extensive ER and Golgi networks, a high degree of 
responsiveness to extracellular signals required to coordinate the actions of many cells, 
and expression of common transcription factors such as the basic helix-loop-helix 
transcription factor Mist1 (discussed in section 1.5) (Acosta-Alvear et al., 2007; Pin et al., 
2000). Additionally, secretory cells often cooperate and form structures that allow 
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multiple individual cells to secrete their contents into a shared lumen that relays the now 
concentrated products into a ductal network. These structures, termed acini, can be 
found in body tissues including lactating mammary glands and the pancreas. These 
cellular characteristics are essential to the regulation of the complex secretory process. 
 
All eukaryotic cells utilize separate but overlapping pathways for internalization 
(endocytosis) of receptors and extracellular molecules and externalization (exocytosis) 
of required cell surface molecules, extracellular matrix components, and secreted factors 
(Figure 1.01). Vesicular endocytosis often initiates at clathrin- or caveolin-coated pits 
that form upon assembly of protein complexes at the membrane and initiate the 
internalizing process, although specialized pathways dependent on IL2Rβ, ARF6, flotillin 
and other proteins have also been described (Doherty and McMahon, 2009). 
Internalized vesicles are typically tagged and sorted into one of several categories 
including, but not limited to, the recycling endosome for return to the cell surface, the late 
endosome for sorting and transport along microtubules to various cell compartments, or 
the endolysosome for degradation (Mellman, 1996). This sorting process assures that 
the separate tasks of facilitating the relay of signals from the extracellular environment 
and acquisition and recycling of membrane and ECM components can utilize similar 
cellular machinery without interference.  
 
Exocytosis, or more specifically protein secretion, is divided into two unique pathways; a 
constitutive and a regulated system (Figure 1.02a). The constitutive pathway is utilized 
for packing of proteins into vesicles that are constantly released from the membrane, 
while regulated secretion is used to generate vesicles with highly concentrated protein 
contents that are stored and only secreted upon receipt of an external secretory signal, 
termed a secretagogue (Burgess and Kelly, 1987). Both pathways share early trafficking 
steps as peptides destined for secretion or requiring extensive protein modification enter 
the endoplasmic reticulum (ER) and proceed to the cis golgi network for processing 
(Figure 1.1) (Kelly, 1985). Specifically, membrane-bound ribosomes synthesize a pre-
protein containing the complete amino acid sequence but lacking substantial secondary 
structure (Mains et al., 1987). These peptides typically contain signal sequences on their 
N-terminal tails that trigger translocation of the pre-proteins into the ER and subsequent 










Figure 1.1 Vesicular transport is utilized to convey signals and transport cell 
products to and from the plasma membrane.  
Exocytosis (red arrows) of secreted products involves vesicle-mediated transport from 
the ER to the cis Golgi, through the Golgi cisternae, and packaging into one of several 
types of secretory vesicle. Endocytosis (blue arrows) begins in coated pits that trigger 
vesicle formation around the internalized component and eventual sorting either back to 
the membrane or to other cell compartments. Retrograde movement of preexisting 









Figure 1.2 Proteins requiring extensive folding or processing traffic through the trans 
Golgi 
(A) Constitutively secreted proteins (red circles) are packed loosely into vesicles and are 
delivered directly to the membrane (left). Both lysosomal enzymes and proteins 
undergoing regulated secretion are highly concentrated into budding vesicles (right). 
Lysosomal enzymes (blue triangles) form separate vesicles based on the presence of a 
mannose-6-phosphate tag. Proteins destined for regulated secretion (green diamonds) 
are packaged into immature secretory granules (ISGs) where excess lipid and cytosolic 
components are reclaimed. These vesicles then undergo fusion with other ISGs to 
become mature secretory vesicles. (B) Pancreatic acinar cells form polarized, multi-
cellular structures called acini (left, yellow dotted line) with basally-localized nuclei (N) 
and ER and apically-localized zymogen granules (ZGs). These zymogen granules are 
coordinately secreted into an adjoining ductal network (left, white dotted line). Electron 
microscopy (right) reveals an extensive ER network and the apically localized zymogen 
granules (white arrows).   
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the ER lumen, glycoproteins destined for secretion or other cell fates are modified by the 
addition of carbohydrate groups, while the cis Golgi network serves to modify these 
attachments to allow for proper sorting and packaging into vesicles (Cooper, 2000). 
Upon entering the trans Golgi network (TGN), proteins fated for either the constitutive or 
regulated secretory pathways diverge and are packaged separately (Burgess and Kelly, 
1987). 
 
Sorting of processed proteins occurs in the TGN, where products can be diverted to 
lysosomes, passed directly to the membrane via constitutive secretion, or stored in 
secretory vesicles for regulated secretion. Lysosomal glycoproteins passing through the 
Golgi are heavily modified and tagged for transport to the lysosome via attachment of 
mannose 6-phosphate (M6P) to carbohydrate groups previously added in the ER 
(Figure 1.02a, right). The M6P attachment is recognized by receptors in the TGN and 
triggers packaging of the tagged enzymes into clathrin-coated vesicles for transport to 
the lysosome (Glickman and Kornfeld, 1993). For secreted proteins, the constitutive 
secretion pathway serves as a default, as proteins lacking any other recognition 
sequences are directly trafficked to the plasma membrane (Burgess and Kelly, 1987). 
The constitutive pathway is utilized for targeting of necessary cellular components 
including plasma lipids and extracellular matrix components such as glycoproteins 
(Burgess and Kelly, 1987). Constitutive secretion does not generate vesicles that are 
stored within the cell for long periods of time; exocytosis takes place immediately after 
vesicle formation rather than in response to external stimuli (Figure 1.02a, left) (Kelly, 
1985). Indeed, constitutive secretory vesicles often traffic from the TGN to the plasma 
membrane in as little as 10 minutes as compared to regulated secretory vesicles with a 
cytoplasmic lifetime from hours to days (Grampp et al., 1992). As a result, proteins 
secreted in this fashion do not achieve a high degree of protein concentration within 
vesicles, a feature unique to the regulated secretory pathway (Burgess and Kelly, 1987). 
 
Regulated secretion defines a specific exocytosis pathway common to secretory cells in 
which synthesized products are diverted to specialized compartments within the TGN. 
The sequestering of secretory proteins within the TGN allows for a substantial increase 




of the early Golgi (Burgess and Kelly, 1987). After deposition of proteins into the isolated 
compartment, the chamber is budded off from the TGN as an immature vesicle. This 
vesicle fuses with other immature vesicles and continues to be modified as excess 
membrane and cytosolic components are reclaimed and recycled, resulting in a mature 
secretory vesicle with a much higher concentration of protein than the initial 
compartment (Figure 1.02a, right) (Vitale and Denecke, 1999). These vesicles are 
carried via attachment to the cytoskeleton to specific locations within the cell for storage 
before eventual exocytosis in response to a hormonal or chemical signal (Burgess and 
Kelly, 1987; Wacker et al., 1997). Cytoskeletal trafficking to distinct membrane locations 
(required for apical/basal polarized cells) is accomplished via vesicle membrane-
embedded tags as well as the action of multiple members of the Ras superfamily of 
small GTPases (Hsu et al., 2004). Standard light as well as electron microscopy of 
exocrine secretory cells reveal that secretory vesicles appear as electron-dense 
granules that are often localized to a specific location within the cell in order to allow for 
rapid, directional release into an adjoining ductal network (Figure 1.02b). Due to the 
prodigious quantities of protein required for the generation of secretory vesicles, 
secretory cells utilize unique adaptive responses to control protein throughput. 
 
All secreted proteins require ER processing, as correct peptide modifications and 
arrangement of hydrophobic amino acids into the interior of the protein structure are 
necessary for both membrane and extracellular fluid solubility. As such, secretory cells 
have a uniquely specialized cellular anatomy, often utilizing transcriptional networks to 
establish a physically expanded ER lumen in order to accommodate increased protein 
biosynthesis (Federovitch et al., 2005). This expansion was first noted during B 
lymphocyte differentiation into plasma B cells (Wiest et al., 1990), and has been 
demonstrated in both B cells and fibroblasts to be dependent upon expression of the ER 
stress-responsive transcription factor XBP1 (Shaffer et al., 2004; Sriburi et al., 2004). 
XBP1 serves to upregulate a number of genes as a component of the compensatory 
unfolded protein response (UPR), discussed at length in section 1.4. These gene targets 
both expand the ER and increase the production of protein transporters necessary for 
moving proteins in and out of the ER. Other transcriptional programs, discussed in 
section 1.3, also serve to ameliorate the stress placed on secretory cells by high protein 
synthesis demands. These responses serve as one component of an extensive quality 
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control system designed to guarantee both efficient synthesis and correct folding and 
packaging of proteins. 
 
1.2 Quality control mechanisms ensure proper protein folding following synthesis 
Eukaryotic cells utilize various quality control mechanisms throughout the cell to ensure 
that only properly synthesized and folded proteins are produced. This quality monitoring 
system begins during transcription, when the intrinsic 3’-5’ exonuclease activity of some 
DNA polymerases allows them to excise incorrectly base paired nucleotides that are 
inadvertently added during replication and replace them with the correct base using the 
matching strand as a template (Khare and Eckert, 2002). Similarly, DNA integrity is 
monitored prior to synthesis by a checkpoint mechanism regulated by the p53 and 
Ataxia-Telangiectasia Mutated (ATM) proteins (Banin, 1998). Mutations in DNA damage 
regulators are intimately linked to human disease, particularly in the case of p53 which is 
known to be mutated in greater than 50% of human cancers (Olivier et al., 2010). The 
importance of correct transcription and translation of proteins beyond the DNA damage 
pathway is illustrated in RAS-driven cancers. The oncogenic form of the Kirsten rat 
sarcoma (KRAS) protein possesses a single point mutation and amino acid substitution 
(G12D) that serves as the activating mutation in multiple cancers, including greater 
than 90% of tumors arising in pancreatic ductal adenocarcinoma (PDA) (discussed 
extensively in Chapter 6) (Hidalgo, 2010). As such, mechanisms to maintain the integrity 
of the DNA sequence serve as vital controls in prevention of disease. Maintenance of 
proper protein folding, however, is equally important for cell survival and homeostasis. 
The folding process is primarily regulated post-transcriptionally via production of 
chaperone and sensor molecules that control cellular responses to accumulations of 
misfolded proteins. 
 
Protein denaturation can be triggered both physiologically and experimentally by 
exposing cells to short durations of heat. Heat exposure above normal physiological 
temperatures results in accumulation of misfolded or aggregated proteins in the cytosol 
as the denatured regions assume non-native conformations (Richter et al., 2010). In 
unstressed conditions, hydrophobic amino acids are internalized during protein folding or 
membrane embedding, and the presence of exposed hydrophobic residues in the 
cytoplasm can result in dangerous protein aggregates or anomalous activity, thus 
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necessitating a means for cells to sequester the misfolded proteins and to assist their 
refolding. Eukaryotic cells express a class of molecules known as molecular chaperones 
that aid in the refolding of these proteins as well as serving roles in the normal synthesis 
of certain peptides. These chaperones, typically referred to as heat shock proteins 
(HSPs) due to a characteristic increase in their expression following heat treatment, are 
present throughout the cell and bind to exposed hydrophobic surfaces in denatured or 
unfolded proteins (Richter et al., 2010). The specific means by which HSPs assist 
protein folding vary depending on the class of chaperone and subcellular location.  
 
Some chaperones, including the predominantly mitochondrial-localized HSP60-like 
proteins, attach to exposed hydrophobic surfaces in denatured proteins and assume a 
conformation that forms a protective shell around the residues to isolate them from the 
surrounding cytosol (Figure 1.03a) (McClellan et al., 2005). This generates a favorable 
environment for refolding of the protein as well as preventing the interaction of the 
hydrophobic residues with other exposed proteins that could lead to protein aggregation. 
Additionally, this complex interacts with the pro-apoptotic proteins BAX and BAK, a 
binding that allows HSP60 to serve as an anti-apoptotic regulator while proteins are 
given time to assume their correct conformations (Itoh et al., 2002). Other classes of 
chaperones utilize different mechanisms to assist refolding.  
 
The HSP70-like family of chaperones assists protein folding as new peptides assume 
their initial conformation following translation (Figure 1.03b) (Mayer and Bukau, 2005). 
Prior to interaction with an unfolded protein, HSP70-like chaperones are ATP-bound and 
have an open conformation with an exposed protein binding domain and exhibit only 
weak intrinsic ATPase activity (Mayer and Bukau, 2005). Upon binding to (and 
effectively sequestering) hydrophobic residues in a folding peptide, ATP hydrolysis takes 
place and the chaperone changes conformation, now exhibiting an increased affinity for 
the bound protein. During this time, mechanisms that have not been fully elucidated 
allow HSP70-like proteins to change conformation and directly assist in solubilization 







Figure 1.3 Heat-shock proteins and the proteasome cooperate to repair or degrade 
misfolded proteins  
(A) HSP60 interacts with misfolded proteins via binding to exposed hydrophobic 
domains. An ATP-dependent interaction allows a GroES “cap” to bind, resulting in a 
protected, internal cavity that facilitates protein refolding. (B) HSP70 binds hydrophobic 
regions of proteins emerging from the ribosome in an ATP-dependent reaction. HSP70 
remains bound until hydrophobic residues are sequestered inside the folding protein, 
then dissociates. (C) The proteasome is a multi-subunit complex that forms a hollow, 
tube-like structure with internal proteolytic activity. (D) The E1a-c proteins form a 
complex with E1 loading ubiquitin molecules onto E2, which subsequently adds the 
ubiquitin to a substrate held in place by E3. Ubiquitinated proteins are then bound by a 
recognition factor (RF) which promotes proteasome formation that subsequently 




and Pi and reloading of the ATP, HSP70-like chaperones return to their open state and 
release their bound substrate. These two chaperone families, as well as most chaperone 
classes, all share common features that allow them to bind to unfolded protein regions in 
an attempt to generate a soluble or sufficiently protected structure (McClellan et al., 
2005). When proteins are unable to assume their native conformations despite 
chaperone action, cells utilize alternative strategies to identify, tag, and destroy 
misfolded peptides.  
 
The chaperone-mediated mechanism for assisted refolding operates alongside a 
destructive pathway that utilizes proteolytic enzymes to degrade proteins with exposed 
hydrophobic regions (Heinemeyer et al., 1991). This process is accomplished via an 
ATP-dependent, multi-subunit complex termed the proteasome that, in the case of 
misfolded proteins, uses embedded protease enzymes to unfold and cleave bound 
substrates (Figure 1.03c) (Elsasser and Finley, 2005). Misfolded proteins are marked 
for degradation via attachment of a polyubiquitin tag by a series of ubiquitin-activating 
enzymes (UAEs) termed E1, E2, and E3 ligases (Pines and Lindon, 2005). UAEs 
become targeted to misfolded proteins either via attachment of signal molecules by ER-
resident sensors that can be recognized by E3 (discussed in section 1.3) or via 
recognition by E3 of certain hydrophobic motifs that are aberrantly exposed in denatured 
proteins (Pines and Lindon, 2005). The UAEs each function in a coordinated manner, 
with E1 enzymes loading ubiquitin molecules onto E2, while the E2 and E3 enzymes act 
in concert to target (a process mediated by the E3 subunit) to polyubiquitinate (via the 
E2 subunit) proteins that are to be destroyed (Pines and Lindon, 2005). The presence of 
the polyubiquitin tail added by the E2 subunit following recognition stimulates attachment 
of any of several targeting proteins that then trigger the formation and binding of the 
proteasome complex and subsequent proteolytic degradation of the tagged protein 
(Elsasser and Finley, 2005). While both the proteasome and the heat-shock proteins 
allow recovery and destruction of misfolded proteins, neither of these systems can 
regulate the process of translation that initially produces these peptides. This limits their 
responsiveness to intrinsic protein folding stresses that may be triggered by the sudden, 




Correct protein folding is particularly important for peptides destined for membrane 
deposition or secretion from the cell. For proteins trafficked to the membrane, improper 
arrangement of hydrophobic and hydrophilic regions can lead to insolubility in the lipid 
bilayer, improper trafficking of receptors, or receptors that are unable to relay signals 
from extracellular stimuli, all conditions observed as causative agents in human disease 
(Kim and Rao, 2010). Improperly folded secreted proteins can also be detrimental due to 
the possibility of aggregation in extracellular spaces or loss of function at the target site. 
Indeed, secreted protein aggregates are believed to contribute to a number of human 
diseases including the aggregation of amyloid-β in neuronal spaces in Alzheimer’s 
disease and the aggregation of islet amyloid polypeptide in the pancreas during type II 
diabetes (DeToma et al., 2012). In order to maintain efficient and effective protein 
synthesis, homeostatic mechanisms have evolved in order to sense and respond to 
accumulations of misfolded proteins while peptides are still progressing through the ER, 
a condition known as ER stress (Oslowski and Urano, 2011). These mechanisms, 
collectively termed the unfolded protein response (UPR), serve to regulate protein 
processing, folding, and degradation via upregulation of chaperones, increased 
expression of ER-associated degradation (ERAD) proteins, and direct modulation of 
translation initiation (Walter and Ron, 2011). Additionally, specific components of the 
UPR can trigger apoptosis if ER stress cannot be ameliorated. Recent work has 
demonstrated that the UPR plays a vital role in maintaining secretory cell viability. 
 
1.3 The unfolded protein response (UPR) is a multi-component compensatory 
mechanism that maintains cellular homeostasis 
In contrast to quality control mechanisms that respond to cytoplasmic protein 
denaturation, the UPR is initiated by an accumulation of misfolded proteins within the 
ER, a condition described as ER stress (Figure 1.04). ER stress can be caused 
physiologically by a production demand that temporarily exceeds the physical capacity of 
the ER, including the high levels of synthesis required following clearance of secretory 
vesicles after signal-mediated release in secretory cells (Lee et al., 2005). ER stress can 
also be triggered experimentally by treatment of cells with any number of drugs 
including, but not limited to, thapsigargin (an inhibitor of sarco/endoplasmic reticulum 






Figure 1.4 The unfolded protein response regulates gene targets associated with all 
stages of protein synthesis 
Translated proteins are inserted via membrane import complexes (blue). Proteins are 
initially glycosylated via enzymatic modification (brown) before being acted upon by 
enzymes (pink) that facilitate folding. Improperly folded proteins are bound by 
chaperones (green) in an attempt to further facilitate folding. Successful folding results in 
transport to the Golgi via COPII-coated vesicles, while improperly folded proteins are 
exported from the cell (purple). Large accumulations of misfolded proteins generate 





reducing agent, also known as DTT) (Samali et al., 2010). These drugs all impair protein 
folding within the ER by disrupting either the transport of peptides/proteins into and out 
of the ER (thapsigargin) or the proper addition of necessary modifications (glycosylation 
for tunicamycin, disulfide bond formation for DTT) that are required for proteins to 
properly fold (Samali et al., 2010). During ER stress proteins with exposed hydrophobic 
resides begin to accumulate within the ER lumen. These residues interact with both ER-
resident chaperones and embedded sensor molecules that traverse the ER membrane 
and initiate transcriptional cascades, altering protein synthesis and processing in an 
attempt to allow clearance of the misfolded peptides.  
 
In eukaryotes, the UPR is primarily initiated through the action of the ER-resident 
chaperone Binding Immunoglobulin Protein (BIP), a member of the HSP70 class of 
chaperones (Haas, 1994). BIP serves as an ER lumen-specific chaperone by binding to 
exposed hydrophobic residues (similar to the previously discussed mechanism regarding 
HSP70) in order to prevent aggregation within the ER as well as allow for proper folding 
(Haas, 1994). BIP functions in concert with the ER-specific enzyme Protein Disulfide 
Isomerase (PDI) to maintain newly synthesized proteins in a non-aggregated and 
accessible conformation that allows PDI to modify disulfide bonds for structural 
arrangement of the protein (Mayer et al., 2000). BIP also functions to regulate calcium 
levels and prevent initiation of ER stress-induced apoptosis via an interaction with ER-
resident caspase-7 (Reddy et al., 2003). While each of these functions aid in 
maintenance of normal protein production and cell homeostasis, BIP also serves as the 
primary sensor for each of the three transmembrane proteins that serve as master 
regulators of the UPR cascades.  
 
In an unstressed state, steady-state levels of protein production require small amounts 
of BIP in order to facilitate proper folding of proteins as they initially enter the ER. BIP 
molecules normally remain docked to three separate transmembrane proteins; (PKR)-
like ER kinase (PERK), activating transcription factor 6 (ATF6), or inositol requiring 
enzyme 1 (IRE1) (Walter and Ron, 2011). When unbound by misfolded peptides, BIP 
stably binds to all three proteins individually and serves as an inhibitor of their functions 
(Figure 1.05). Upon binding exposed hydrophobic residues in folding peptides, BIP 
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dissociates from the UPR initiator protein it was bound to, allowing the UPR master 
regulators to initiate their downstream pathways (Ron and Walter, 2007). Once  
 
sufficient dissociation has occurred, the UPR branches can initiate positive feedback 
loops that sustain the response until the ER stress is resolved. Recent studies have 
shown that IRE1 may also directly interact with misfolded proteins, although the bound 
BIP chaperone is still thought to serve as a modulator of this activity (Mori, 2009; Walter 
and Ron, 2011). The three branches coordinately trigger expression of both branch-
specific and multi-branch gene targets in an attempt to ameliorate ER stress. 
 
Each specific master regulator (PERK, ATF6, or IRE1) initiates a unique signaling 
cascade that ultimately aids in one of three general functional stress responses: 
adaptive response of the cell to ER stress, feedback control of the UPR process itself, or 
cell fate determination in cases of unresolved ER stress (Figure 1.05) (Oslowski and 
Urano, 2010). While ATF6 and IRE1 are uniquely activated in response to ER stress, 
PERK has substantial crosstalk with other pathways, as its primary effector (eIF2α) is 
also utilized by several other independent stress responses (Marchand et al., 2006).  
 
During the adaptive response phase, protein throughput is attenuated while processing 
of misfolded proteins is increased. Attenuation is primarily accomplished via the PERK 
component of the UPR (Figure 1.05, right). Upon dimerization within the ER membrane 
following BIP dissociation, PERK-dependent phosphorylation of eukaryotic translation 
initiation factor 2A (eIF2α) leads to a reduction in global mRNA translation via inhibition 
of the eIF2 complex (Chakrabarti et al., 2011). This slowdown preferentially allows for 
production of certain proteins, including activating transcription factor 4 (ATF4), a 
transcription factor that is involved in feedback regulation of the UPR (via expression of 
the transcription factor XBP1) and cell fate determination (via expression of C/EBP 
homologous protein, or CHOP) (Walter and Ron, 2011). Additionally, PERK 
phosphorylates NF-ED-related factor 2 (NRF2) in order to drive antioxidant and 
detoxification cascades along with proteasome components (Lee et al., 2012).  
 
Independent of PERK activation, the ATF6 master regulator is released by BIP and 










Figure 1.5 Diagram of the mammalian unfolded protein response (UPR) 
The UPR consists of three separate pathways, each under the control of a different 
transmembrane master regulator. The ATF6 branch (left, green) is activated via 
proteolytic processing of the ATF6 receptor following activation and dissociation from the 
ER membrane. The IRE1 branch (center, blue) is activated via mRNA splicing of the 
Xbp1 mRNA into a new form encoding a potent transcription factor, XBP1s. The PERK 
branch (right, orange) initiates a phosphorylation cascade resulting in global translation 
slowdown as well as activation of the ATF4 and NRF2 transcription factors. All branches 
are shown with examples of downstream cell responses/gene targets provided.  
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translocate to the Golgi (Figure 1.05, left). The protein is then proteolytically processed 
prior to further translocation to the nucleus (now termed nuclear ATF6 or nATF6) where 
it upregulates expression of a number of chaperone proteins including BIP, XBP1, and 
glucose-regulated protein 94 (GRP94) (Okada et al., 2002). The ATF6-dependent 
expression of XBP1 is itself an example of the crosstalk and feedback control 
mechanisms that exist between UPR branches, as XBP1 is the primary effecter of the 
IRE1 branch via a unique activation mechanism (discussed extensively in section 1.4). 
IRE1 functions primarily to promote expression of XBP1s (Figures 1.5, middle), an 
active form of XBP1 that translocates to the nucleus and activates a number of genes 
associated with adaptive response to ER stress including ERdj4 (associated with the 
ER-resident degradation machinery) and EDEM1 (associated with translocation of 
misfolded proteins from the ER back into the cytoplasm for degradation). 
 
In higher eukaryotes, each of the UPR branches are utilized differently depending on cell 
type, with different responses observed following attenuation of the individual branches 
in various cells. Extensive characterization has been done on the IRE1 branch of the 
UPR in yeast, as it is both the only UPR branch present in the species and because it is 
the most conserved of the three branches among all metazoans. Increased UPR 
complexity is a hallmark of higher eukaryotes, as multiple ATF6 variants exist that 
function differently in the mammalian UPR. Similarly, IRE1 is expressed in two forms, α 
and β, that may specify unique mechanisms for different UPR functions depending on 
cell type (Walter and Ron, 2011). Interestingly, despite substantial overlap in function 
and targets among the three UPR branches, individual embryonic deletion of the three 
branches generates significant phenotypic differences varying from no substantial effect 
to embryonic lethality in the case of the IRE1/XBP1 branch (Reimold et al., 2000; Urano 
et al., 2000; Yamamoto et al., 2007; Zhang et al., 2002). This suggests a unique role for 
the IRE1/XBP1 axis during development and possibly as a principle component of the 
mammalian UPR.  
 
1.4 XBP1 is the primary transcription factor utilized by the IRE1 branch of the UPR 
IRE1 utilizes an unconventional mechanism to activate its portion of the mammalian 








Figure 1.6 IRE1-dependent splicing of the Xbp1 mRNA is responsible for generation 
of the XBP1s protein 
(A) The Xbp1 mRNA contains a 26-nucleotide splice acceptor in Exon 4 (red). This 
mRNA is localized to vicinity of the ER by unknown mechanism. (B) Upon activation, 
IRE1 utilizes its endoribonuclease functions to excise the intron. A cytoplasmic ligase 
then anneals to two ends of the mRNA, generating a novel transcript. (C) The unspliced 
Xbp1 transcript is translated into XBP1u, a short-lived protein that remains largely in the 
cytoplasm. The spliced transcript is translated into XBP1s. XBP1s has a unique C-
terminus as the splice event causes a frameshift, resulting in a new transcriptionally 




IRE1 proteins in the ER membrane, IRE1 activates an endoribonuclease domain located 
on the cytosolic side of the molecule (Chakrabarti et al., 2011). This endoribonuclease 
activity cleaves an ER-resident mRNA called Xbp1u (for Xbp1, unspliced variant). The 
exact role of the translated XBP1u protein generated by the unspliced Xbp1u transcript 
is unknown, although recent work has indicated a possible role as a regulator of 
autophagy via interaction with FOX01 (Zhao et al., 2013). The IRE1-dependent splicing 
event excises a 26-nucleotide long intron from the Xbp1u transcript (Lee et al., 2002). 
This excision generates a frameshift coding for a novel protein, termed XBP1s (for Xbp1, 
spliced variant) (Figure 1.06c). Despite sharing extensive N-terminal homology with 
XBP1u including the basic leucine zipper motif, XBP1s has a distinct C-terminal domain. 
This unique C-terminus contains a potent nuclear localization signal as well as a 
transcription activation domain, while the XBP1u C-terminus has competing nuclear 
localization and nuclear exclusion domains as well as an uncharacterized “degradation 
domain” that prevents its accumulation in the cell (Yoshida et al., 2006).  
 
A possible but not yet fully characterized mechanism for modulation of XBP1s utilizes 
dimerization of the unstable XBP1u with XBP1s and subsequent retention in the 
cytoplasm and proteasomal degradation (Yoshida et al., 2006). This mechanism is 
believed to serve only as a small component of the overall feedback control of the UPR, 
as XBP1s levels are drastically upregulated following splicing after ER stress onset, 
producing far more protein than the low levels of XBP1u could regulate via dimerization 
(Yoshida et al., 2006). Other research suggests a possible role for XBP1u as a 
transcriptional partner of XBP1s, but only for a very small subset of genes outside the 
canonical UPR targets (Guo et al., 2010), suggesting that XBP1s can regulate both UPR 
and non-UPR transcriptional networks, an idea discussed more thoroughly in chapter 5. 
 
XBP1s is a potent basic leucine zipper (bLZ) transcription factor that, upon translation 
from the newly spliced mRNA, translocates to the nucleus and activates its target genes. 
The IRE1-dependent splicing of Xbp1 is conserved in metazoans and has been heavily 
studied in yeast where HAC1, an XBP1 homologue, is spliced by IRE1 and is 
responsible for initiation of the entire UPR (Cox and Walter, 1996). Mammalian XBP1s 
binds to a number of consensus sequences including ER Stress Elements (ERSE) I and 
II and the Unfolded Protein Response Element (UPRE) (Acosta-Alvear et al., 2007). 
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While binding to ERSE sequences and subsequent transcriptional activation is a 
common feature of both XBP1 and nATF6, XBP1 preferentially binds the UPRE while 
nATF6 shows very low affinity, indicating that XBP1 has a distinct role from ATF6 in the 
UPR (Yamamoto et al., 2004) (Figure 1.07). Additionally, ATF4 (upregulated via the 
PERK UPR branch), has a unique binding site independent of nATF6 and XBP1, likely 
due to the fact that the phosphorylation of eIF2α carried out by PERK in the UPR is also 
utilized by other enzymes as part of unrelated stress pathways including amino acid 
deprivation and viral infection (Marchand et al., 2006). Recent work by the Yoshida 
group has also illustrated that XBP1, BiP, and CHOP can cross-regulate each other, and 
that CHOP can form a positive feedback loop via low-affinity binding to a number of 
promoter regulatory sequences including ERSE (Takayanagi et al., 2013). This is 
hypothesized to be a means of allowing a transition from a pro-survival, pro-recovery 
UPR state to one promoting apoptosis driven by steadily increasing expression of 
CHOP. 
 
Embryonic knockout studies in mice have examined the roles of each of the three UPR 
master regulators, as well as XBP1. Deletion of PERK or its primary effector, ATF4, 
generates viable offspring, however PERK-/- mice have secretory cell defects in the 
pancreas, an unsurprising result given the extensive secretory load placed upon 
pancreatic cells (Tanaka et al., 1998; Zhang et al., 2002). Knockout of either ATF6α or 
ATF6β has no effect on embryonic development, however compound knockout of the 
two proteins results in embryonic lethality (Yamamoto et al., 2007). Interestingly, this 
study also revealed extensive dimerization between ATF6α and XBP1, indicating 
possible crosstalk between the two pathways independent of their co-activation of ERSE 
sequences. IRE1 or XBP1 deletion in mice results in embryonic lethality. However, 
targeting of a liver-specific XBP1 transgene (LivXbp1) in Xbp1-/- mice rescues this 
phenotype, although mice die during post-natal development (Lee et al., 2005; Reimold 
et al., 2000). Interestingly, Xbp1-/-;LivXbp1 post-natal pups have extensive abnormalities in 
secretory tissues, with the presumed cause of death attributed to lack of pancreatic 
enzyme production (Lee et al., 2005). The dependency of secretory tissues on an intact 
UPR has prompted numerous researchers to utilize mouse models in order to 











Figure 1.7 XBP1 and nATF6 bind common and unique DNA consensus sequences 
Three ER stress-specific consensus sequences (ERSE, ERSEII, and UPRE) have been 
identified. ERSE can be bound by nATF6 only in concert with NF-γ, while XBP1s can 
bind by itself. ERII can be bound by either nATF6 or XBP1s. UPRE preferentially binds 
XBP1s and has only low affinity for ATF6. Underlined sequences represent core motifs 





Multiple mouse models have been generated in order to interrogate the role of XBP1 in 
secretory cells and tissues. A mouse strain with a heterozygous deletion of Xbp1 
(Xbp1+/-) has been used recently to show that impaired XBP1 function, due to reduced  
levels of its expression, results in exacerbated damage in an alcohol-induced model of 
exocrine pancreatic disease (Lugea et al., 2011). Chimeric mice generated from the 
previously described Xbp1-/- model are noticeably deficient in plasma cells and incapable 
of secreting substantial amounts of immunoglobulin (Reimold et al., 2001). A Cre-
inducible Xbp1 null mouse (Xbp1fl/fl) was recently generated that was utilized to 
investigate the effects of adult ablation of Xbp1 in the chief cells of the stomach (Huh et 
al., 2010). Interestingly, this work revealed little increase in ER stress but a marked 
failure of cells to establish a fully differentiated gene expression pattern. Taken together, 
these models have revealed variable roles for Xbp1 that are highly dependent on cellular 
context. In addition to expression of Xbp1, the three cell types investigated (pancreatic 
exocrine cells, plasma B cells, and gastric chief cells) also share expression of a number 
of transcription factors linked to cell identity and secretion, among them the basic helix-
loop-helix protein MIST1. This prompted a close examination of the possible role of 
MIST1 as a component of the XBP1 transcriptional network. 
 
1.5 MIST1 is a transcription factor linked to proper functioning of secretory cells 
The pancreas is responsible for endocrine-mediated regulation of blood glucose levels, 
for the production of digestive enzyme precursors, termed zymogens, and for the 
secretion of the zymogens via a ductal network that leads into the duodenum (Figure 
1.08a). The digestive exocrine component of pancreatic function is accomplished by 
coordinate action of multiple cell types including secretory acinar cells and duct cells 
(Figure 1.08b). Spheres of acinar cells, termed acini (plural) or acinus (singular), are 
connected to a branched ductal network, often described as analogous to grapes on a 
vine. These duct networks merge, eventually becoming the main pancreatic duct that 
joins the common bile duct before emptying into the duodenum. Pancreatic acinar cells 
are responsible for production of the vast majority of digestive enzymes secreted into the  
duodenum (Williams, 2010), and in humans they synthesize more protein than any other 
cell type (Case, 1978). This function is facilitated via a characteristic cell organization in 















Figure 1.8 Pancreatic acinar cells secrete digestive enzyme precursors into the 
duodenum 
(A) The exocrine pancreas consists of large numbers of acinar clusters, arranged in a 
“grapes on a vine” formation. These clusters are sites of zymogen synthesis and empty 
into centralized lumens that eventually join to the pancreatic duct before joining the 
common bile duct and emptying into the duodenum. (B) Acinar cells are arranged into a 
spherical cluster termed an acinus (plural = acini). These acini are polarized with 
zymogens clustered at the apical end. Additional cell types are present in the cluster 
including duct cells that form a tubular network for zymogen transport and centroacinar 





zymogens are stored at the apical side, awaiting secretion into an adjoining ductal lumen 
(Figure 1.08b). This organization is dependent on specific cytoskeletal arrangements as 
well as surface attachment points for zymogen vesicles, all of which are controlled via 
specific transcriptional programs. In the pancreas, the transcription factor MIST1 has 
been extensively studied as a key factor in maintaining the organization and efficient 
functioning of pancreatic acinar cells.  
 
MIST1 is a basic helix-loop-helix transcription factor that is exclusively expressed in 
secretory tissues including the serous secretory cells of the immunoglobulin secreting B 
cells, zymogenic gastric chief cells, and pancreatic acinar cells (Capoccia et al., 2011; 
Pin et al., 2000). Embryonic knockout or expression of a dominant negative Mist1 
construct leads to pancreatic acinar cells that exhibit a number of defects including 
disorganization of cell structures and loss of polarity, as well as impaired cellular 
communication due to loss of intracellular gap junctions (Jia et al., 2008; Pin et al., 2000; 
Rukstalis et al., 2003; Zhu et al., 2004). Additionally, deletion of Mist1 causes an 
acceleration in Kras-induced development of pancreatic intraepithelial neoplasia, an 
early event observed in mouse models of pancreatic cancer (Shi et al., 2009b). These 
findings identify MIST1 as a critical regulator of pancreatic acinar cell organization and 
function. Recent work has also established that MIST1 may serve to maintain proper 
secretory function in acinar cells. 
 
Intracellular communication via membrane channels is required for proper zymogen 
biosynthesis as well as packaging and secretion in the pancreas (Meda, 1996). 
Additionally, the polarized state of epithelial cells in multi-cell structures is highly 
dependent on effective cell-to-cell communication via intracellular channels (Mellman 
and Nelson, 2008). Recently, a system in which MIST1 expression is induced in a Mist1-
/- animal (effectively a rescue of MIST1 expression, termed LSL-Mist1myc model) was 
used to demonstrate that MIST1 is directly responsible for maintaining intracellular 
communication and coordinated secretion between pancreatic acinar cells (Direnzo et 
al., 2012). This facilitation is accomplished via transcriptional control of Connexin 32 
(Cx32), a protein that forms a functional channel between acinar cells that aids in 
coordination of secretory actions (Figure 1.09a) (Direnzo et al., 2012; Rukstalis et al., 







Figure 1.9 MIST1 is essential for pancreatic acinar cell communication and secretion 
(A) Quantification of connexin 32 aggregates following in Mist1-/- pancreata reveals near 
complete loss of gap junction formation that is rescued upon ectopic expression of 
MIST1. (B) Single cell injection of 6-carboxyfluorescein (6-FAM) into acinar clusters 
indicates that Mist1-/- acinar cells do not communicate via gap junctions, as they are 
unable to pass the dye from cell to cell. (C) Measurement of amylase secretion from 
isolated acinar clusters following administration of cholescystokinin (CCK) demonstrates 
that Mist1-/- acinar cells have significantly less secretion than wildtype or MIST1 rescue 




secretion process necessary for normal digestive processes. The loss of MIST1 impairs 
cell-to-cell communication as demonstrated by fluorescein dye injections of isolated 
acinar clusters from mice (Figure 1.09b). This loss of communication was hypothesized 
to be an underlying cause for the drastic drop in secretory capability seen in MIST1-/- 
animals (Figure 1.09c). In addition to its role in facilitating cell communication and 
coordination within the pancreatic acinus, MIST1 also directly enables successful 
secretory vesicle formation and secretion. 
 
Rescue of MIST1 expression via the previously described LSL-Mist1myc mouse model 
restores the secretory capability of pancreatic acinar cells after being significantly 
diminished when MIST1 expression is limited (Figure 1.09c). Ultrastructural analysis 
reveals that acinar cells lacking MIST1 have decreased secretory vesicle size and 
number, as well as a general lack of apical ER localization and expansion, a similar 
defect as that seen in Xbp1-null pancreatic acini after birth (Direnzo et al., 2012; Lee et 
al., 2005). Bioinformatic screens in mouse models examining MIST1-positive chief cells 
and pancreatic acinar cells have also revealed that MIST1 regulates a subset of genes 
in the RAB protein family, specifically Rab3D and Rab27a (DiRenzo, 2012; Huh et al., 
2010). The RAB3 family and RAB27a are typically associated with mature secretory 
vesicles and may function as sensors for mature vesicles, thus serving as a bridge 
between MIST1 and control of the final stages of exocytosis (Fukuda, 2008). These data 
collectively indicate that MIST1 is transcriptionally linked to the synthesis, packaging, 
trafficking, and coordinated secretion of zymogens in pancreatic acinar cells, making its 
possible actions and mode of regulation during ER stress a prime area for investigation.  
 
1.6 The unfolded protein response and MIST1 both play roles in maintenance and 
recovery of acinar cell identity following damage in the exocrine pancreas 
The mammalian pancreas is initially formed during development as two separate 
outgrowths of the primordial gut tube that merge to form the complete organ (Slack, 
1995). All mature pancreatic cells, including both the endocrine and exocrine linages, 
derive from a common, multi-potent progenitor cell (Figure 1.10, left) (Jensen et al., 











Figure 1.10 Exocrine development in the pancreas involves expression of key 
transcription factors including MIST1 
All pancreatic cells begin as a common progenitor expressing PDX1, SOX9, and HES1. 
The endocrine lineage (lower path) loses expression of SOX9 and HES1 while gaining 
expression of ISL1. These cells eventually initiate unique transcription programs for each 
of the unique endocrine cell types. Exocrine cell differentiation (upper branches) is 
marked by a loss of PDX1, followed by a split into the duct/centroacinar program 
(marked by continued expression of SOX9 in both cases and HES1 in centroacinar cells) 





transcription factors (TFs), including coexpression of pancreatic and duodenal 
homeobox 1 (PDX1), Sry/HMG box transcription factor 9 (SOX9), and active Notch 
signaling components including hairy and enhancer of split-1 (Hes1) (Jensen et al., 
2005). Importantly, this unique progenitor signature is not fully recapitulated in any adult 
cell type in the pancreas.  
 
Developing cells in the pancreas achieve their differentiated state via repression or 
expression of key transcription factors (Figure 1.10). The endocrine lineage includes five 
distinct cell types (α, β, δ, ε, and PP) that upon maturation reside in the pancreatic islets 
of Langerhans (Elayat et al., 1995). Each of these cell types has a unique transcriptional 
program, although early endocrine specification involves continued expression of PDX1, 
loss of SOX9, and expression of insulin gene enhancer protein 1 (ISL1) (Edlund, 2002). 
Differentiated endocrine cells are identified via expression of their secreted products 
including glucagon (α), insulin (β), somatostatin (δ), ghrelin (ε), and pancreatic 
polypeptide (PP) (Elayat et al., 1995). 
 
The mature exocrine lineage is marked by a lack of PDX1 expression and is divided into 
three cell types; duct cells, centroacinar cells, and acinar cells. Duct and centroacinar 
cells continue expression of the progenitor factor SOX9, while centroacinar cells also 
continue to express HES1, leading to the hypothesis that centroacinar cells may be the 
most “stem-like” cell within the pancreas (discussed in section 1.6). Acinar cells are 
specified via coexpression of PTF1a/ RBPJL complex as well as MIST1 (Jensen et al., 
2005; Rooman and Real, 2011). The commitment of most pancreatic lineages to 
specific, terminally differentiated cell identities has prompted extensive discussion as to 
whether a persistent stem cell population exists within the adult pancreas. This question 
is of key importance to the study of human diseases, including pancreatitis, in which 
repair and replacement of damaged exocrine cells in required for proper organ function. 
Attempts to identify and characterize repair mechanisms and specific cell compartments 
that function to restore damaged acinar tissue have often yielded conflicting results. 
 
Damage-responsive cell types exist both outside and within the exocrine compartment 
(Figure 1.11a). Outside of the acinar/duct system, pancreatic stellate cells (PaSCs) are 











Figure 1.11 Pancreatic cells outside the acinar compartment respond to damage  
(A) Pancreatic stellate cells (star-shaped) reside in the peri-acinar space between acini 
and are activated in response to damage. Centroacinar cells are found at the junction 
between acinar and duct cells and are also known to proliferate in response to damage. 
(B) Red dotted line marks a small, pre-cancerous metaplastic duct. 
Immunohistochemical staining for Vimentin reveals both tissue resident (black arrows) 
and damage-responsive (red arrows) pancreatic stellate cells. (C) Anti-HES1 stain 
shows localization of centroacinar cells at the center of a cross-sectioned acinus.  
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(Figure 1.11b) (Omary et al., 2007). PaSCs have been extensively studied, as they 
serve as damage-responsive remodelers of the extracellular matrix. When activated via 
tissue damage, PaSCs undergo a number of phenotypic and molecular changes 
including altered size and shape, increased size and prominence of the ER, and 
expression and secretion of ECM components including collagen I and II and fibronectin 
(Bachem et al., 1998; Omary et al., 2007). Stellate cells are responsible for generating 
new support structures when pancreatic damage results in substantial loss of acinar 
tissue. Extensive development of fibrosis resulting from continued pancreatic damage is 
a feature of many pancreatic tumors, often resulting in impaired treatment effectiveness 
and complications in surgical resection (Garber, 2010). Extracellular remodeling, 
however, is not capable of regenerating damaged tissue nor generating a primary tumor 
mass, thus prompting investigations into which cells repopulate the pancreas following 
injury. 
 
A unique, non-secretory exocrine cell type, termed centroacinar cells (CACs), resides at 
the junction of the acinar lumen and the adjoining ductal network (Figure 1.11c) (Slack, 
1995). These cells have high expression of aldehyde dehydrogenase 1, a known marker 
of stem cells in other organs, as well as a number of ductal genes, often making them 
indistinguishable from normal ducts (Rovira et al., 2010). Interestingly, isolation of CACs 
and subsequent growth in culture results in spontaneous reprogramming and 
differentiation of centroacinar cells into both endocrine and exocrine cell lineages (Rovira 
et al., 2010). Additional research has shown that following damage via pancreatic duct 
ligation, cells within the ductal compartment (including CACs) can give rise to β-cells, an 
endocrine cell type (Wang et al., 1995). This suggests that centroacinar cells may serve 
as multi-potent, tissue-resident stem cells, but their regenerative activity may vary based 
on the means in which damage is induced. 
 
Most exocrine pancreas research focuses on two primary ailments: pancreatitis and 
pancreatic cancer. Pancreatitis is often subdivided into two specific forms; chronic and 
acute. Chronic pancreatitis is most commonly the result of alcoholism or familial 
mutations (Omary et al., 2007; Pandol et al., 2010). Chronic pancreatitis has also been 
linked to development of pancreatic cancer, although this correlation is largely limited to 
patients with an underlying mutation in the cationic trypsinogen gene (PRSS1) (Gao et 
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al., 2012; Hernández-Muñoz et al., 2008). Acute pancreatitis accounts for over 80% of 
diagnosed pancreatitis cases and is most frequently caused by gallstone-triggered 
blockage of the common bile duct or alcoholism (Dufour and Adamson, 2003; Pandol et 
al., 2010). Both chronic and acute pancreatitis have been extensively studied in mouse 
models, and they are both characterized by severe necrosis within the organ as well as 
by extensive localized and systemic inflammatory responses (Su et al., 2006).  
 
Pancreatic cancer (discussed extensively in Chapter 6) has been demonstrated in 
mouse models to be the result of metaplastic conversion of acinar cells into 
precancerous ductal lesions, termed PanINs (Schmid, 2002). This plasticity in acinar cell 
identity (discussed in detail later) is also observed as part of the exocrine damage 
response during recovery from pancreatitis, possibly linking chronic pancreatic injury and 
cancer development. Additionally, chronic pancreatitis has been shown to exacerbate 
PanIN development in KRAS-transformed acinar cells (Guerra et al., 2007). This 
promotion may be linked to stromal and inflammatory interactions with acinar cells, as 
stromal factors allow senescent PanINs to reenter a proliferative cycle and contribute to 
cancer progression (Guerra et al., 2011). As demonstrated above, both pancreatitis and 
pancreatic cancer are associated with acute or long-term acinar distress, conditions 
replicated in the Xbp1fl/fl mouse model. 
 
In order to study the effects of damage on the adult pancreas, multiple experimental 
systems utilizing wild-type mice have been devised. Alcohol-induced pancreatitis can be 
triggered by feeding mice alcohol-enriched diets, although this leads to only mild 
pancreatic damage triggered by oversecretion of the endogenous acinar secretagogue 
cholecystokinin (CCK) from duodenal cells (Su et al., 2006). Diet-induced models in 
which mice are fed choline-deficient chow supplemented with ethionine lead to severe 
necrotizing pancreatitis. This system, however, has a high mortality rate and does not 
resemble the cause or appearance of human disease (Lombardi et al., 1975; Su et al., 
2006). One model that does mimic the changes in acinar structure seen in human 
pancreatitis patients utilizes the CCK analog caerulein (Su et al., 2006). 
 
Caerulein can be administered via a number of techniques, most frequently using an 
intraperitoneal injection. Caerulein induces a supramaximal response in acinar cells, 
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leading to aberrant secretion across the basolateral membrane and into the pancreatic 
interstitial space rather than via the apical membrane into the ductal network 
(Jungermann et al., 1995). This accumulation of zymogens in the periacinar space 
triggers enzyme auto-activation and subsequent proteolytic digestion of the tissue 
(Jungermann et al., 1995). Digestion leads to extensive pancreatic edema, local 
inflammation and necrosis, and increases in serum levels of pancreatic enzymes as 
activated zymogens escape into the bloodstream (Mayerle et al., 2013). 
Advantageously, the damage induced in the caerulein model of pancreatitis is 
completely recoverable despite severe exocrine necrosis, making it ideal for study of 
pancreatic regeneration (Jensen et al., 2005). 
 
Recovery following either disease-driven or experimentally-induced pancreatitis is 
marked by activation of pancreatic stellate cells and subsequent deposition of new 
extracellular matrix (Neubauer et al., 1995). This matrix fills voids left following acinar 
necrosis and must be generated and then extensively remodeled in order to allow 
regrowth of new cells, a task accomplished via coordinated secretion of ECM proteins, 
adhesion molecules, and matrix proteases (Lugea et al., 2006). Drawn out periods of 
injury can impair acinar cell repopulation and encourage continued deposition of 
extracellular stromal and matrix proteins, eventually leading to development of fibrosis 
that remains for the life of the organ (Hernández-Muñoz et al., 2008; Stetler-Stevenson, 
1996). In addition to stimulation of organ repair and remodeling, pancreatic damage also 
induces a rapid change in the transcriptional state of the acinar cells themselves. 
 
Acinar cell damage (either extrinsic as is the case in caerulein-induced pancreatitis or 
intrinsic in the case of activating oncogene expression) results in downregulation of 
acinar differentiation regulators including MIST1 and loss of zymogen expression 
(Figure 1.12a,b) (Rooman and Real, 2011). Acinar cells lacking high expression of 
these differentiation factors have altered duct-like morphology, drastically reduced levels 
of zymogen synthesis, and begin to express duct-restricted genes including the 
transcription factor Sox9 (Figure 1.12b) (Kopp et al., 2012). This transdifferentiation 
from a mature acinar to a more duct-like state is called acinar-ductal metaplasia (ADM) 
and has been demonstrated in mouse models to be an key step in early development of 











Figure 1.12 Loss of acinar characteristics including expression of MIST1 occurs 
following pancreatic damage  
(A) H&E and IHC staining for MIST1 in mice with experimentally-induced pancreatitis. 
Cells undergoing ADM in response to damage (left sides of images) lose expression of 
MIST1, while healthy acinar cells (AC) retain expression. (B) H&E staining of a KRAS-
induced precancerous lesion shows an acinus in which half of the acinar cells have lost 
acinar-like zymogen staining (labeled as “ductal”) while half of the cells retain an acinar-
like appearance. (C) Proposed model for acinar cell plasticity in which damage or stress 
causes a sharp decrease in acinar transcription factors including MIST1. This reduction 
is accompanied by increased expression of ductal genes CK19 and SOX9. Upon 
restoration of homeostasis, cells begin to express MIST1 and return to an acinar 





(Shi et al., 2009b, 2012; Zhu et al., 2007). Cells undergoing ADM also activate 
previously silenced developmental signaling pathways including Notch signaling, 
frequently detected via expression of the HES1 protein (Figure 1.12c) (Rooman and 
Real, 2011). These transcriptional changes are believed to make acinar cells more 
capable of proliferation, a unique state as the adult pancreas is typically regarded as a 
quiescent organ, with unstressed rodents having less than 1% observed acinar cell 
turnover (Oates and Morgan, 1982).  
 
Various techniques have been used to study pancreas regeneration, generating differing 
hypotheses regarding which cell type serves as the source of new acinar cells. In 
support of an acinar origin of regeneration, Jensen and colleagues utilized caerulein-
induced pancreatitis and transcriptional profiling of recovering cells to establish that 
surviving acinar cells repress their terminal differentiation program and activate 
expression of PDX1 as well as activation of both the β-catenin and Notch signaling 
pathways (Jensen et al., 2005). Similar results were seen using Cre-mediated lineage 
tracing and multiple models of injury to investigate pancreatic plasticity, indicating that 
acinar cells in the damaged pancreas dedifferentiate, form a unique duct-like transitional 
state, and then give rise exclusively to new acinar cells (Houbracken et al., 2011; Means 
et al., 2005). Notably, the use of caerulein in these experiments mimicked the acinar 
structural changes seen in human disease but did not represent an endogenous stress, 
as human acinar cells do not respond to caerulein (Ji et al., 2002). 
 
In contrast, work by Esni and others recently utilized a model in which diphtheria toxin 
receptors were expressed exclusively in acinar cells, allowing the selective ablation of 
the entire acinar compartment but sparing the duct and centroacinar cells (Criscimanna 
et al., 2011). In this system proliferative analysis revealed that the ductal/centroacinar 
compartment (which share expression of the SOX9 marker and were thus 
indistinguishable) was responsible for regenerating new acinar cells, also via activation 
of embryonic signaling pathways (Criscimanna et al., 2011). These data indicate that at 
least two distinct mechanisms for acinar repopulation may exist, although the lack of 
inflammatory response in the Esni model may reduce the clinical relevancy of the data. 
Mouse models utilizing endogenous stressors, including ER stress, and that also 
generate tissue inflammation would be ideal for painting a clinically relevant picture of 
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how acinar cells respond to damage. Notably, multiple experimental damage models 
have now demonstrated a correlation between pancreatic injury and activation of the 
unfolded protein response. 
 
The UPR is activated in response to both alcohol- and L-arginine-induced experimental 
pancreatitis (Alahari et al., 2011; Kubisch et al., 2006; Lugea et al., 2011). Pandol and 
colleagues observed that impairment of XBP1 expression (and therefore only the IRE1 
component of the UPR) results in reduced zymogen granule formation, increased 
autophagy, and acinar cell apoptosis (Lugea et al., 2011). This suggests that the IRE1 
branch of the UPR may be a key component of the acinar cell damage response 
program. Interestingly, separate work by Pin and others utilizing Mist1-/- mice in an 
alcohol-induced pancreatitis model demonstrated that the absence of MIST1 leads to 
reduced UPR activity and an increase in pancreatic damage (Alahari et al., 2011). This 
suggests that MIST1 may be regulating acinar cell damage responses, a hypothesis 
recently confirmed in unpublished work by the Konieczny group showing that 
misregulation of MIST1 expression in a caerulein-induced pancreatitis model can trigger 
extensive acinar cell death. Indeed, given the extensive role that MIST1 plays in normal 
secretory function as well as its emerging role in mitigating exocrine damage, 
investigations as to whether MIST1 is a component of the pancreatic acinar cell UPR are 
warranted. 
 
In this study, an acinar cell-specific, Cre-inducible Xbp1 ablation model 
(Mist1Cre/+;Xbp1fl/fl) was used to investigate the role of XBP1 in maintaining homeostasis 
in pancreatic acinar cells. Specifically, targeted gene ablation was used to investigate 
the effects of XBP1 on acinar cell viability. Additionally, cells still expressing XBP1 in the 
pancreas were characterized following ER stress-induced organ damage as a means to 
study pancreatic proliferative and regenerative mechanisms. Finally, in vitro cell culture 
systems were used to investigate whether MIST1 is a direct target of XBP1 as well as its 









CHAPTER 2. MATERIALS AND METHODS 
2.1 Mouse strains 
Xbp1fl, Mist1CreER, Rosa26LacZ, LSL-KrasG12D, and Mist1Kras mouse lines have all been 
described previously (Habbe et al., 2008; Hetz et al., 2008; Jackson et al., 2001; 
Soriano, 1999; Tuveson et al., 2006). All mice were maintained on a C57Bl/6 
background. Mouse experiments were conducted with approval and in accordance with 
PACUC regulations. Mouse euthanasia was conducted via CO2 asphyxiation followed by 
cervical break.  
 
2.2 Mouse genotyping 
Mouse tail tips were harvested at post-natal day 21 in accordance with PACUC 
regulations. Tail tips were digested in tail lysis buffer supplemented with 0.2 mg/mL 
Proteinase K overnight at 56°C. Digested material was centrifuged for 10 minutes at 
14,000 x g to remove tail debris. DNA isolation was accomplished via isopropanol 
precipitation of supernatants followed by washing of DNA pellets in 70% ethanol and 
subsequent resuspension in 100 μL of TE buffer at 65°C.  
 
PCR genotyping using 1 μL of tail DNA was performed using standard protocols 
provided with the Mango Taq PCR system (BIO-21083, Bioline, Taunton, MA). PCR 
conditions included 35 cycles of 94°C for 30 seconds, 65°C for 90 seconds, and 72°C for 
60 seconds. Tissue isolation and PCR conditions were identical for genotyping and for 
monitoring DNA recombination events. Primers for both types of reactions are listed in 
Table 2.01.  
 
2.3 Tamoxifen administration for Cre-mediated induction 
Tamoxifen (T5648, Sigma, St. Louis, MO) solution was prepared to a final concentration 
of 20 mg/mL in corn oil (C8627, Sigma, St. Louis, MO), then placed in a scintillation vial 








Table 2.1 Primer list for mouse genotyping and detection of recombination 
 
Genotyping Primers 
Transgene Forward Reverse Band Size (bp) 
Xbp1fl/+ 5'-acttgcaccaacacttgccatttc-3' 5'-caaggtggttcactgcct-3' WT=141 
FL=183 
Mist1CreER * 5'-ggttaaagcaaattgtcaagtacgg-3' 5'- atagtaagtatgtgcgtcagcg-3' WT=750 
5'-gaagcattttccaggtatgctcag-3' Cre=520 
Rosa26LacZ * 5'-gcgaagagtttgtcctcaacc-3' 5'- ggagcgggagaaatggatatg-3' WT=650 
5'-aaagtcgctctgagttgttat-3' LacZ=350 
LSL-
KrasG12D 5'-tctgaattagctgtatcgtcaagg-3' 5'-gtcgagggacctaataacttcgta-3' KR=500 
Mist1Kras * 5'-aggtgtccactaagcaccagt-3' 
5'ctggaaggcattgttgagttt-3' WT=449 
5'gctccaaccaccacaagttta-3' KR=200 
Recombination Primers  
Allele Forward Reverse Band Size (bp) 
Xbp1WT 5'-ttgggactctctcgtgtg-3' 5'-caaggtggttcactgcct-3' 1682 
Xbp1ΔEx2 5'-tggccacgtctacaaatgaa-3' 5'-caaggtggttcactgcct-3' 997 







tamoxifen via intraperitoneal injection into the left side to initiate nuclear Cre localization. 
Total volume of injected tamoxifen was 200 μL, for a total tamoxifen delivery of 4 mg. 
Mice were injected three times 24 hours apart, with the second injection set to time zero 
for experimental timings. 
 
2.4 Tissue section preparation, immunohistochemistry, and immunofluorescent 
staining 
For paraffin embedding, isolated tissues were placed in 10% neutral buffered formalin 
for overnight fixation following necropsy. Tissues were then dehydrated in a graded 
ethanol series proceeding from 70% to 100% ethanol before final dehydration in xylenes 
and embedding in paraffin using an automated tissue processor (Citadel 1000, Thermo 
Scientific, Waltham, MA). Tissues were subsequently embedded in paraffin blocks, and 
a microtome was used to generate 5 μM thick sections that were placed on charged 
microscope slides and heated to 40°C to ensure adherence to the glass. 
 
For cryo-preserved tissues, isolated tissues were placed in a 4% paraformaldehyde/PBS 
solution for 1 hour at 4°C followed by transfer and gradual dehydration in a 30% sucrose 
solution for 4 hours at 4°C. Tissues were embedded in O.C.T. (4583, Sakura, Torrance, 
CA) in plastic tissue molds before snap freezing via placement of the molds into 2-
methylbutane (78-78-4, Alfa Aesar, Ward Hill, MA) cooled in liquid nitrogen. Cryo blocks 
were stored at -20°C before sectioning via cryostat, with 5 μM sections placed on 
charged slides and stored at -80°C for subsequent staining. 
 
Deparrafinization of tissue sections was accomplished by passing tissues from xylenes 
through a decreasing percentage of ethanol baths (2X 100%, 2X 95%, 1X 70%, 1X 50%) 
before final washing in distilled water. General histological analysis was accomplished 
via standard hematoxylin (47199-010, Lerner Labs, Pittsburgh, PA) and eosin (41799-
028, Lerner Labs, Pittsburgh, PA) staining on deparaffinized tissue sections. Collagen 
staining was performed by incubating deparaffinized sections with Sirius red stain 
(365548, Sigma, St. Louis, MO) for 1 hour at room temperature followed by two washes 
in acidified water (0.5% glacial acetic acid in distilled water). X-gal staining for β-
galactosidase activity was performed on cryo sections that were thawed for 5 minutes at 
room temperature before fixing with 10% neutral buffered formalin for 10 minutes and 
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incubation in X-gal staining solution (1 mg/mL X-Gal, 5 mM potassium ferricyanide, 5 
mM potassium ferrocyanide, 2 mM MgCl in PBS) at 37°C for six hours. Paraffin sections 
were counterstained with hematoxylin while cryo sections were counterstained with 
nuclear fast red (H-3403, Vector Labs, Burlingame, CA). 
 
Immunohistochemistry (IHC) and immunofluorescence (IFC) staining was performed on 
deparaffinized sections following antigen retrieval in antigen unmasking solution (H-
3300, Vector Labs, Burlingame, CA) that was heated in a 2100-Retriever (PickCell 
Laboratories, Amsterdam, The Netherlands). Sections were then blocked using the 
MOM blocking reagent (BMK-2202, Vector Labs, Burlingame, CA) for one hour. Primary 
antibodies were diluted in MOM protein diluent and placed on sections for 1 hour at 
room temperature or overnight at 4°C. Secondary biotin-conjugated antibodies were 
then incubated with the sections for ten minutes. For IHC, Vectastain ABC reagent (PK-
7100, Vector Labs, Burlingame, CA) was incubated on the sections for 1 hour at room 
temperature before development via Immpact DAB peroxidase substrate (SK-4105, 
Vector Labs, Burlingame, CA). For IFC, tertiary, avidin- and fluorescent-group 
conjugated antibodies were incubated with sections for 5 minutes along with DAPI. 
Following final staining/developing, IHC slides were passaged through baths of 95% 
ethanol, 100% ethanol, and xylenes and mounted using Vectamount (H-5000, Vector 
Labs, Burlingame, CA) while IFC slides were directly mounted using Vectashield Hard-
mount Media (H-1400, Vector Labs, Burlingame, CA). Primary and secondary antibody 
information is provided in Table 2.02. 
 
Analysis of images was performed using ImageJ with the cell counter plugin. All 
statistical analyses on cell and nuclear counts utilized a student’s T-test with a 
significance threshold of 95%. 
 
2.5 Electron microscopy 
Harvested pancreata were fragmented and fixed in 3% paraformaldehyde/0.5% 
glutaraldehyde in PBS. Samples were dehydrated via graded ethanol series and 






Table 2.2 Primary and secondary antibodies used 
 
Antigen Dilution Company Cat # 
Amylase  1:100 Calbiochem, San Diego, CA 171534 
Amylase  1:1000 Santa Cruz Biotechnology, Santa Cruz, CA sc-12821 
β-gal 1:300 Novus Biologicals, Littleton, CO NB100-65209 
Chop  1:500 Cell Signaling, Boston, MA 2895S 
CPA  1:1000 AbD Serotec, Raleigh, NC 1810-0006 
E-Cadherin  1:1000 Abcam, Cambridge, MA ab53033 
Erk1/2 1:1000 Cell Signaling, Boston, MA 9102S 
Glucagon  1:100 Dako, Carpinteria, CA A0565 
Hes1 1:1000 Gift of Tetsuo Sudo ----- 
K19  1:100 Dev. Studies Hybridoma Bank, Iowa City, IA Troma3 
Ki67  1:500 Dako, Carpinteria, CA M7249 
LC3B  1:200 Cell Signaling, Boston, MA   3868S 
Mist1  1:500 Pin et al, 2000 C175 
nATF6a 1:1000 Santa Cruz Biotechnology, Santa Cruz, CA sc-22799 
p38 1:1000 Cell Signaling, Boston, MA 9212S 
p-eIF2a 1:1000 Cell Signaling, Boston, MA 3597S 
p-Erk1/2 1:1000 Cell Signaling, Boston, MA 9101S 
pH3  1:100 Upstate (Millipore), Billerica, MA 06-570 
S6 1:1000 Santa Cruz Biotechnology, Santa Cruz, CA   sc-74459 
Sox9 1:500 Millipore, Billerica, MA AB5535 
Avidin (Alexa 
594) 1:200 Invitrogen S-11227 
Avidin (Oregon 
Green) 1:200 Invitrogen S-6368 
Mouse (2°) 1:200 Vector BA-9200 
Rabbit (2°) 1:200 Vector BA-1000 





were taken of 100 nM ultra-thin sections on a Phillips CM-100 (Philips, Andover, MA) 
electron microscope with the assistance of Dr. Barbara Damsz. 
 
2.6 RT-qPCR 
Pancreatic RNA was isolated following initial harvesting of a small tissue piece for 
histology. PBS was then injected into the left ventricle of the heart to clear the tissues of 
blood and plasma fluids. A 1 mm3 fragment of pancreatic tissue was then excised and 
harvested following homogenization with a Tissue Tearor (985-370, Biospec Products, 
Bartlesville, OK) using the Total RNA Kit 1 (R6664-02, Omega Biotek, Norcross, GA). 
Isolated RNA was converted to cDNA using the iScript cDNA synthesis kit (170-8891, 
Bio-Rad, Hercules, CA). Real-time PCR was performed using FastStart Universal SYBR 
Green (04913914001, Roche, Indianapolis, IN) in an ABI 7300 Real-Time PCR System 
(Applied Biosystems, Foster City, CA). PCR conditions involved 40 cycles of 95°C for 30 
seconds, 59°C for 60 seconds, and 72°C for 30 seconds. Relevant Ct data were 
generated using the ABI 7300 software package followed by analysis using the 2-ΔΔCT (or 
ΔΔCT) method in which all values were normalized first to 18s expression levels as an 
internal control and then renormalized to a control biological sample for fold analysis. 
 
2.7 Cell Culture 
Cell culture experiments were conducted using mouse 266-6 pancreatic acinar cells 
(CRL-2151, ATCC, Manassas, VA) and primary mouse embryonic fibroblasts (MEFs). 
Wild-type MEFs were obtained from the Purdue University Transgenic Mouse Core 
Facility following isolation from harvested embryos and a single passage in 2D culture. 
Xbp1KO MEFs were a generous gift from Dr. Ann-Hwee Lee at Harvard University. 
 
266-6 cells were cultured in high-glucose Dulbecco’s Modified Eagle Medium (hgDMEM) 
supplemented with 10% fetal bovine serum (FBS) and 1% Pen/Strep antibiotic solution 
(15140-122, Invitrogen, Grand Island, NY). MEFs were grown in hgDMEM 
supplemented with 10%FBS, 0.5% Pen/Strep, 1% L-Glutamine, 1% non-essential amino 






Table 2.3 Primers used for RT-qPCR. All sequences are for mouse transcripts 
 
  Forward Primer Reverse Primer 
18S 5'-tgtctcaaagattaagccatgc-3' 5'-gcgaccaaaggaaccataac-3' 
Amylase 5'-cagagacatggtgacaaggtg-3' 5'-atcgttaaagtcccaagcaga-3' 
Arcn1 5'-agcagctttcccaaaactca-3' 5'-tcctctaaggctcggcaata-3' 
Arfgap3 5'-tttgactgtggtgccaaaaa-3' 5'-ttgagttccctccaacttgc-3' 
Atp2a2 5'-aaaccttgctggaacttgtga-3' 5'-ccacgattgcattggctac-3' 
Bip  5'-gtgtcctctctggtgatcagg-3' 5'-tgtcttttgttaggggtcgtt-3' 
Chop  5'-cctgaggagagagtgttccag-3' 5'-cagatcctcataccaggcttc-3' 
Dnajb9/ERdj4 5'-ccccagtgtcaaactgtaccag-3' 5'-agcgtttccaattttccataaatt-3' 
Dnajc1 5'-gacctggagttgttcgacttg-3' 5'-tgagtttgtgcattttcatcttt-3' 
Dnajc3 5'-ccgacgccttatcacagttt-3' 5'-aagtccatcttcagcgcaat-3' 
Edem3 5'-agcgtcatggagcctggt-3' 5'-gttgccataagcatgatcaaa-3' 
Elastase 5'-actatgtccagctgggtgttc-3' 5'-cagtaagaggagctggagcag-3' 
Gli1  5'-tttcttgaggttgggatgaag-3' 5'-ggtggagtcattggattgaac-3' 
H47 5'-gcagagcagagaggagcag-3' 5'-agctgtctctgcctcaaagc-3' 
Hes1 5'-agagaaggcagacattctgga-3' 5'-gtcacctcgttcatgcactc-3' 
Htra2 5'-cattggagtgatgatgctgac-3' 5'-aatggccaagatcacatcac-3' 
Mist1 5'-tggtggctaaagctacgtgt-3' 5'-catagctccaggctggtttt-3'   
Nestin  5'-gagagtcgcttagaggtgcag-3' 5'-gatctgagcgatctgactctgt-3' 
Os9 5'-ggtccaaatgtgatctcaacg-3' 5'-ggtcagtacgtaggagcagga-3' 
Pdi1  5'-caagatcaagccccacctgat-3' 5'-agttcgccccaaccagtactt-3' 
Piga 5'-gacccatttaggaggcatga-3' 5'-tggtccctctcctccaatta-3' 
Ppib 5'-gcgcaatatgaaggtgctct-3' 5'-ttccaaagagtccaaagacga-3' 
Ppp1r15b 5'-tcttgtaaggcccagctgtt-3' 5'-gccaatggcaacttctgttt-3' 
Reg1 5'-atggctaggaacgcctacttc-3' 5'-cccaagttaaacggtcttcagt-3' 
Rrbp1 5'-gctgccaatcagggtaaaaa-3' 5'-gcttccaaccgtagagacca-3' 
Sec11c 5'-aaggcctgattgttctcacg-3' 5'-tcggaatgtctcttccttcaa-3' 
Sec61a  5'-ctatttccagggctccgagt-3' 5'-aggtgtgtactggcctcggt-3' 
Sec61b 5'-atccactgttcggcagag-3' 5'-cagcagcgatgaacagaaga-3' 
Serp1 5'-agaaaaggcgtcggtaggac-3' 5'-cacatgcccatcctgatactt-3' 
Sox9 5'-cttctgtgggagcgacaactt-3' 5'-agggagggaaaacagagaacg-3' 
Spcs2 5'-ggatgactctgccaaaaagg-3' 5'-ctggcttggactcaggaaag-3' 
Spcs3 5'-aactccctgttcgccttctc-3' 5'-tgtgatgaatcccaggtcac-3' 
Ssr3 5'-cctgctccttcaggatttca-3' 5'-cattcttgtacgcgaaggcta-3' 
Uso1 5'-cgcttagaagtgggaatcca-3' 5'-gagtgacattttctggctgct-3' 
Xbp1ΔEx2  5'-agaaagcgctgcggagaac-3' 5'-cctccacctctggaacctc-3' 
Xbp1s  5'-tgagtccgcagcaggt-3' 5'-agagaaagggaggctggtaag-3' 




ER stress induction was achieved via treatment with either 500 nM thapsigargin (T9033, 
Sigma, St. Louis, MO), 2.5μM tunicamycin (654380, EMDMillipore, Billerica, MA), or 
5mM dithiothreitol dissolved in DMSO. DMSO alone was used as a control vehicle. 
 
2.8 Generation of shCtrl, shXbp1, and shMist1 viruses and cell lines 
Lentiviral plasmids (pLKO.1 backbone) were obtained from Sigma-Aldrich (St. Louis, 
MO) containing validated sequences for silencing of XBP1 or MIST1 as well as a control, 
non-targeting shRNA (sequences in Table 2.04). The plasmids were grown up in DH5α 
cells, mini-prepped, and transfected along with viral packaging plasmids in 293T cells.  
 
Table 2.4 Sequences of shRNA plasmid constructs against mouse transcripts 
 
Name Sequence Target 
shXbp1 5'CCGGCCATTAATGAACTCATTCGTTCTCGAGAACGAATGAGTTCATTAATGGTTTTT-3' 3' UTR 
shMist1 5'CCGGCGGATGCATAAACTCAACAATCTCGAGATTGTTGAGTTTATGCATCCGTTTTT-3' CDS 
shCtrl 5'CCGGCAACAAGATGAAGAGCACCAACTCGAGTTGGTGCTCTTGTTGTTTTT-3' N/A 
 
The transfected cells were allowed to synthesize virus for 24 hours before having 
supernatants collected at 12 hour intervals for 3 days (24 through 72 hours post-
transfection). Supernatants were then spun at 25,000 x g for two hours and pellets were 
resuspended in 1 mL of TNE buffer (50 mM Tris-HCl – pH 7.4, 100 mM NaCl, 0.1 mM 
EDTA) and stored in 200 μL aliquots at -20°C.  
 
To infect new cells, a 70% confluent 10cm plate of 266-6 cells was treated with a 
solution consisting of 2 mLs complete hgDMEM, 10 μg/mL polybrene, 10 mM HEPES, 
and 200 uL of thawed viral aliquot. Cells were given 24 hours to become infected before 
media was replaced with selection media consisting of complete hgDMEM with 1.0 
μg/mL puromycin added. Complete control (uninfected) cell death was achieved in 
puromycin selection within three days, with virally infected cells being passaged twice to 





2.9 Luciferase assays 
Mist1-promoter luciferase vectors were generated by Dr. Jeff Ishibashi using the pBRIT-
PURO viral backbone. 266-6 cells were transfected using standard protocols for PEI 
(polyethyleimine) (23966-2, Polysciences Inc., Warrington, PA) transfections. Briefly, this 
involved seeding 6 cm plates with 266-6 cells to 70% confluence. Transfection mixes 
contained 400μL serum-free, antibiotic-free hgDMEM at room temperature, 1.5 μg each 
of Mist1pr-luc vector and pBRIT-Xbp1s or pBRIT PURO control, 2 ng Renilla luciferase 
expressing vector (for internal control purposes), and 9 μL PEI (1 μg/μL stock). Mixes 
were created and allowed to incubate at room temperature for 15 minutes, then added 
dropwise to a culture dish in which the cells had been washed three times in media to 
remove any secreted growth factors. Cells were incubated for 48 hours before being 
harvested in passive lysis buffer (E194A, Promega, Madison, WI) and analyzed using 
the Luciferase Assay System (E1501, Promega, Madison, WI) and Renilla Luciferase 
Assay System (E2820, Promega, Madison, WI). 10 μL of each supernatant was added 
to both luciferin-containing and coelenterazine-containing glass vials (with each in its 
respective buffer from the Promega kits). Luminescence readings were obtained using a 
Lumat luminometer (LB9501, Berthold, Oak Ridge, TN). Luciferin luminescence values 
were normalized to coelenterazine luminescence values via simple division as an 
internal control, as all samples had the same amount of Renilla plasmid added at time of 
transfection.  
 
2.10 Bioinformatic analysis of candidate MIST1 effectors 
Generation of the initial list of candidate MIST1 effectors was accomplished via analysis 
of pooled data from multiple sources including: ChIP-Seq data generated from Mist1WT 
mice in collaboration with Dr. Raymond MacDonald at UT Southwestern (unpublished), 
microarray data from a Mist1 rescue mouse panel (Direnzo et al., 2012), a mouse UPR-
specific PCR array (PAMM-089, SA Biosciences, Valencia, CA), published gene lists 
reporting secretory genes associated with XBP1- and nATF6-transfected NIH3T3 
fibroblasts (Bommiasamy et al., 2009; Sriburi et al., 2007), and microarray data from 
tunicamycin-treated Ire1KO liver samples (So et al., 2012).  
 
Selection criteria for candidate genes initially involved selection of all general UPR and 
secretion-specific UPR genes available from the previously listed sources, generating a 
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184 candidates. These candidates were analyzed for ChIP enrichment (see Appendix A) 
using the MochiView software suite (Homann and Johnson, 2010). This eliminated 65 
candidates that had no MIST1 enrichment within the target gene’s promoter or first two 
exons/introns. We then used sequence analysis on the 500 base pair regions 
surrounding ChIP enrichment sites in the remaining genes and scanned for the presence 
of GC or TA E-boxes, known DNA binding sites for MIST1. We eliminated genes with no 
detectable E-boxes. We then analyzed the resulting genes via utilization of microarray 
data previously generated by Dr. Daniel DiRenzo that detected the relative gene 
expression differences between Mist1WT, Mist1KO, and Mist1KO;LSL-Mist1myc transgenic 
mice. These animals expressed a Mist1 transgene in a Mist1KO background for 36 hours 
prior to RNA harvesting, thus allowing us to determine whether expression of any of the 
candidate effectors was significantly altered in Mist1KO acinar cells and fully or partially 
rescued upon Mist1myc expression (see Appendix B). By restricting our search to genes 
that displayed expression changes upon MIST1 expression, we reduced our list of 
possible targets to 54 candidates. As a final refining step, we checked our candidates 
against published microarray data (available in the NCBI Geo repository) analyzing WT 
and Ire1KO liver samples treated with tunicamycin. We then grouped the remaining list of 
candidate effectors based on ChIP-Seq enrichment, expression levels after MIST1myc 
expression, and demonstrated significance in ER stressed, IRE1KO liver samples. This 
final list of candidate effectors contained 15 high-scoring genes, and we chose 6 
additional effectors missing a single criteria but with highly significant ChIP enrichment 
or expression changes upon rescue. These genes are listed in Table 5.02, with a 
summary diagram of the selection criteria in Figure 5.08. All genes are shown in 
Appendices A-D with relative ChIP enrichment scores (Appendix A,B) and Mist1 rescue 











CHAPTER 3. XBP1 IS A NECESSARY COMPONENT OF THE PANCREATIC 
ACINAR CELL UNFOLDED PROTEIN RESPONSE 
3.1 Introduction 
Studying the unfolded protein response (UPR) requires consideration of a number of 
factors regarding cell type and function. As previously described, all cells utilize 
secretory pathways in some fashion, typically via constitutive secretion of membrane 
and extracellular matrix (ECM) components (Burgess and Kelly, 1987). Constitutively 
secreted proteins typically mature extensively in the Golgi, often requiring substantial 
modification including glycosylation of N-terminal protein signals, phosphorylation, 
sulfation or hydroxylation of specific residues, and early proteolytic processing steps 
(Mains et al., 1987). Constitutive secretion, however, generates vesicles with low protein 
titers, placing little stress on the ER/Golgi machinery and leading to low UPR activation 
(Grampp et al., 1992). As such, non-secretory cells typically have a reduced UPR 
activity and are not ideal models for studying UPR regulation. 
 
One exception to reduced protein throughput being a characteristic of non-secretory 
cells is during development, when secreted protein families, including the bone 
morphogenetic proteins (BMPs), are essential to proper body planning (Hogan, 1996). 
Additionally, gene-trap experiments targeted specifically to secreted and transmembrane 
proteins have demonstrated the importance of secreted proteins and an intact secretory 
pathway during development (Mitchell et al., 2001). However, embryonic knockout 
studies utilizing a compound knockout of Atf6α/β or deletion of Ire1/Xbp1 result in 
embryonic lethality, making developmental systems difficult to utilize in the investigation 
of the UPR (Lee et al., 2005; Reimold et al., 2000; Yamamoto et al., 2007). Therefore, 
an ideal experimental system for UPR research should utilize an inducible mechanism 
for ablation or activation of necessary UPR components. Such a system must also utilize 
a cell type that relies upon the UPR in order to observe any changes in cell phenotype 




Non-secretory cell types, including the NIH3T3 fibroblast cell line, have been used to 
bioinformatically analyze the effects of Xbp1s via transfection studies. As summarized in 
Table 3.01, XBP1s transfection results in expression of target genes associated with 
nearly every step in the secretory pathway (see Figure 1.04 for matching classifications 
of XBP1 target genes) (Sriburi et al., 2007). This data illustrates the importance of XBP1 
in driving cellular responses to ER stress. The exact means by which XBP1 controls 
homeostasis in secretory cells has been difficult to study, owing to a lack of normal 
secretory cell systems and the previously described lethality of Xbp1-knockout mice. 
 
Dedicated secretory cells are typically polarized, thus requiring extensive interaction of 
the endo- and exocytic pathways, cytoskeletal regulatory mechanisms, and the secretory 
machinery (Deitcher, 2002). Exocrine cells therefore make extensive use of the UPR 
both during secretion and in the basal state. In situ hybridization analysis of developing 
mouse embryos revealed extensive Xbp1 mRNA expression in osteoblasts and exocrine 
glands (Clauss et al., 1993). This data also indicated that Xbp1 expression peaks at 
E14.5, suggesting a developmental role for XBP1 outside of its role in the UPR (Clauss 
et al., 1993). However, follow up studies utilizing XBP1s reporter mice established that 
XBP1 is constitutively expressed and spliced in the adult pancreas, indicating that a 
basal level of UPR activity is maintained there, making it ideal for studying the 
IRE1/XBP1 branch (Iwawaki et al., 2004).  
 
XBP1 is of key interest in the study of pancreatic disease and cancer. Impaired 
expression via hemizygous gene deletion in mice demonstrated that XBP1  
specifically protects the exocrine pancreas from alcohol-induced damage (Lugea et al., 
2011). This is particularly interesting as alcoholism is a known risk factor. 
Pharmacological inhibitors of Xbp1 splicing with standard chemotherapeutics has shown 
synergistic effects in halting the growth of multiple myeloma cells (Mimura et al., 2012). 
for development of chronic pancreatitis, possibly linking XBP1 and pancreatic disease 
(Dufour and Adamson, 2003). XBP1 may also play a role in tumorigenesis, as transgenic 
models have revealed a positive correlation between rates of XBP1 splicing and tumor 
cell growth, indicating a possible avenue for new therapeutics (Spiotto et al., 2010). This 
development would be particularly important, as pancreatic ductal adenocarcinoma   
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1. Targeting and translocation 
Signal recognition particle Srp9, Srp19, Srp54a, Srp68, Srpr, Srprb  
Signal sequence receptor Ssr1, Ssr2, Ssr3, Ssr4  
Translocon Sec61a1, Sec61b, Sec61g, Sec63, Tram1  
Signal peptidase Spcs2, Spcs3, Sec11a, Sec11c 
2. N-linked glycosylation 
Core oligosaccharide synthesis Alg2, Alg12, Mgat2  
Oligosaccharyltransferase Ddost, Dad1, Rpn1, Rpn2  
Oligosaccharide processing Mogs 
3. Facilitation of protein folding 
Chaperones 
Dnajb2, Dnajb9, Dnajb11, Dnajc1, Dnajc10  
Fkbp1b, Fkbp2, Fkbp7, Fkbp10, Fkbp11, Fkbp14  
Hspa5, Hspa13, Hsp90b1, Hyou1, Ppib 
Disulfide bond formation Ero1lb, Erp29, Erp44, Pdia3, Pdia4, Pdia6, Selm, Txndc5, Txndc11  
ER-associated degradation  Derl1, Edem1, Herpud1, Syvn1  
4. Vesicular trafficking and transport 
Anterograde transport 
(ER→Golgi)   
        COPII vesicles Sec23a, Sec23b, Sec24d, Sec31a, Yipf5, Yif1a  
        Cargo receptors Lman1, Mcfd2  
        SNAREs Bet1, Betl1, Sec22b  
Retrograde transport (ER←Golgi)   
        COPI vesicles Arcn1, Arfgap3, Copb1, Copb2, Cope, Copg, Copz1  
        Cargo receptors Kdelr2, Kdelr3, Lman2  
Transport/recycling in the Golgi Blzf1, Cog3, Cog6, Gosr2, Rab33b, Uso1  
Exocytosis   
        SNAREs Stx5a, Stx18, Vamp2, Vamp4, Vamp7  
        Small GTPases Rab3a  
5. Others 
ER proteins 
Atf6, Atp2a2, Bfar, Creb3, Creb3l1, Crebl1, 
Dolpp1, Eif2ak3, Ggcx, H13, Hmox1, Lepre1, 
Ormdl3, Rrbp1, Rcn3, Piga, Sdf2l1, Surf4, Wfs1 
Golgi proteins Golga3, Golga4, Golgb1, Gcc1, Golph3, Golph3l, Gopc, Gorasp2, Rabac1 
 
Table 3.1.  XBP1 target genes are involved in multiple steps of normal protein 
synthesis and degradation in the ER 
Transfection of XBP1s in NIH3T3 fibroblasts results in expression of genes associated 
with facilitation of secretory protein synthesis (diagrammed in Figure 1.04).  
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(PDA) has a dismal 6% 5-year survival rate due in large part to ineffective 
chemotherapeutics (Siegel et al., 2013). In fact, recent pre-clinical work combining  
 
Initial studies utilizing Xbp1-/- mice demonstrated that complete knockout of the gene is 
embryonic lethal, although liver-specific expression of an Xbp1 transgene (Xbp1-/-
;LivXbp1) allows mice to survive into neonatal development (Lee et al., 2005). As shown in 
Figure 3.01, Xbp1-/-;LivXbp1 mice die due to pancreatic insufficiency, an expected finding 
given previous data showing that XBP1 is required for initial development of the exocrine 
secretory machinery and that pancreatic acinar cells have the highest protein production 
level of any human secretory cell (Case, 1978; Lee et al., 2005). Interestingly, recent 
work utilizing an inducible XBP1-knockout model in gastric chief cells demonstrated that 
XBP1 was required for expression of the key differentiation marker MIST1, a basic helix-
loop-helix transcription factor also expressed in differentiated pancreatic acinar cells 
(Huh et al., 2010). However, our analysis of Xbp1-/- post-natal pup pancreata revealed 
sparse acini with that surprisingly still expressed MIST1 despite lacking Xbp1 (Figure 
3.01c, right panel). This indicates that the regulation of XBP1 target genes, and 
possibly the determinination as to whether a gene is actually a target, is likely cell-type 
dependent. These data prompted us to study whether XBP1 is essential for acinar cell 
UPR activation and homeostasis in the adult pancreas. 
 
In this study, we addressed the issue of Xbp1 knockout lethality via generation of an 
acinar cell-specific, Cre-inducible mouse line. Our work has demonstrated that acinar-
specific Xbp1 ablation results in a gradual onset of ER stress and activation of the PERK 
and ATF6 components of the UPR. Furthermore, the activities of the PERK and ATF6 
branches are unable to restore normal protein throughput levels in acinar cells, resulting 
in visible distress including loss of ER staining and integrity, accumulation of autophagic 
vesicles, and decreased acinar cell zymogen synthesis. The loss of Xbp1 eventually 
leads to apoptotic cell death approximately four weeks after ablation. These findings 
demonstrate that XBP1 is an essential component of the pancreatic acinar cell UPR, and 





Figure 3.1 Xbp1-/-;LivXbp1 mice have malformed pancreata with sparse acini and 
patchy expression of MIST1 
(A) Xbp1-/-;LivXbp1 mice (bottom) die during post-natal development and are substantially 
smaller than wild-type counterparts (top). (B) Wild-type pancreata at 10 days post-natal 
development have substantial zymogen accumulation (left image, pink staining) with 
strong expression of MIST1 (right image). (C) Xbp1-/-;LivXbp1 pancreata have reduced 
zymogenic staining with reduced numbers and size of acinar cells (left image and inset) 




3.2 Generation and testing of Mist1CreER/+; Xbp1fl/fl mice 
The goal of this work was to generate a mouse line that would facilitate acinar-specific 
ablation of Xbp1 in the adult pancreas. This system allows the study of XBP1 as a 
component of the UPR in fully developed, wild-type acinar cells. Two established lines 
were crossed to generate a CreERT2-mediated system allowing ablation of Xbp1 via simple 
intraperitoneal (i.p.) injection of tamoxifen. 
 
An established mouse line, termed Xbp1fl/fl, was obtained from Dr. Laurie H. Glimcher at 
Harvard University in order to effectively study inducible Xbp1 ablation. The Xbp1fl/fl 
mouse line was originally generated in the Glimcher lab by Dr. Ann-Hwee Lee and is 
diagrammed in Figure 3.02a/b (Hetz et al., 2008). The wild-type Xbp1 gene (responsible 
for producing the Xbp1u transcript that can be spliced to Xbp1s) has five exons, with the 
DNA-binding and leucine zipper spanning exons 2 and 3 and the 26nt splice site located 
in exon 4 (Figure 3.02a/b). Two loxP sites flanking exon 2 were engineered via standard 
techniques to generate the Xbp1fl/fl line. Upon Cre-mediated recombination, exon 2 is 
excised, resulting in transcription of a modified mRNA transcript that no longer encodes 
active XBP1s (Hetz et al., 2008). Importantly, despite being unable to be translated into 
a functional protein, the Xbp1fl transcript still contains the intact 26nt splice site, allowing 
the monitoring of IRE1-dependent splicing, and thus UPR activity, via RT-qPCR with 
splice-specific primers (Hetz et al., 2008). This construct was then paired with an acinar 
cell-specific Cre recombinase line generated in the Konieczny lab. 
 
The Mist1CreERER line was designed by Dr. Guanglu Shi in collaboration with the Purdue 
Transgenic Mouse Core Facility (Figure 3.02c) (Shi et al., 2009b). Briefly, homologous 
recombination and embryo injection of ES cells were used to generate a knock-in mouse 
line in which the coding sequence of the Mist1 gene was replaced with a new sequence 
encoding the Cre-ERT2 fusion protein at the endogenous Mist1 locus. This fusion protein 
is a standard Cre-recombinase fused to a tamoxifen-sensitive mutant human estrogen 
receptor that forces cytoplasmic localization of the recombinase (Feil et al., 1997). The 
modified estrogen receptor is bound to the recombinase and prevents its nuclear 
localization until tamoxifen (typically administered to the animal via i.p. injection or oral 











Figure 3.2 Schematic of transgenes used in creation of the Mist1CreER/+; Xbp1fl/fl; 
R26LacZ mouse line  
(A) Schematic of the normal Xbp1 locus, with boxes representing translated exons. The 
DNA-binding, basic leucine zipper (bLZ, yellow) domain spans exons 2 and 3, while the 
IRE1-dependent splice site (red) is in exon 4. (B) Schematic of the Xbp1flox (Xbp1fl) locus 
with loxP sites flanking exon 2 at the endogenous Xbp1 locus. (C) Schematic of the 
Mist1CreERER (Mist1CreER) transgene that was knocked into the endogenous Mist1 locus. 
(D) Schematic of the ROSA26LacZ (R26LacZ) locus, showing Cre-dependent, conditional 





Cre and allowing nuclear translocation of the recombinase (Feil et al., 1997). 
Importantly, the cytoplasmic restriction of the protein prevents Cre-mediated ablation of 
Xbp1, thus creating a system in which intact XBP1 expression can be inducibly switched 
off. The knock-in model restricts expression of Cre-ERT2 to cells that natively express 
MIST1, including pancreatic acinar cells.  
 
Mist1CreERER/CreER; Xbp1+/+ mice were mated to Mist1+/+; Xbp1fl/fl over multiple generations, 
yielding mice with a Mist1CreER/+;Xbp1fl/fl genotype as well as relevant variations used as 
experimental controls. Additionally, a transgene that conditionally encodes the β-
galactosidase (LacZ) gene from the ROSA26 locus was crossed into the line (Figure 
3.02d). The ROSA26 locus, originally identified via gene-trap experiments in mouse ES 
cells, is constitutively active in all cells and is frequently utilized for transgenic expression 
of reporter genes (Casola, 2010; Friedrich and Soriano, 1991). In ROSA26LacZ (R26LacZ) 
mice, a lox-stop-lox (LSL) cassette containing multiple in-frame stop codons preceding 
the LacZ gene was knocked in to the ROSA26 locus. This results in a non-coding locus 
that becomes active upon Cre-mediated excision of the LSL cassette and begins low-
level transcription of β-galactosidase. This results in permanent labeling of all cells in 
which Cre has been active or was active in a progenitor cell. Importantly, because this is 
a permanent recombination event, all progeny of β-gal-positive cells will remain β-gal-
positive. 
 
By combining all three transgenes through standard crosses, we generated a mouse line 
with inducible, cell-specific ablation of XBP1 along with coexpression of β-galactosidase 
for lineage tracing (Figure 3.02e). As diagrammed in Figure 3.03a, ablation of Xbp1 
exon 2 generates a frameshift that encodes an early stop codon six amino acids into 
XBP1 exon 3, resulting in a transcript that codes for a truncated protein lacking DNA-
binding, transcriptional activation, and nuclear localization domains (Figure 3.03b). This 
truncated protein (Xbp1ΔEx2) has no transcriptional activity and is rapidly degraded, 
completely eliminating XBP1s in all progeny cells. 
 
Initial testing for CreER efficacy using DNA extracts from tamoxifen-treated mice revealed 












Figure 3.3 Effects of Cre-mediated recombination at the Xbp1flox locus  
(A) Cre-mediated recombination results in a modified gene that no longer encodes for a 
portion of the basic leucine zipper (bLZ). Additionally, a frameshift resulting from the loss 
of exon 2 encodes a STOP codon located six amino acids into exon 3 in the translated 
protein. (B) XBP1u is a direct translation of the unspliced Xbp1 transcript and has few 
well-studied functions in cells. XBP1s has a unique C-terminus that contains a potent 
transcriptional activation domain and nuclear localization signal, resulting in its 
translocation to the nucleus and activation of its target genes. XBP1ΔEx2 consists of exon 

















administered pancreata and not in tail, kidney, or untreated tissues (Figure 3.04a). 
These were selected as representatives of MIST1-expressing (pancreas) and non-
expressing (kidney, tail) cell types. The restriction of Cre activity was mimicked using 
standard qPCR (Figure 3.04b), confirming restriction of Cre-mediated recombination to 
MIST1-expressing tissues. Further analysis was conducted to determine the subset of 
pancreatic cells in which Xbp1 had been ablated. 
 
As a first step to monitor acinar-specific recombination, pancreatic sections were 
generated from Mist1CreER/+; Xbp1fl/fl; R26LacZ mice treated with corn oil (vehicle) or 
tamoxifen (TM). As shown in Figure 3.05a,b, X-gal staining, a marker for β-
galactosidase (β-gal) activity, revealed substantial staining of pancreatic acinar cells with 
no staining in the untargeted pancreatic islets or ducts. Histological analysis of harvested 
pancreata from these animals also showed normal appearance and protein expression 
in both the β-gal negative islets and duct cells (Figure 3.05c,d). Quantification of β-gal 
activity via X-gal staining (Figure 3.05e) indicated virtually no recombination in untreated 
or MIST1-negative tissues. In contrast, approximately 90% of Mist1CreER/+; Xbp1fl/fl; 
R26LacZ acinar cells were positive for β-gal. These data demonstrated that Cre 
recombinase activity in Mist1CreER/+; Xbp1fl/fl; R26LacZ mice was restricted to Mist1-
expressing organs, and recombination is restricted within the pancreas specifically to 
acinar cells. Further testing was conducted to determine whether the tissue-specific 
expression of the Xbp1ΔEx2 transcript resulted in loss of Xbp1 activity. 
 
As previously shown in Figure 1.05, each UPR branch activates both branch-specific 
gene targets as well as shared effectors that are coactivated by one of the other master 
regulator cascades. IRE1/XBP1 is responsible for activation of a number of branch-
specific UPR targets, among them protein disulfide isomerase (PDI, a regulator of 
disulfide bond formation in the ER), the related protein disulfide isomerase associated 2 
(PDIA2/PDIp), and Sec61α (a component of the ER translocation apparatus used for 
moving proteins into and out of the ER) (Todd et al., 2008, 2009). Constitutive, low-level 
XBP1s activity has been previously observed in the pancreas (Figure 3.07a) (Iwawaki et 
al., 2004), prompting us to investigate the expression of known XBP1-specific target 














Figure 3.4 Mist1CreER/+; Xbp1fl/fl mice express the Xbp1dEx2 transcript in a pancreas-
restricted fashion 
(A) Standard PCR utilizing primers specific for the Xbp1ΔEx2 transcript were used on 
homogenates from pancreas (P), kidney (K), and tail (T) tissues in tamoxifen-treated and 
untreated Mist1CreER/+; Xbp1fl/fl mice. Expression of the recombined transcript is only 
detected in the pancreas of tamoxifen-treated mice. (B) qPCR for the Xbp1ΔEx2 transcript 
also reveals expression effectively restricted to tamoxifen (TM)-treated pancreata. (* = p-
value < 0.001 relative to tamoxifen-treated kidney sample). RT-qPCR analysis 














Figure 3.5 Ablation of Xbp1 in tamoxifen-treated Mist1CreER/+; Xbp1fl/fl; R26LacZ mice is 
restricted to the acinar cells in the pancreas 
(A) X-gal staining of pancreata from Mist1CreER/+; Xbp1fl/fl; R26LacZ mice without tamoxifen 
shows no staining, indicating a lack of Cre activity. (B) X-gal staining of tamoxifen-
treated Mist1CreER/+; Xbp1fl/fl; R26LacZ mouse pancreata shows extensive β-galactosidase 
activity in acinar cells, but not islets (black arrow). Additionally, the red outline marks a β-
gal negative centroacinar cell. (C) Staining for insulin and glucagon in Mist1CreER/+; 
Xbp1fl/fl; R26LacZ mouse pancreata show normal arrangement of cells and protein 
expression. (D) Staining for cytokeratin 19 (K19) in Mist1CreER/+; Xbp1fl/fl; R26LacZ 
pancreata reveals normal appearance and K19 expression in ducts (black arrows). (E) 
Quantification of acinar β-gal activity demonstrating Cre-activity in approximately 90% of 





As shown in Figure 3.06a, expression of PDI, PDIp, and Sec61α is immediately and 
significantly reduced in Mist1CreER/+; Xbp1fl/fl samples within 48 hours of TM treatment. 
This is contrasted by expression of CHOP (Figure 3.06a, right), an ER stress response 
gene regulated by multiple UPR branches that shows no significant change. These 
results suggest than Xbp1 ablation effectively silenced the IRE1 component of the UPR 
without effect on the other branches. 
 
We next sought to verify that ablation of Xbp1 had not altered upstream UPR activators. 
To confirm that IRE1 was still actively splicing Xbp1 transcripts, IRE1 activity was 
assayed via RT-qPCR using splice-specific primers that detected IRE1-dependent 
excision of the 26 nucleotide intron still present in the Xbp1ΔEx2 transcript (diagrammed in 
Figure 3.03a). As shown in Figure 3.06b, splicing of the Xbp1ΔEx2 transcript confirmed 
robust IRE1 activity within the pancreas following tamoxifen-mediated Xbp1 ablation. 
This activity was sustained over several weeks, showing significant increases following 
ablation (discussed in section 3.3). Despite the high level of IRE1 activity, the XBP1 
targets Sec61α and PDI were not significantly upregulated (Figure 3.06c), indicating that 
tamoxifen-mediated Cre-dependent splicing abrogates XBP1 function in the pancreas. 
These mice will henceforth be referred to as Mist1CreER/+; Xbp1ΔEx2 mice. 
 
 
3.3 Xbp1 ablation causes ER stress and activation of an incomplete UPR in 
Mist1CreER/+; Xbp1ΔEx2  acinar cells 
Previous work performed by the Miura research group utilized transgenic mice to 
express an XBP1s-GFP fusion protein to be used as a reporter of ER stress (Iwawaki et 
al., 2004). These mice have substantial expression of the tagged fusion protein 
specifically in the pancreas, indicating that ER stress with  
corresponding UPR activation is constitutive in the normal adult pancreas (Iwawaki et 
al., 2004) (Figure 3.07a). The constant secretory load and corresponding UPR makes 
the pancreas an ideal target for investigating the degree of crosstalk between the three 
master regulator molecules and their downstream signaling components. The extensive 
overlap in UPR targets and functions prompted us to ask whether XBP1 is an essential 











Figure 3.6 Tamoxifen administration in Mist1CreER/+; Xbp1fl/fl mice disables the XBP1-
dependent expression of target genes 
(A) RT-qPCR analysis of pancreata from tamoxifen-treated Mist1CreER/+; Xbp1fl/fl mice 
indicates that expression of PDI, PDIp, and Sec61α is significantly reduced compared to 
CHOP. (B) RT-qPCR using primers specific for IRE1-mediated Xbp1 RNA splicing 
indicates significant and sustained activity of IRE1. (C) RT-qPCR for XBP1-specific 
targets PDI and Sec61α show no significant increase in expression over control despite 
active splicing of the Xbp1 transcript. (* = p-value < 0.05 relative to control samples, 
normalized to 18s expression) RT-qPCR analysis (Figure C) conducted in collaboration 









Figure 3.7 Ablation of Xbp1 results in sustained and progressive activation of the 
unfolded protein response (UPR) 
(A) Gut isolates of ER stress-activated indicator (ERAI) mice expressing an Xbp1-Venus 
fusion protein that fluoresces upon splicing of the Xbp1 transcript (Iwawaki et al., 2004). 
Transgenic mice reveal constitutive expression of XBP1s specifically in the mouse 
pancreas (P) but not the intestine (I) or stomach (S). (B) Protein isolates from 
Mist1CreER/+; Xbp1ΔEx2 pancreata reveal increasing activation of the PERK (assayed via 
phosphorylation of eIF2α) and nATF6 (primary effector of ATF6) pathways. (C) RT-
qPCR analysis of ER stress indicators in pancreatic RNA isolates reveal progressively 
increasing expression of both Chop and Bip. (D) Chop and Bip are upregulated in RNA 
isolates from Mist1CreER/+; Xbp1ΔEx2 pancreata at three weeks post-ablation but not in 
Mist1CreER/+; Xbp1ΔEx2/+ or untreated Mist1CreER/+; Xbp1fl/fl controls. (* = p-value < 0.05 
relative to control samples, normalized to 18s expression). RT-qPCR analysis conducted 




investigations of other master regulators indicated that ablation of PERK or ATF6α failed 
to generate increases in ER stress indicators (Iida et al., 2007; Wu et al., 2007). Both of 
these studies concluded that the UPR could function in the absence of one of the three 
branches. 
 
In order to monitor the effects of Xbp1 ablation, mice were administered tamoxifen and 
sacrificed at one week intervals. Pancreata were harvested for histology, protein, and 
RNA isolation to allow for complete analysis of each organ. As seen in Figure 3.07b, 
loss of Xbp1 was followed by steadily increasing detection of phosphorylated eIF2α 
(eIF2α) and nuclear ATF6 (nATF6), indicative of activation of the PERK and ATF6 
master regulators, respectively. (see Figure 1.05 for diagram). This increase in UPR 
pathway activation correlated with increasing transcript levels of both Bip and Chop 
(Figure 3.07c), previously described as key UPR targets activated by multiple UPR 
master regulator branches. These data suggest that loss of XBP1 function leads to 
progressively increasing levels of ER stress. 
 
Previous investigations by other groups have indicated that loss of one Xbp1 allele can 
substantially impair UPR function in mice with experimentally-induced acute pancreatitis 
(Lugea et al., 2011). We investigated whether the UPR activation we observed 
accompanying basal pancreatic functioning could be similarly triggered via heterozygous 
deletion of one copy of Xbp1. As shown in Figure 3.07d, Xbp1ΔEx2/+ mice failed to show 
increased expression of Bip or Chop at three weeks post tamoxifen treatment, indicating 
a lack of significant ER stress due to loss of one Xbp1 allele. This illustrates that the 
apparent increase in ER stress indicators Bip and Chop is specifically due to the 
complete loss of XBP1 function and that a single Xbp1 allele is capable of sustaining the 
unfolded protein response during normal pancreatic functioning.  
 
3.4 Loss of Xbp1 triggers progressive cell damage in acinar cells 
Pancreatic acinar cells make extensive use of their protein production machinery in 
order to synthesize and secrete digestive zymogens. As such, zymogen production and 
activation are effective ways of measuring cell stress levels and protein throughput. 
Specifically, zymogen forms of amylase, elastase, and carboxypeptidase A (CPA) are all 
expressed at high levels in acinar cells. Additionally, accumulation of aberrantly auto-
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activated CPA is a hallmark of improper acinar secretion that is triggered by pancreatic 
damage, leading to inflammation seen in pancreatitis patients (Jaffray et al., 2000). 
Certain acinar transcription factors, including MIST1, are also affected during stress, with 
a marked decrease in expression associated with pancreatic damage due to pancreatitis 
or oncogenic transformation (Shi et al., 2009b). We thus sought to investigate the overall 
health of Mist1CreER/+; Xbp1ΔEx2 acinar cells via analysis of MIST1 levels and the 
presence of intact and damage-associated zymogen forms. 
 
In contrast to the increased ER stress markers seen previously, expression of amylase 
and elastase transcripts progressively declined following  
ablation of Xbp1, suggesting that there may be a reduction in overall protein throughput 
(Figure 3.08a). This finding is also seen at the protein level, along with an inversely 
correlated accumulation of activated CPA, indicative of acinar cell distress (Figure 
3.08b). These data prompted an investigation of whether visible signs of distress could 
be observed via histological analysis. 
 
Due to the limited efficacy of Cre-mediated recombination, a small subset of acinar cells 
(<10%) were expected to continue expressing normal XBP1s derived from the 
unrecombined Xbp1flox allele. This fortuitously allowed a comparison of Xbp1ΔEx2 acinar 
cells to unablated cells within the same tissue. LacZ staining of four week post-tamoxifen 
tissue samples revealed isolated acini which had not responded to tamoxifen induction 
and thus failed to activate β-gal expression or ablate Xbp1 (Figure 3.08c, red outlines). 
The previously described loss of zymogen and Mist1 expression known to be a 
consequence of acinar cell damage was restricted to the β-gal positive cells, confirming 
that “normal” acini were unaffected by neighboring cell loss of Xbp1 (Figure 3.08d). 
These two distinct populations were thus dubbed the zymogenic (XBP1-expressing) and 
non-zymogenic (Xbp1ΔEx2) populations. The presence of two distinct populations 
provided an opportunity to comparatively analyze the cell architecture within the 












Figure 3.8 Ablation of Xbp1 results in reduction of protein expression that is 
accompanied by increased damage indicators 
(A) RT-qPCR for amylase and elastase transcripts show a progressive drop in steady-
state levels following loss of XBP1. (B) Protein blot for amylase (AMY) and activated 
CPA (CPAActive) levels show a decrease in amylase protein while activated CPA, a 
marker for pancreatic damage, accumulates over the same period. (C) LacZ staining 
reveals isolated acini that failed to ablate Xbp1 (β-gal negative) and retain expression of 
acinar hallmark proteins. (D) Immunofluorescence staining for amylase and MIST1 
reveals a loss of both proteins in the Mist1CreER/+; Xbp1ΔEx2 population with continued 
expression in the cells that failed to ablate Xbp1. (* = p-value < 0.05 relative to control 
samples, normalized to 18s expression) RT-qPCR analysis done in collaboration with 




As previously described, expression of XBP1s is linked to expansion of the ER in cells 
undergoing ER stress, implying that ablation of Xbp1 could result in altered cellular ER 
morphology (Federovitch et al., 2005; Shaffer et al., 2004; Sriburi et al., 2004). 
Consistent with this idea, hematoxylin and eosin (H&E) staining of isolated pancreata 
(Figure 3.09a-c) showed a progressive loss of basophilic (dark purple) ER staining, 
along with a decrease in eosinic (pink) zymogen staining. Notably, this loss in zymogen 
staining is absent in the zymogenic population (Figure 3.09c, white outlines).  
 
Comparative electron microscopy between zymogenic and non-zymogenic cells at 4 
weeks post-ablation (Figure 3.09d,e) showed a marked change in endoplasmic 
reticulum appearance, with overall disorganization of the ER, disruption of the nuclear 
envelope, and a near absence of secretory/zymogen vesicles. The ER itself was swollen 
and lacked the orderly stacking seen in normal cells. Additionally, loss of Xbp1 triggered 
an increase in protein degrading autophagy as determined by increased expression of 
the autophagy-related protein LC3B and direct observation of autophagosomes by TEM 
in Xbp1ΔEx2 acinar cells (Figure 3.09f).  
 
3.5 Acinar cells lacking Xbp1 die approximately four weeks after ablation 
Unchecked ER stress and continued activation of the UPR results in initiation of an 
apoptotic cascade via coordinated action of all three master regulators of the UPR 
(Szegezdi et al., 2006). A key regulator of this process is the C/EBP homologous protein 
(CHOP) transcription factor that is activated by all three pathways but only dependent on 
activation of the PERK branch (Harding et al., 2000). CHOP leads to numerous pro-
apoptotic expression changes including a decrease in expression of pro-apoptotic BCL2 
and an increase in expression of pro apoptotic proteins such as GADD34, ERO1α, and 
TRB3 (Szegezdi et al., 2006). Notably, the IRE1 component of the apoptotic arm is not 
XBP1-dependent but rather relies on a direct interaction of IRE1 and TRAF2, a known 
upstream regulator of the BCL2 family of proteins that prevent apoptotic initiation 
(Szegezdi et al., 2006). Though the exact mechanism of ER stress-induced cell death is 
still being elucidated, it is apparent that persistent activation of the UPR results in 













Figure 3.9 Loss of Xbp1 triggers altered acinar morphology, ER disorganization, and 
increased autophagy 
(A) Hematoxylin and eosin (H&E) staining of Mist1CreER/+; Xbp1ΔEx2 pancreata 24 hours 
post-TM with normal morphology. (B) Mist1CreER/+; Xbp1ΔEx2 pancreata two weeks after 
Xbp1 ablation. (C) Mist1CreER/+; Xbp1ΔEx2 pancreata four weeks after Xbp1 ablation. White 
outline denotes a zymogenic region. (D) Transmission electron micrograph (TEM) of a 
zymogenic acinar cell four weeks post-ablation. Yellow arrows denote normal stacked 
ER (also shown in high magnification inset). White arrows denote zymogens with a 
normal, electron-dense appearance. (E) TEM of a Mist1CreER/+; Xbp1ΔEx2 non-zymogenic 
acinar cell. White arrows and inset show disorganized ER with free ribosomes (inset). 
Yellow arrows denote aberrant zymogen granules and a black arrow denoting an 
autophagosome, indicative of autophagy. (F) Immunofluorescence staining for LC3B 
reveals increased autophagy in the non-zymogenic population at four weeks post-Xbp1 
ablation (red outlines denote zymogenic clusters).  
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dependent pathways. This prompted us to investigate the fate of the Xbp1ΔEx2 acinar 
cells. 
 
As noted in section 3.2, Xbp1ΔEx2 acinar cells exhibit a progressive activation of the UPR 
following Xbp1 ablation (Figure 3.08). The noted increase in CHOP transcripts 
discussed earlier is correlated with increased expression of CHOP protein that is 
restricted to the Xbp1ΔEx2 acinar cells (Figure 3.10a). This marked  
increase in CHOP expression is not observed until four weeks post-ablation. 
Additionally, at the four week time point electron microscopy allowed for direct 
observation of large numbers of autophagosomes, again indicating an increase in 
autophagy likely related to extensive protein misfolding (Figure 3.10b). This time point 
coincides with the onset of cell death as determined by labeling of tissue sections via 
terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), again restricted 
to the non-zymogenic population (Figure 3.10c). Isolated protein homogenates from this 
time point also reveal increases in stress pathway markers pERK1/2 (MAPK pathway) 
and p38 (Figure 3.10d). All of these data indicate that the non-zymogenic, Xbp1ΔEx2 
acinar cells die via apoptosis following a period of progressive increasing ER stress. 
 
3.6 Discussion 
The unfolded protein response (UPR) plays an essential role in maintenance of 
homeostasis within secretory cells. While the mechanics of activation and execution of 
each master regulatory branch have been well studied, the complex interplay between 
branches and their reliance on each other for full effectiveness is still being investigated. 
Indeed, various studies have indicated that the substantial overlap between the three 
UPR networks can largely compensate for each other, as elimination of individual 
branches typically results in no increase in ER stress (Huh et al., 2010; Iida et al., 2007; 
Wu et al., 2007). Understanding this interplay between branches is essential as 
knowledge of the UPR is increasingly being utilized to design novel therapeutics against 
various malignancies (Wang et al., 2010). This emphasis is due to increasing numbers 









Figure 3.10 Xbp1 ablation leads to activation of apoptotic UPR pathways and 
eventual cell death  
(A) Immunofluorescent analysis of 4-week post-ablation pancreata shows strong 
expression of CHOP localized to the non-zymogenic population. Zymogenic cells remain 
CHOP-negative. (B) Transmission electron micrograph of a non-zymogenic acinar cell 
reveals an autolysosome, indicative of end stage autophagy. (C) TUNEL staining of 4-
week post-ablation pancreata reveals positive staining in the non-zymogenic acinar 
population. (D) Protein blots on isolated pancreatic extracts reveal extensive, 





indicating that ER stress is a common hallmark in cancerous cells (Cyr and Hebert, 
2009; Kaufman, 2002; Koong et al., 2006; Walter and Ron, 2011; Wang et al., 2010) as 
well as a viable means of inducing cell death in combination with standard 
chemotherapeutics (Martins et al., 2011; Nawrocki et al., 2005a, 2005b). The need for 
such novel approaches is particularly important in pancreatic ductal adenocarcinoma 
(PDA), a nearly untreatable malignancy with a five-year survival rate of only 6% (Siegel 
et al., 2013). In this study a cell-specific, inducible Xbp1-knockout mouse model was 
utilized to determine if nullification of the IRE1 branch of the UPR could be compensated 
for by the PERK and ATF6 networks in pancreatic acinar cells.  
 
The pancreas has been shown previously to have a basal activation of the unfolded 
protein response (Figure 3.07a). This is presumed to be due to the high secretory 
demands placed on pancreatic acinar cells. Based on this information, we hypothesized 
that impairment of proper UPR function via ablation of Xbp1 would result in a sustained 
ER stress response. Indeed, we observed a progressively increasing activation of the 
PERK and ATF6 branches of the UPR (Figure 3.07), consistent with an inability to 
properly resolve basal ER stress in acinar cells. UPR activation reached a maximum at 
four weeks post-ablation, which also correlated with the highest degree of cell death. 
These results suggest that XBP1, while essential to provide a full unfolded protein 
response, is not required for the action of the other two branches. Indeed, the PERK and 
ATF6 branches appear fully functional and active via analysis of their immediate 
effectors. Thus, the incomplete UPR initiated in the absence of XBP1 might be sufficient 
to counter short, minor periods of stress in cells with lower protein loads, but the PERK 
and ATF6 branches are not sufficient to mitigate chronic ER stress. 
 
As shown in Figure 3.09, two distinct acinar cell populations are present in Mist1CreER/+; 
Xbp1ΔEx2 pancreata, likely due to limitations in Cre efficacy. Fortuitously, the 90% 
recombination frequency permits observations of the 10%  XBP1-expressing, 
“zymogenic” acinar cells in contrast to their Xbp1ΔEx2 counterparts. This served as an 
excellent system for analyzing the effects of XBP1-null cells vs. normal cells under 
identical conditions. Electron micrographs revealed substantially altered morphology in 
Xbp1ΔEx2 acinar cells including degradation of the ER (Figure 3.09d,e). These findings 
are consistent with previous data showing that XBP1 is responsible for the physical 
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remodeling of the ER during periods of ER stress (Shaffer et al., 2004; Sriburi et al., 
2004). Indeed, loss of XBP1 and the associated disruption of ER architecture results in a 
swelling of the ER, possibly due to insufficient protein transport out of the ER, a process 
known to be regulated by the XBP1-target EDEM1 (Table 3.01). It is thus likely that 
XBP1 functions primarily as a mediator of the adaptive phase of the UPR, remodeling 
the ER to expand capacity and increasing export of misfolded proteins.  
 
Ablation of Xbp1 also has apparent cell-wide consequences. As shown via 
immunofluorescent staining for the autophagy marker microtubule-associated protein 
light chain 3b (LC3B) (Figure 3.09f), cells lacking XBP1 have increased autophagy, a 
likely consequence of accumulating large amounts of improperly folded proteins that are 
no longer being modulated by the remaining UPR branches. This finding is of particular 
importance, because induction of autophagy in transformed cells is emerging as a 
possible druggable mechanism for tumor suppression (Suh et al., 2012), supporting the 
idea that modulators of XBP1 could serve as a novel therapeutic intervention in human 
disease. 
 
Long-term loss of XBP1 function is deleterious to acinar cells, as non-zymogenic cells 
express high levels of CHOP four weeks after ablation (Figure 3.10). This again 
demonstrates that the PERK and ATF6 of the UPR are unaffected by loss of XBP1. 
CHOP expression is primarily under the control of the PERK UPR master regulator, 
although recent work has implicated XBP1 as a coregulator (Takayanagi et al., 2013). 
Indeed, the gradual accumulation of CHOP over the four weeks following Xbp1 ablation 
supports recent work by the Yoshida group showing that CHOP expression may be 
auto-regulatory in nature (Takayanagi et al., 2013).Thus, our studies lead to a model in 
which ablation of XBP1 causes mounting ER stress, resulting in continuous expression 
of CHOP that eventually triggers a switch to an apoptotic cell fate (Figure 3.11). Indeed, 
the extended window of ER stress seen in the Mist1CreER/+; Xbp1ΔEx2 model may serve as 
a novel tool for investigating regulation of the unfolded response.  
 
Complete loss of XBP1 activity is ultimately fatal in pancreatic acinar cells (figure 3.10). 
The observed co-localization of CHOP and TUNEL staining to the non-zymogenic, 











Figure 3.11 Proposed model regarding the effects of Xbp1 ablation on ER stress in 
pancreatic acinar cells 
(A) Standard model of XBP1s action in which IRE1-dependent splicing of Xbp1 leads to 
production of XBP1s. This in turn leads to expression of target genes which work in 
concert with the other pathways to resolve ER stress. (B) In Xbp1ΔEx2 acinar cells, 
XBP1s cannot be synthesized, resulting in disabling of the entire IRE1 branch of the 
UPR. This leads to increasing ER stress, which eventually feeds back to the PERK and 





apoptotic arm of UPR. The progressive activation of both the MAPK and p38 stress 
pathways also indicates that acinar cells are under substantial stress due to basal 
metabolic demands but that the effect is sub-lethal for an extended period of time. This 
observation could indicate that modulation of the UPR may be an effective means of 
controlling the viability of stressed cells, including those undergoing oncogenic 
transformation. This hypothesis is supported via studies of bortezomib, a 
chemotherapeutic drug used to treat multiple myeloma that induces ER stress while 
suppressing the UPR (Mimura et al., 2012; Nawrocki et al., 2005a). Future studies are 
required to see if induction of ER stress in acinar cells is sufficient to prevent cancerous 
transformation. Preliminary data regarding the interaction of ER stress and oncogenesis 
in Mist1CreER/+; Xbp1fl/fl mice will be presented in Chapter 4. 
 
This study revealed that XBP1 is essential for the homeostasis and viability of pancreatic 
acinar cells via its role in the unfolded protein response. Future studies will investigate 
whether specific, downstream effectors of XBP1 are similarly capable of controlling 
viability in stressed cells (see Chapter 6). Additional work, detailed in Chapter 5, has 
focused on a specific XBP1-target, MIST1, which itself has been shown to be a key 
regulator of acinar cell identity during pancreatic disease (Kowalik et al., 2007; Shi et al., 
2009b, 2012; Zhu et al., 2004). Together, this work demonstrates that XBP1 and its 























CHAPTER 4. PANCREATIC DAMAGE IN Mist1CreER/+; Xbp1ΔEx2 MICE TRIGGERS A 
COORDINATED, MULTI-CELL COMPARTMENT REGENERATIVE RESPONSE 
4.1 Introduction 
Damage in the exocrine pancreas is generally caused by one of two insults; oncogenic 
transformation or pancreatitis. Oncogenic transformation refers to the transdifferentiation 
of acinar cells into duct-like structures via acinar-ductal metaplasia (ADM). Acinar cells 
undergoing ADM can then develop into pre-cancerous lesions called pancreatic 
intraepithelial neoplasia (PanINs), eventually progressing into pancreatic ductal 
adenocarcinoma (PDA). This transition occurs after initial expression of mutated, 
constitutively active KrasG12D oncogene, thus representing an intrinsic stress on the cells 
(Hruban et al., 2006). Pancreatitis is an inflammatory disease in which autoactivation of 
digestive enzymes (experimentally induced by secretagogue treatment) results in acinar 
cell death, pancreatic edema, and the appearance of ductal structures also from acinar-
ductal metaplasia (Klöppel and Maillet, 1993; Strobel et al., 2007). Multiple mouse 
models have been generated to investigate both of these exocrine pancreas diseases. 
 
As shown in Figure 4.01a, PanIN development is governed by expression of 
constitutively active forms of the KRAS protein, a downstream effector of extracellular 
growth factor (Maitra and Hruban, 2008). At least ten mouse model systems have been 
made utilizing activated KRAS, primarily differing in whether KRAS is expressed via 
constitutive or inducible promoters (Hruban et al., 2006). The most prevalent model 
system uses Cre-mediated induction of activated KRASG12D via deletion of a STOP 
cassette, generating a Cre-inducible mutant KRAS allele with tissue specificity based on 
the choice of Cre used (Figure 4.01b) (Jackson et al., 2001). These systems have been 
used extensively to characterize early oncogenic transformation events in mice, 
demonstrating alongside human patient samples that pancreatic cancer development is 
associated with an intense desmoplastic response resulting from extensive inflammation 
(Pandol et al., 2009). The pronounced inflammatory environment seen during PDA 








Figure 4.1 Exocrine pancreas damage leads to acinar-ductal metaplasia and 
inflammation 
(A) Illustration of PanIN development showing initial conversion of acinar cells to duct-
like cells via expression of mutant KRAS, a mutation found in approximately 90% of 
human pancreatic cancers. Later steps involve mutations in the p16 gene followed by 
mutations in the TP53, Smad4, and Brca2 genes. Figure modified from Maitra and 
Hruban, 2008. (B) Schematic showing the Mist1CreER/+; LSL-Kras mouse line with acinar 
cell-specific expression of KrasG12D. Activation of Cre removes the STOP cassette and 
allows for expression of the mutant KRASG12D protein. (C) Representative image of 
caerulein-induced pancreatitis showing intralobular stromal deposition (black arrow) as 
well as open lumened, acinar cells undergoing ADM (red arrows). Figure A adapted from 
Maitra and Hruban, 2008. Figure C courtesy of Dr. Daniel DiRenzo.  
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Multiple mouse models of pancreatitis also exist, differing primarily in how exocrine 
damage is inflicted. Model systems based on surgical obstruction of the pancreatic duct 
(Watanabe et al., 1995), feeding of alcohol (Su et al., 2006) or L-arginine (Lerch and 
Adler, 1994), or administration of the cholesystokinin (CCK) homologue caerulein 
(Jungermann et al., 1995) have all been used extensively in the literature with varying 
degrees of success. Caerulein injection has become the predominant model system due 
to its ease of delivery via intraperitoneal injection. Caerulein administration triggers 
supramaximal levels of acinar cell zymogen secretion, resulting in aberrant release of 
digestive enzymes across the basal acinar membrane as well as autoactivation of 
intracellular granules (Jungermann et al., 1995). This results in proteolytic tissue 
digestion, edema, and inflammation that mimics the appearance of human disease 
(Figure 4.01c) (Dawra et al., 2007). Interestingly, acinar-ductal metaplasia is also 
observed during pancreatitis, linking both oncogenic and inflammatory damage to 
maintenance of acinar cell identity, discussed extensively in Chapter 5. 
 
Acinar-ductal metaplasia serves as a prime example of the plasticity of adult pancreatic 
cells. The ability of acinar cells to convert into a duct-like progenitor state when damaged 
has been demonstrated in response to oncogenic transformation (Zhu et al., 2007), 
caerulein-induced pancreatitis (Strobel et al., 2007), and following dissociation of human 
tissue explants in culture (Houbracken et al., 2011). Additionally, the use of growth 
factors on cultured acinar cells can trigger conversion of the exocrine-lineage, digestive 
enzyme-producing acinar cells to endocrine-lineage, insulin-producing β-cells, a 
transition that occurs through a duct-like intermediate (Baeyens et al., 2009; Minami et 
al., 2005). These transitional events indicate that damaged or stressed acinar cells 
become more duct-like via dedifferentiation, presumably entering a damage-refractory 
progenitor state and subsequently redifferentiating following resolution of stress. The 
specific transcriptional networks and stress signaling pathways active within acinar cells 
are therefore particularly important in maintaining the differentiated identity of the cell. 
 
ADM has been studied using numerous model systems. Isolated acinar cells have been 
observed to transdifferentiate into duct-like cysts in culture (Means et al., 2005), while 
lineage tracing studies in mice with activated KRAS expression have confirmed that 
acinar cells contribute to duct-like PanIN structures in vivo (Habbe et al., 2008; Shi et al., 
74 
 
2009b). The use of these model systems has identified specific signaling pathways that 
are required for ADM, including the mitogen-activated protein kinase (MAPK) pathway, a 
key regulatory pathway known to be affected by the activating KrasG12D mutations that 
initiate pancreatic cancer (Habbe et al., 2008; Houbracken et al., 2011). ADM can also 
be accelerated via loss of key acinar differentiation factors including MIST1, discussed in 
Chapter 5 (Shi et al., 2009b, 2012). Signaling studies using caerulein-induced 
pancreatitis models have similarly revealed a need for activation of embryonic signaling 
pathways during pancreatic regeneration, specifically the Hedgehog and Notch 
pathways (Fendrich et al., 2008). A combination of oncogenic and inflammatory damage 
can also synergize in regards to ADM and disease progression, with some studies 
indicating that a chronic inflammatory environment is essential for oncogenic 
progression in mouse models expressing activated KRAS proteins (Guerra et al., 2007, 
2011). Interestingly, both cancer progression and pancreatitis have been linked to 
activation of the unfolded protein response. 
 
Expression of the key UPR mediator BiP has been associated with poor prognosis and 
lack of chemo-sensitivity in multiple secretory organ cancers including prostate 
(Daneshmand et al., 2007), hepatocellular (Su et al., 2010), and breast (Lee et al., 2006) 
malignancies. Additionally, multiple chemotherapeutics have been utilized to induce ER 
stress as a means of inducing cancer cell cycle arrest or apoptosis (Martins et al., 2011; 
Nawrocki et al., 2005b; Wang et al., 2010). UPR activation is also observed in several 
experimental models of pancreatitis including L-arginine, alcohol, and caerulein-induced 
systems (Alahari et al., 2011; Kubisch et al., 2006; Lugea et al., 2011), with full activation 
of the unfolded protein response and all of its branches observed within 8 hours of 
pancreatitis induction (Kubisch et al., 2006). Specific studies of Xbp1+/- mice have 
indicated that loss of a single copy of Xbp1 also impairs acinar cell recovery in alcohol-
induced pancreatitis, supporting the idea that the UPR is a necessary component in 
maintaining pancreatic homeostasis during damage. Existing models of pancreatic 
damage, however, have produced conflicting data regarding cellular maintenance and 
regeneration during damage, necessitating the development of new ways of examining 




Current pancreatic damage models, while useful, have limitations regarding their 
applicability to human disease. Secretagogue-induced mouse models mimic the 
histological appearance of human disease but this model relies on the use of caerulein, 
a chemical that does not produce a response in human acinar cells and thus may not 
accurately replicate the molecular signature of recovering human patients (Ji et al., 
2002). Non-inflammatory, endogenous stress models, including acinar-specific 
expression of diphtheria toxin receptors, generate striking levels of acinar cell 
destruction and regeneration (Criscimanna et al., 2011). The lack of inflammation in 
these models, however, does not mimic the environment of a diseased or damaged 
pancreas and thus fails to account for complex epithelial-stromal interactions that may 
take place during damage. An ideal system for studying pancreatic damage would 
generate sufficient inflammation to mimic human disease while also generating damage 
via an intrinsic acinar mechanism known to affect humans. We sought to investigate 
whether pancreatic damage resulting from ER stress-induced acinar cell loss in the 
Mist1CreER/+; Xbp1fl/fl model system could recapitulate known histological and gene 
expression patterns associated with pancreatic damage and regeneration. 
 
In this study we analyzed the effects of extensive, progressive damage on the murine 
pancreas following the loss of the Xbp1ΔEx2 acinar cell population. We determined that 
ER stress-induced acinar cell loss is compensated for by cell cycle reentry by both the 
acinar and centroacinar compartments, with subsequent regeneration of exocrine tissue. 
Furthermore, we demonstrate that recovering acinar cells are histologically unusual, with 
swollen zymogen compartments and increased cell and nuclear dimensions that may 
indicate a compensatory response to exocrine destruction. Finally, we show that loss of 
Xbp1 results in long-term pancreatic remodeling and damage, but this damage does not 
appear to predispose the pancreas to oncogenic transformation. 
 
4.2 Xbp1ΔEx2 pancreata develop a pronounced inflammatory response and activate 
embryonic signaling components 
As described in Chapter 3, acinar cells in Mist1CreER/+; Xbp1ΔEx2 mice fail to execute a 
sufficient unfolded protein response, leading to progressive UPR activation and eventual 
ER stress-induced crisis. One of the hallmarks of exocrine pancreatic damage in both 
human patients and rodent models is a pronounced mixed inflammatory/desmoplastic 
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response involving tissue-resident macrophage activation and systemic B and T cell 
infiltration (Kim, 2008; Whitcomb, 2004). Post-damage tissue regeneration is also linked 
to expression of normally silenced pancreas-specific progenitor markers including Pdx1, 
Hes1 (a Notch signaling component) and Nestin (Jensen et al., 2005; Means et al., 
2005). We sought to determine whether ER stress-induced damage within the acinar 
compartment of Xbp1ΔEx2 mice was sufficient to generate an inflammatory response and 
activation of embryonic signaling pathways. 
 
Histological examination of pancreatic sections isolated from two-week post-crisis (6 
week post-ablation) Mist1CreER/+; Xbp1ΔEx2 mice revealed extensive cell remodeling within 
the intra-acinar spaces. This remodeling included formation of tubular complexes 
(Figure 4.02a, white arrows), a common feature seen in caerulein pancreatitis models 
and caused by either acinar-ductal metaplasia or reorganization of preexisting ductal 
cells (Strobel et al., 2007). These tubular complexes were themselves surrounded by 
extensive collagen deposits as determined by Sirius Red staining (Figure 4.02b). 
Immunohistochemical staining for the T-cell marker CD3 revealed an extensive influx of 
T-cells surrounding the tubular complexes (Figure 4.02c, red arrows). Additional 
staining for the B-cell marker F4/80 also revealed the presence of B-cells among the 
non-epithelial, tubular complex-adjacent cells (Figure 4.02d, red arrows). These data 
indicated that a mixed stromal/inflammatory response occurred within the intra-acinar 
spaces in post-crisis pancreata.  
 
We next sought to determine whether Mist1CreER/+; Xbp1ΔEx2 pancreata had altered 
progenitor marker expression. RNA isolates from Mist1CreER/+; Xbp1ΔEx2 mice taken 
weekly from two to six weeks post-Xbp1 ablation were analyzed for expression of the 
progenitor marker/genes Nestin, Hes1, and Pdx1. As shown in Figure 4.03a-c, all three 
genes exhibited a similar expression pattern, with significantly upregulated expression 
following ablation that progressively increased until four weeks post-Xbp1 ablation. This 
was then followed by decreasing expression of all three genes to wild-type levels by six 
weeks, with the exception of Pdx1 which still had significantly higher expression levels, 










Figure 4.2 Mixed inflammatory response occurs in recovering pancreata of 
Mist1CreER/+; Xbp1ΔEx2 mice 
(A) H&E image of pancreatic section taken from recovering pancreas showing 
development of mucinous, duct-like tubular complexes (TCs) (white arrows). (B) Sirius 
Red staining of 6 week post-ablation pancreatic section showing extensive collagen 
deposition surrounding tubular complexes (black arrows). (C) Histological stain of 
stromal infiltrate and tubular complexes (red outlines) for CD3, showing CD3-positive T-
cells (red arrows) surrounding the TCs. (D) Histological stain of stromal infiltrate showing 










Figure 4.3 Recovering pancreata in Mist1CreER/+; Xbp1ΔEx2 mice have increased 
expression of progenitor genes 
RNA isolates from Mist1CreER/+; Xbp1fl/fl pancreata taken at weekly intervals following 
Xbp1 ablation. Relative transcript levels for progenitor genes (A) Nestin, (B) Hes1, and 
(C) Pdx1 are shown. All genes were progressively expressed, peaking at 4 weeks post-
ablation before to near basal levels. (* = p-value < 0.05 relative to control samples, 
normalized to 18s expression)  
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correlation between the increasing levels of ER stress described in Chapter 3 and the 
expression of known, damage-responsive progenitor genes associated with pancreatic 
regeneration. 
 
4.3 Pancreata in post-crisis Xbp1ΔEx2 mice have diminished UPR activation and 
recover normal exocrine parameters 
Despite the pronounced inflammatory and transcriptional responses to ER stress in the 
Mist1CreER/+; Xbp1ΔEx2 mice, we were interested in determining if the pancreata retained 
long-term damage or whether there might be a post-crisis restoration of the exocrine 
compartment. Histological examination of four-week post-Xbp1 ablation pancreatic 
isolates undergoing ER stress-induced crisis revealed a nearly complete lack of acinar 
zymogen staining in Xbp1ΔEx2 cells relative to wild-type tissue (Figure 4.04b,e). This 
pronounced exocrine deficiency, however, did not result in early lethality in these mice, 
prompting us to investigate how the pancreas was capable of continued function despite 
a diminished exocrine compartment. Specifically, we sought to identify whether the 
remaining acinar cells compensated for the loss of the Xbp1ΔEx2 population or whether a 
regenerative response was mounted to replace the damaged cells. We first attempted to 
establish if post-crisis Mist1CreER/+; Xbp1ΔEx2 mice were histologically normal. 
 
As shown in Figure 4.04c/f, increased eosinic (zymogen) staining is observed in 
samples isolated two weeks after ER stress-induced crisis (6 weeks post-ablation). The 
observed acinar cells have substantially increased zymogen staining relative to the four 
week post-ablation pancreata, although isolated regions of tissue (Figure 4.04c/f, black 
arrows) continue to show signs of residual damaged acinar cells as well as open tubular 
structures (yellow arrow). We also noted a pronounced increase in the size of the 
acinar compartment (discussed in section 4.5). Given the reestablishment of acinar cells 
with substantial zymogen staining, we sought to quantify whether the previously 
observed increase in UPR activation seen in Xbp1ΔEx2 acinar cells had been resolved.  
 
Monitoring of the IRE1 branch of the UPR was accomplished via RT-qPCR using Xbp1 
splice-specific primers. As seen in Figure 4.05a, IRE1 activity (measured by Xbp1 










Figure 4.4 Damaged pancreata in Xbp1ΔEx2 mice regenerate the acinar cell 
compartment 
All images are paired at 20X (A-C) and 60X (D-F) magnification. (A,D) Control (no 
tamoxifen) pancreatic sections with normal strong eosinic staining (pink) surrounded by 
dense ER and polarized nuclei (purple). (B,E) Four week post-ablation pancreata with 
near complete loss of zymogenic staining outside the small, zymogenic clusters of cells 
(white outlines). (C,F) Recovering, six week post-ablation pancreatic sections with dense 
stromal infiltrate (black arrows) and tubular complexes (yellow arrow). The majority of 








Figure 4.5 Pancreas-wide UPR activity returns to near-basal levels following loss of 
the Xbp1ΔEx2 acinar population 
(A) IRE1 activity (as determined by RT-qPCR analysis of splicing of the Xbp1 transcript) 
escalates up to four weeks post-ablation and then returns to control levels by six weeks. 
(B) Protein blot of pancreatic homogenates shows that activation of the PERK (p-eIF2α) 
and ATF6 (nATF6) branches also returns to control levels by 6 weeks. (C) Downstream 
effector BiP was elevated and then returned to control levels as determined by RT-
qPCR. (D) Expression of Chop was drastically reduced in recovering pancreata, 
although not quite reaching control levels. (* = p-value < 0.05 relative to control samples, 




reaching wild-type levels by six weeks post-ablation. This was accompanied by a similar 
reduction in UPR activity in the PERK and ATF6 UPR branches as determined by 
protein analysis of pEIF2α and nATF6 levels (Figure 4.05b). RT-qPCR analysis was 
conducted on the UPR downstream effectors BiP and Chop, both of which were reduced 
to control (BiP) or near-control (Chop) levels by six weeks post-ablation (Figure 4.05c-
d). These results indicated that UPR activation had returned to basal levels following ER 
stress crisis in the Xbp1ΔEx2 acinar cells. As a next step, we investigated whether 
zymogen production and localization were similarly returned to wild-type levels in the 
post-crisis acinar cells.  
 
RT-qPCR analysis of Amylase transcripts revealed a pronounced increase in expression 
following the ER stress crisis observed at four weeks post-ablation in Mist1CreER/+; 
Xbp1ΔEx2 mice (Figure 4.06a). This was accompanied by increased protein levels for 
amylase as well as a reduction in aberrantly activated carboxypeptidase A (Figure 
4.06b), indicating reduced zymogen autoactivation and thus damage within the exocrine 
compartment. Immunofluorescence for amylase staining on 4-week post-ablation 
pancreatic sections revealed tightly concentrated pockets of amylase expression 
restricted to the previously described zymogenic, Xbp1fl/fl acinar cell population (Figure 
4.06c, white outlines). This was in stark contrast to 6-week post-ablation sections 
(Figure 4.06d) in which amylase was more diffused throughout the pancreas. This 
confirmed that the reestablished acinar population observed in Figure 4.04 was correctly 
expressing and localizing intracellular zymogens. The 6-week exocrine compartment 
also showed an increased presence of ductal cells and duct-like structures, previously 
described in section 4.2 (Figure 4.06d, red outlines). 
 
Closer analysis of six week post-ablation pancreatic sections indicated that the recovery 
process within the pancreas was accompanied by increased fat deposition (Figure 
4.07a,b). Fat deposition is a known hallmark of acute pancreatic damage, and in this 
model it is a likely consequence of acinar cell destruction following loss of the Xbp1ΔEx2 
population (Klöppel et al., 2004). Additionally, the intra-acinar spaces were analyzed for 








Figure 4.6 Acinar parameters including zymogen synthesis, localization, and 
activation all return to normal in recovering Xbp1ΔEx2 pancreata 
(A) RT-qPCR of amylase transcripts reveals a return to control expression levels during 
recovery. (B) Protein blot of amylase (amy) and damage-induced activated 
carboxypeptidase-A (CPAActive) indicating that amylase protein increases to control levels 
during recovery while CPAActive disappears. (C) Immunofluorescence staining showing 
the restriction of strong amylase staining to the zymogenic, Xbp1fl/fl acinar cells (white 
outlines) in 4 week post-ablation pancreata. (D) Immunofluorescence staining showing a 
return to clustered, distributed amylase in recovering pancreata. Red outlines depict 
amylase-negative ductal and stromal cells in the periacinar space. (* = p-value < 0.05 















Figure 4.7 Recovering pancreata express high levels of the ductal/progenitor marker 
SOX9  
(A) Six week post-ablation pancreatic sections have signs of damage including fat 
deposition and formation of duct-like tubular complexes (white outlines). (B) Staining for 
the ductal marker SOX9 shows extensive expression in normal ducts (D) and 
ductal/tubular complexes (black arrows) but not in the stromal cells (red arrow) or acinar 
tissue (Ac). (C) Sox9 transcripts are elevated during peak damage but remain high in 




ductal cells (black arrows) accumulate in recovering pancreata, a separate response 
from the previously described mixed inflammatory cells (red arrow). These duct-like 
cells are primarily in the form of tubular complexes, also a known facet of pancreatic 
damage (Strobel et al., 2007). RT-qPCR similarly revealed increased expression of Sox9 
during and continuing after acinar cell crisis (Figure 4.07c). This is likely due to the 
persistent ductal cell population observed in these pancreata. 
 
4.4 Exocrine regeneration following loss of Xbp1ΔEx2 acini is accompanied by 
proliferation of both the acinar and centroacinar compartments 
The restoration of normal acinar parameters in the recovering Mist1CreER/+; Xbp1ΔEx2 
exocrine compartment, coupled with the TUNEL-labeled non-zymogenic acinar cells 
reported in Chapter 3, strongly suggested that cells lacking XBP1 died and were 
replaced with new acinar cells. There was, however, a possibility that the restored acinar 
compartment could have been composed of acinar cells that managed to overcome the 
lack of XBP1 and resume their normal program. Indeed histological analysis of 
pancreatic sections in 6 week post-ablation mice revealed areas with small acini 
expressing low levels of zymogen (Figure 4.08a, white outlines). Additionally, 
expression analysis of RNA samples utilizing primers specific for the Xbp1ΔEx2 transcript 
revealed persistent, low levels of expression (Figure 4.08b), possibly indicating a 
subpopulation of Xbp1ΔEx2 cells that survived within the pancreas.  
 
In order to test whether Xbp1ΔEx2 acinar cells were contributing to the restored acinar 
compartment, we performed lineage tracing experiments using the Mist1CreER/+; Xbp1ΔEx2 
; R26LacZ reporter line. As described in Chapter 3 (Figure 3.02), cells in Mist1CreER/+; 
Xbp1ΔEx2 ; R26LacZ mice express the β-galactosidase gene in response to Cre activity. 
This expression occurs following a permanent, Cre-mediated DNA splicing event that 
marks both Cre-expressing cells and their progeny. As shown in Figure 4.08c, staining 
of stressed 4 week post-ablation pancreatic sections for β-galactosidase expression 
revealed that the minor zymogenic acinar population was β-gal negative, while the 
majority of the non-zymogenic acinar cells were β-gal positive and thus lacked XBP1. 









Figure 4.8 Regenerated acinar cells are derived from a non-Xbp1ΔEx2 lineage 
(A) Histological stain showing persistent, small acini (white outlines) within recovering (6 
week post-ablation) pancreata. (B) RT-qPCR analysis of the Cre-remodeled Xbp1ΔEx2 
transcript shows a significant reduction in levels during recovery, although still above 
control (no tamoxifen) values. (C) β-galactosidase (β-gal) immunofluorescence analysis 
of four week post-ablation pancreatic sections indicates that non-zymogenic cells 
expressed active Cre for recombination while the zymogenic acini (white outline) did not. 
(D) β-gal analysis of 8 week post-ablation pancreata indicates that restored acinar cells 
are not derived from cells that underwent Cre-mediated DNA recombination. (E) β-gal 
analysis shows rare isolated acini that were positive for β-gal but with normal zymogen 
content and no signs of ER stress. (* = p-value < 0.05 relative to control samples, 
normalized to 18s expression)  
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that the recovered acinar compartment was almost entirely β-gal negative, indicating that 
these acinar cells were not derived from the Xbp1ΔEx2 population. Interestingly, a small 
minority of isolated acini remained β-gal positive despite no obvious cell defects (Figure 
4.08e). These cells likely represent acinar cells in which the open ROSA26 (reporter) 
locus was recombined while both copies of the endogenous Xbp1fl/fl locus was not. 
Given the overwhelmingly β-gal negative state of the restored acinar compartment, we 
sought to investigate which pancreatic lineage was responsible for the acinar 
regeneration response observed in this model.  
 
Initial investigation of recovering pancreata revealed visual evidence of proliferating 
acinar cells via the presence of mitotic figures (Figure 4.09a). This was supported by 
immunohistochemical staining for the proliferation marker Ki67 which showed a distinct 
and significant increase in proliferative cells following ablation of Xbp1 (Figure 4.09b). 
Regeneration was further confirmed by coexpression of Reg1, a protein known to be 
associated with regenerating pancreatic cells (Okamoto, 1999). These data suggested 
that the restoration of normal acinar properties in recovering acinar cells was due to both 
proliferative and regenerative mechanisms. 
 
We next sought to investigate the nature of the exocrine restoration via population 
analysis of proliferative staining patterns. As shown in Figure 4.10a,b, cells positive for 
both Ki67 and the mitosis-associated phospho-histone 3 (pH3) were found within the 
zymogenic, Xbp1fl/fl acinar population in 4 week post-ablation pancreata. This is 
consistent with previous findings utilizing caerulein-induced pancreatitis that indicated 
that preexisting acinar cells give rise to new acinar cells during pancreatic damage 
(Strobel et al., 2007). Interestingly, however, proliferative analysis also revealed Ki67 
staining within the centroacinar compartment (Figure 4.10c-e), a HES1/SOX9-positive 
cell type that has also been implicated in separate studies as a possible source for 
regenerating acinar cells (Criscimanna et al., 2011). Unfortunately, it is not possible to 
use lineage tracing in these cells because neither the zymogenic acinar nor centroacinar 
compartments would express β-gal, since zymogenic cells did not undergo Cre-
mediated recombination and centroacinar cells do not have an active Mist1 promoter to 
express the Cre protein. Therefore, the restored acinar compartment could be 









Figure 4.9 Recovering pancreata display visible signs of proliferation and express 
proliferative and regenerative markers  
(A) Histological examination of early recovering pancreata (5 weeks post-ablation) 
reveals the presence of mitotic figures in the regenerating acinar compartment. (B) 
Analysis of immunohistochemical stains for the proliferative marker Ki67 shows a 
significant increase in proliferation as cell damage peaks followed by a reduction in 
staining during late recovery. (C) RT-qPCR analysis of RNA isolates shows an increase 
in the pancreatic recovery-associated factor Reg1 as ER stress accumulates followed by 
a reduction during recovery. (* = p-value < 0.05 relative to control samples, Fig. C 
normalized to 18s expression)  
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4.5 Recovered pancreata retain abnormal long-term histological features but show 
no evidence of increased pancreatic malignancies 
Fully regenerated acinar cells (12 weeks post-ablation) in Mist1CreER/+; Xbp1ΔEx2 mice 
display no evidence of higher than normal ER stress and express wild-type levels of 
amylase. From a morphological perspective, however, the process of regeneration was 
seen to alter the structure of the restored cells. As shown in Figure 4.11a, the overall 
area of localized zymogens per acinus (white outlines) increased in Mist1CreER/+; 
Xbp1ΔEx2 mice relative to control animals. This effect is quite striking at high 
magnification (Figure 4.11b, right), where immunofluorescence analysis of amylase 
revealed a nearly membrane-to-membrane distribution of zymogen granules within a 
recovered acinus. This pattern was very different from the focal, apically-localized 
zymogen granules observed in control cells. Quantification of cell and nuclear area in 
post-ablation cells via analysis of E-cadherin stained pancreatic sections showed a 
progressive increase in both attributes (Figure 4.11c). This increase began to lessen by 
12 weeks post-ablation, though still remained significantly higher than wild-type animals.  
 
Given the previously reported link between inflammation and increased likelihood of 
pancreatic cancer development (Farrow and Evers, 2002), we also sought to investigate 
whether ablation of Xbp1 would increase the likelihood of developing pancreatic 
malignancies. Mist1CreER/+; Xbp1ΔEx2 mice were allowed to age for 12 months following 
ablation. As shown in Figure 4.12a, pancreata in these animals have a largely 
unremarkable acinar compartment populated by histologically normal acinar cells. 
Extensive fat deposits, first observed at six weeks post-ablation, remained throughout 
the pancreas (Figure 4.12b-d), although tubular complexes are largely absent, 
indicating a return to steady-state conditions. Examination of the tissue for precancerous 
lesions revealed a general lack of PanINs, although several small proliferative ductal 
lesions were apparent (Figure 4.12c,d – black boxes). The observed lesions were 
presumably derived from the Xbp1fl/fl tissues in response to the inflammatory 
environment generated, since we had previously demonstrated that these mice had 
nearly complete loss of the Xbp1ΔEx2 acinar population. These lesions expressed high 





Figure 4.10 Proliferation takes place in multiple cell compartments following ER 
stress-induced death of the Xbp1ΔEx2 acinar cells 
(A,B) Ki67 and phospho-Histone 3 (pH3) stainings of 4 week pancreatic sections show 
expression (black arrows) and proliferation in the Xbp1fl/fl acinar population. (C,D) 
Staining shows coexpresion of HES1 and SOX9 in centroacinar cells (black arrows). (E) 




Figure 4.11 Regenerated acinar cells are larger than control cells and contain more 
widely distributed zymogen granules 
(A) Comparison of control and 12 week post-ablation pancreata showing a larger 
zymogen compartment (white outlines). (B) Amylase stain revealing cell-wide zymogen 
localization of amylase vs. tight, apical localization in control pancreata. Outlines denote 
cell boundaries among individual acini. (C) Quantification of cell and nuclear size shows 
increases relative to control that persist through 12 weeks post-ablation. (* = p-value < 







Figure 4.12 12 month post-ablation pancreata have normal acinar compartments but 
persistent signs of damage 
(A) 12 month post-ablation acinar cells have normal histological appearance and 
zymogen localization. (B) Fat deposition remains throughout the pancreas, although 
healthy acinar cells (Ac) exist within the deposits. (C) Histologically unusual areas exist 
in 12 month post-ablation pancreata including ductal structures (black boxes). (D) High-
magnification image of a ductal structure (black box) showing mucinous deposition 
(purple stain) but no nuclear atypia.  
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known histological feature of developing PanINs (Figure 4.01a). The lack of typical 
precancerous lesions is not unexpected, as previous reports have shown that 
even the presence of the potent the KrasG12D oncogene is unable to rapidly generate 
pancreatic tumors without the addition of either other oncogenes or inflammation via 
induced pancreatitis (Guerra et al., 2007; Hruban et al., 2006). We thus sought to 
investigate whether addition of a Cre-inducible KrasG12D transgene (LSL-Kras) into the 
Mist1CreER/+; Xbp1fl/fl line would lead to increased development of PanIN lesions 
immediately following ER stress-induced acinar cell loss.  
 
Mist1CreER/+; Xbp1fl/fl; LSL-KrasG12D (XKC) mice were generated through standard 
breeding techniques. These mice underwent acinar-specific Xbp1 ablation with 
simultaneous expression of the KrasG12D oncogene (Figure 4.01b). Activation of the 
LSL-KrasG12D transgene in otherwise normal mice (Mist1CreER/+; LSL-KrasG12D, or KC 
mice) leads to formation of small, focal PanIN lesions with occasional advanced, 
mucinous neoplasms and desmoplasia by six weeks post-Cre administration (Figure 
4.13 a,b, yellow outlines). We therefore administered tamoxifen to KC and XKC mice 
and sacrificed the animals at six weeks post-ablation/activation to determine whether 
these animals exhibited increased susceptibility to PanIN formation. 
 
As shown in Figure 4.13c, XKC mice have extensive stromal infiltration of their 
periacinar spaces by six weeks post-tamoxifen. This is consistent with standard 
Mist1CreER/+; Xbp1ΔEx2 mice that are recovering from loss of the Xbp1ΔEx2 acinar 
population, indicating that a similar apoptotic fate was encountered by the Xbp1ΔEx2; 
LSL-Kras acinar cells as their counterparts lacking Kras expression. We then used 
standard histological stains on isolated pancreatic extracts in order to identify and 
quantify the types and numbers of lesions found in both Mist1CreER/+; Xbp1ΔEx2; LSL-Kras 
mice and control animals lacking the Xbp1fl/fl allele. As shown in Figure 4.13d, mice in 
which Xbp1 had been ablated had significantly fewer small lesions as well as half as 
many advanced lesions. These data show that ablation of Xbp1 results in significantly 
fewer small lesions per section as well as half as many advanced lesions indicating  








Figure 4.13 Ablation of Xbp1 reduces occurrence of ADM and early PanINs in XKC 
mice 
(A) H&E stain of a focal, KRAS-derived lesion (yellow outline). (B) H&E stain of an 
advanced lesion (yellow outline) with extensive stromal infiltrate (red arrows). (C) 
Comparison of the acinar compartments of 6 week post-tamoxifen Mist1CreER/+; LSL-
KrasG12D (KC) mice and Mist1CreER/+; Xbp1fl/fl; LSL-KrasG12D (XKC) mice reveals extensive 
stromal infiltrate and tubular complex formation (white arrows) in XKC mice. (D) 
Histogram showing numbers of focal and advanced lesions in XKC vs. KC mice per 
tissue section. There is a nearly 16-fold reduction in focal lesions along with a 2-fold 




Studies of pancreatitis damage often focus on rapid, organ-level responses or long term 
development of malignancies. Specifically, the use of rodent models to study damage as 
it relates to oncogenesis often utilizes expression of activated mutant forms of KRAS, an 
intrinsic stressor that drives transformation (Hruban et al., 2006). These studies allow an 
exquisite level of genetic and chemical cell manipulation for studying acinar responses, 
but fail to account for the effects of chronic damage or inflammation on cancer 
progression. In contrast, research involving pancreatitis typically uses administration of 
the secretagogue caerulein to trigger supramaximal levels of aberrant zymogen 
secretion (Jungermann et al., 1995). This damage event mimics the appearance of 
severe acute pancreatitis in human patients including the appearance of inflammatory 
infiltration of the periacinar spaces, loss of exocrine tissue, and edema (Niederau et al., 
1985). Supramaximal zymogen secretion, however, is not a recognized cause of 
pancreatitis in human patients, most of whom exhibit acinar cell loss and inflammation 
following pancreatic duct obstruction by gallstones (Jha et al., 2009). Additionally, 
induction via large doses of caerulein produces inconsistent disease states with mild to 
severe inflammation and a large degree of variability in time until recovery (Su et al., 
2006). Other pancreatitis model systems have similar issues with variable inflammatory 
induction and variable timing until recovery, making none of the existing systems ideal 
for investigating acinar and organ regeneration in response to severe instrinsic stresses 
including ER stress. In this study we characterized recovering pancreata in Mist1CreER/+; 
Xbp1ΔEx2 mice (Figure 4.14) following extensive ER stress-induced acinar cell death in 
order to establish that a near complete exocrine recovery is accompanied by expansion 
of the acinar and centroacinar compartments. 
 
The extensive acinar cell death observed in Mist1CreER/+; Xbp1ΔEx2 mice (Figure 3.10) 
triggered formation of ductal tubular complexes, collagen and stromal matrix deposition, 
and infiltrating immune cells (Figure 4.02). The stromal and immune components of this 
response are a key finding as recent studies have indicated that stromal-epithelial 
interactions may play a substantial role in progression of cancer (Hwang et al., 2008). 
Furthermore, the activation of embryonic signaling pathways  (Figure 4.03) mimics 








Figure 4.14 Timeline of damage and regeneration in Mist1CreER/+; Xbp1ΔEx2 pancreata  
(A) Schematic summarizing the effects of ablation of Xbp1 on ER stress, damage, and 
reporter gene expression before and after crisis. (B) Schematic summarizing the 
regeneration and recovery phenotypes observed following Xbp1 ablation.  
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that the recovery mechanisms following ER stress-induced exocrine damage are 
consistent with other forms of injury. Additionally, the timing of recovery from the ER 
stress-induced apoptotic crisis may increase the utility of the Mist1CreER/+; Xbp1ΔEx2 model 
for studying pancreatic regeneration, as an extended, two-week window would allow for 
increased observation of molecular events that occur fleetingly during recovery. 
 
As previously described, caerulein-induced pancreatitis is highly variable in terms of its 
severity and timing of recovery (Su et al., 2006). In contrast, mice undergoing ER stress-
induced acinar cell death in the Mist1CreER/+; Xbp1ΔEx2 model exhibit an extended and 
consistent period of damage and recovery. Acinar tissue succumbs to apoptosis on or 
about the fourth week following ablation (Figure 4.04), with the majority of recovery 
occurring during a two week period four to six weeks after Xbp1 ablation. This recovery 
completely ameliorates the ER stress condition (Figure 4.05) while restoring normal 
exocrine parameters (Figure 4.06) and exhibiting stromal and ductal cell remodeling in 
the periacinar spaces (Figure 4.07). Additionally, acinar cell zymogen compartments 
remain dilated for at least 12 weeks following ablation (Figure 4.11), but resolve to 
normal size by 12 months (Figure 4.12). Compensatory mechanisms may be 
necessitating this altered acinar morphology during the recovery period, but the 
regenerative process eventually allows cells to resume their normal structure and 
function. These events all take place over a span of weeks or months and allow for a 
thorough analysis of cellular and organ responses. This is a distinct advantage over the 
highly variable and rapid regeneration observed in response to caerulein which fully 
restores the organ 9-12 days following cessation of treatment (Adler et al., 1979). 
While the exact source of regenerated acinar cells in Mist1CreER/+; Xbp1ΔEx2 pancreata 
cannot be determined due to limitations in lineage tracing in the system, proliferation 
analysis indicates that both the acinar and centroacinar compartments reenter the cell 
cycle (Figure 4.10). This finding could lead to a reexamination of how these two cell 
types may play a role in regeneration. Indeed, analysis of pancreata 12 months after 
Xbp1 ablation indicated persistent damage in the form of fat deposition and ductal lesion 
formation (Figure 4.12), a unique long-term affect not typically seen in caerulein-induced 
models of acute pancreatitis. As a result, the Mist1CreER/+; Xbp1ΔEx2 system could be ideal 
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for developing intervention strategies, including treatments for pancreatitis, as the long-
term effects are persistent and unique compared to those seen in other model systems. 
Finally, we examined whether damage inflicted via ER stress-induced acinar cell 
destruction could exacerbate KrasG12D-driven transformation. Our initial hypothesis was 
that the pro-inflammatory environment generated by loss of the Xbp1ΔEx2 population 
would increase the occurrence of ductal lesion formation. However, as shown in Figure 
4.13d, we actually observed a drastic reduction in focal and advanced lesions. Upon 
further consideration, this is likely due to the high levels of stress that were placed on the 
Xbp1ΔEx2; KrasG12D-expressing acinar cells, who likely succumbed to apoptosis prior to 
any substantial oncogenic development. Interestingly, while this hypothesis explains the 
overall lack of small PanIN lesions in the pancreas, the presence of several advanced 
growths could imply that the inflammatory environment generated by Xbp1ΔEx2-driven 
apoptosis created a permissive environment for development of lesions from acinar cells 
that only recombined the LSL-Kras gene without ablation of Xbp1. Alternatively, the 
advanced lesions could represent acinar cells whose transformation had occurred before 
the onset of Xbp1 ablation-mediated ER stress, implying that current work investigating 
ER stress as a means of therapy may need to focus on specific stages of cancer 
progression. Both hypotheses can be tested in future work utilizing independent 
induction systems for the Xbp1flox allele and expression of KRASG12D. 
This study demonstrates that the Mist1CreER/+; Xbp1fl/fl system is a viable system for 
generating intrinsic, ER stress-derived damage in the exocrine pancreas. Furthermore, 
recovery from this damage is prolonged, recapitulating several known characteristics of 
pancreatic regeneration including stromal deposition, immune cell infiltration, and 
proliferation of pre-existing cells. This regeneration is consistent in terms of timing, with 
animals reaching peak pancreatic damage four weeks after Xbp1 ablation and 
subsequent full recovery taking place over a period of at least eight weeks. These 
characteristics make the Mist1CreER/+; Xbp1fl/fl system ideal for studies of acinar cell 














CHAPTER 5. MIST1 FUNCTIONS AS A TRANSCRIPTIONAL SCALING FACTOR IN 
THE XBP1-MEDIATED BRANCH OF THE UNFOLDED PROTEIN RESPONSE 
5.1 Introduction 
As discussed previously and later in Chapter 6, multiple forms of stress can lead to 
acinar-ductal metaplasia in the mature pancreas. This ability of acinar cells, once 
considered a terminally differentiated cell population, to alter their identity to deal with 
stress reveals the remarkable plasticity governed by transcriptional networks in adult 
pancreatic tissues. One of the key transcription factors linked to maintenance of the 
acinar differentiation program is the acinar cell-specific transcription factor MIST1. 
 
MIST1 is a basic helix-loop-helix (bHLH) transcription factor found exclusively in 
secretory tissues including secretory B cells, zymogenic chief cells, and pancreatic 
acinar cells (PACs) (Capoccia et al., 2011; Pin et al., 2000). In the pancreas, MIST1 is 
restricted to healthy acinar cells (Figure 5.01a) and is known to be downregulated as an 
early feature seen in human ADM lesions (Figure 5.01b). While MIST1 is not essential 
for pancreatic development, its presence is refractory to ADM lesion formation, as 
Mist1KO mice develop spontaneous ductal lesions as they age (Pin et al., 2001). This 
suggests that MIST1 plays a role in maintaining acinar cell identity via regulation of its 
transcriptional targets. 
 
MIST1 has also been shown to be essential for a number of normal acinar cell properties 
including cell communication, coordinated secretion, and refraction to oncogenic and 
pancreatitis-induced acinar cell damage (Direnzo et al., 2012; Kowalik et al., 2007; Shi et 
al., 2012). Importantly, these phenotypes are all reversed upon exogenous expression of 
a Cre-inducible MIST1 transgene in adult pancreata, indicating that MIST1 actively 
maintains adult PACs rather than merely facilitating their proper development (Direnzo et 











Figure 5.1 MIST1 is a basic helix-loop-helix transcription factor expressed in 
pancreatic acinar cells 
(A) Immunohistochemical (IHC) stain for MIST1 shows expression in acinar tissue but 
not in islets or blood vessels. (B) IHC stain on a human tissue specimen reveals a lack 
of MIST1 expression in ADM lesions. (C) Consensus sequences for a general E-box as 
well as the preferred MIST1 binding sequences. (D) Diagram of MIST1 truncations and 
relative transcriptional activity, revealing that the bHLH region is sufficient to activate 




MIST1 is a classic bHLH transcription factor, binding to DNA target sequences termed 
E-boxes (enhancer boxes) and, more specifically the TA and GC variants (Figure 5.01c) 
(Direnzo et al., 2012). However, MIST1 has been shown to lack a recognized 
transcriptional activation domain (Tran et al., 2007). In fact, MIST1 can still activate or 
repress its transcriptional targets even when truncated down to only its DNA binding 
bHLH domain (Figure 5.01d) (Tran et al., 2007). This activity is under current 
investigation in the Konieczny lab in an attempt to identify whether MIST1 serves as the 
DNA targeting component of a bHLH protein:protein complex with a transcriptional 
activator or repressor. Recent work by others, however, has postulated that MIST1 is 
part of a relatively new class of transcriptional regulators termed “scaling factors” (Mills 
and Taghert, 2012). 
 
The concept of a scaling factor purports that cells utilize unique transcription factors to 
more effectively specialize in specific tasks following initial differentiation during 
development (Mills and Taghert, 2012). These factors would function to scale up certain 
features including expansion of an extensive secretory compartment or a regulated, 
polarize cellular architecture in secretory cells. Importantly, these genes would not be 
required for the initial establishment of many cell features, but adult cells would require 
their constitutive expression in order to maintain a fully functional repertoire of unique, 
cell-specific capabilities. MIST1 is a prime candidate for classification as a scaling factor, 
as it is not essential for development of the acinar cell secretory machinery or for initial 
specification, but mature acinar cells lacking MIST1 have impaired secretion and a 
predisposition to transdifferentiate (Direnzo et al., 2012; Pin et al., 2001). Interestingly, 
MIST1 is also found exclusively in serous secretory cells, indicating that its scaling 
capabilities may be responsible for increasing the secretory capacity of specialized cells 
(Pin et al., 2000). This characterization of MIST1’s role in acinar cells is remarkably 
similar to the description of many features of the unfolded protein response, which is 
itself a specialized transcriptional network designed to facilitate high protein throughput 
in secretory cells. 
 
The UPR is a reactive transcriptional response in which misfolded proteins trigger 
activation of three distinct ER-embedded sensors; (PKR)-like ER kinase (PERK), 
activating transcription factor 6 (ATF6), or inositol requiring enzyme 1 (IRE1) (See 
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Figure 1.05 for summary) (Walter and Ron, 2011). IRE1 activates its targets via a 
unique endoribonuclease domain that cleaves a 26 nucleotide fragment from the mRNA 
of the Xbp1 gene, which causes a frameshift in the translated XBP1 protein (Ron and 
Walter, 2007). This protein, termed XBP1s, then proceeds to the nucleus where it 
activates its transcriptional targets. We previously have shown that XBP1s is essential 
for proper functioning of the UPR in PACs (Hess et al., 2011).  
 
From a transcriptional standpoint, XBP1 shares extensive overlap in targets with nATF6, 
the downstream effector of the ATF6 branch of the UPR (Yamamoto et al., 2004). In 
fact, both are capable of binding a specific DNA sequence termed the ER stress element 
(ERSE), a variable consensus sequence with a five base pair CCACG core but generally 
described as CCAAT-N9-CCACG (Acosta-Alvear et al., 2007). Interestingly, XBP1 is 
capable of binding the CCACG core directly while nATF6 requires the co-binding of NF-γ 
at the upstream CCAAT site before binding.  XBP1 also has a unique binding site with a 
four-nucleotide ACGT core and a general sequence of CGACGTG(G/A). The relative 
abundance of the short CCACG and ACGT sequences in the genome, coupled with the 
highly variable nature of the consensus binding sequences, has made bioinformatics 
identification of XBP1 direct targets difficult.  
 
MIST1 has been previously linked to expression of XBP1 in a developmental context, as 
zymogenic chief cells (ZC) in the stomach of Xbp1ΔEx2 mice fail to express MIST1 when 
differentiating (Huh et al., 2010). Surprisingly, these cells did not show signs of ER 
stress despite the lack of XBP1 and MIST1, implying that the effects and targets of 
XBP1 may be specific to certain cellular contexts. ZCs and other stomach cells are 
constantly regenerating, as opposed to the adult pancreas which, in an unstressed 
condition, has a turnover rate of less that 1% (Oates and Morgan, 1982). As previously 
shown in Figure 3.01 and in contrast to ZCs, acinar cells in Xbp1KO mice express MIST1 
, again indicating that the developmental role of XBP1 as a regulator of MIST1 may not 
be the same for all cell types.  
 
Generally speaking, XBP1 targets tend to facilitate protein folding including components 
expressed throughout the ER and secretory pathway (Sriburi et al., 2007). ER stress, 
however, is relatively unique in that it occurs infrequently outside of development or in 
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unusual environmental conditions such as hypoxia (Tsang et al., 2010). The exception to 
this general rule is in secretory cells, whose primary function is to generate large 
volumes of proteins that must properly traffic through the ER and Golgi. Highly secretory 
cells, such as pancreatic acinar cells (PACs), have constitutive activation of the UPR 
due to the demand placed on their synthetic machinery (Iwawaki et al., 2004). As a 
result, one can envision a scenario in which the UPR in secretory cells could regulate 
expression of scaling factors that proceed to independently facilitate secretory cell 
homeostasis. Such factors could either regulate the expression of unique target genes 
outside the canonical UPR pathways, or could aid in increased expression of existing 
target genes. We sought to investigate whether ER stress in PACs triggers expression of 
the scaling factor MIST1 and its downstream targets 
 
In this study, we utilized in vitro studies with cell lines to characterize the expression of 
Mist1 following chemically-induced ER stress. We show a similar expression phenotype 
in acinar cells from mice lacking XBP1 or MIST1 in a 3D culture system. We also 
demonstrate that expression of XBP1 following ER stress leads to upregulation of Mist1 
via direct interaction with its promoter. Furthermore we show via bioinformatic analysis 
that a subset of likely MIST1 target genes are induced during periods of ER stress and 
share a similar expression pattern to Mist1. We thus conclude that Mist1 is a direct 
target of XBP1 and that it functions to control target genes as a component of the 
unfolded protein response. 
 
5.2 Induction of ER stress leads to activation of MIST1 
ER stress frequently results when increased demand for protein synthesis surpasses the 
limit of what the basal cellular machinery is capable of producing. Such a condition was 
likely in the Xbp1ΔEx2 pancreata during crisis (4 weeks post-Xbp1 ablation), as the 
minority Xbp1fl/fl acinar cells were forced to synthesize sufficient quantities of zymogens 
to maintain the health of the animal. In order to test this, we stained pancreatic sections 
from Xbp1ΔEx2 mice during crisis (4 weeks post-Xbp1 ablation) for phosphorylated 
eukaryotic initiation factor 2 (pEIF2α), the primary target in the PERK UPR branch.  As 
shown in Figure 5.02b, both zymogenic (red outlines) and non-zymogenic (yellow 
outlines) were positive for pEIF2α while associated blood vessels (BV) and stromal cells 







Figure 5.2 Xbp1fl/fl acinar cells undergo ER stress and express higher than normal 
levels of MIST1 during pancreatic crisis 
(A) IHC stain for phospho-EIF2α (pEIF2α) shows little to no staining in wild-type 
pancreata. (B) IHC stain for pEIF2α in 4 week post-Xbp1 ablation pancreata reveals 
extensive staining (red arrows) in zymogenic (red outlines) and non-zymogenic (yellow 
outline) cells. No staining (black arrows) is present in blood vessels (BV) or associated 
stromal tissue (blue outline). (C) RT-qPCR for Mist1 shows increased expression 
following Xbp1 ablation up until apoptotic crisis, then decreasing to wild-type levels by 6 
weeks. (D) Immunofluorescence image showing high levels of MIST1 staining largely 
restricted to the zymogenic acinar population (white outlines). (* = p-value ≤ 0.05 relative 




acinar population also underwent ER stress, but did not express CHOP or initiate an 
apoptotic cascade, likely due to an intact UPR.  
 
We next sought to determine whether Mist1 expression was affected by ER stress 
induction. Mist1 transcript levels were quantified using pancreatic RNA isolated from 
Xbp1ΔEx2 mice following Xbp1 ablation. As shown in Figure 5.02c, MIST1 expression 
increased over control pancreata by 3.5 fold, peaking during apoptotic crisis before 
returning to normal. This was surprising as Mist1 is constitutively expressed in normal 
acinar cells and is not generally associated with dying cells. We proceeded to stain 
pancreatic sections taken at 4 weeks post-Xbp1 ablation (Figure 5.02d) and saw high 
expression of MIST1 (white arrows) that was restricted to the zymogenic acinar 
population, with only minimal MIST1 staining in the non-zymogenic, Xbp1ΔEx2 cells. This 
indicated that the 3.5-fold increase in Mist1 expression levels was due to the <10% of 
acinar cells that had retained XBP1 expression. This prompted us to investigate whether 
MIST1 expression was a common feature of cells undergoing ER stress. 
 
In order to investigate whether MIST1 expression was a common hallmark of cells 
undergoing ER stress we turned to in vitro cell lines. Cell lines have a distinct advantage 
versus mice as they can be induced to enter ER stress via treatment with a number of 
chemicals, including thapsigargin (a sarco/endoplasmic reticulum calcium ATPase 
inhibitor that slows protein transport in and out of the ER), tunicamycin (an inhibitor of n-
linked glycosylation that prevents ER sorting of peptides), and DTT (a reduction agent 
that cross-links protein disulfide bonds). Each of these induces transient ER stress and a 
subsequent UPR within treated cells, allowing analysis of downstream signaling 
pathways and molecular events. 
 
We first screened a number of non-transformed and transformed cell lines for normal 
UPR initiation, since the tumors that were used to derive transformed lines are usually 
subjected to and survive hypoxia and UPR-mediated apoptosis, possibly indicating an 
aberrant cellular response to stress  (Ma and Hendershot, 2004). As shown in Figure 
5.03a-b, analysis of non-transformed mouse embryonic fibroblasts (MEFs) and mouse 
266-6 cells (SV40 large T antigen immortalized, non-transformed pancreatic acinar cells) 
showed significant Xbp1 splicing following ER stress induction via thapsigargin that 
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remained high at 36 hours post treatment. In contrast, HEK293 (human embryonic 
kidney), MDA231 (human mammary gland adenocarcinoma), and PANC1 (human 
pancreatic cancer) cell lines all lacked significant Xbp1 splicing following treatment 
despite strong induction of BiP expression, confirming that these cells also exhibited 
increased ER stress (Figure 5.03c-e). Thus, we concluded that non-transformed cell 
lines would be the most effective cells for studying UPR targets. 
 
We next sought to determine whether we could replicate the induction of Mist1 
expression following ER stress that we observed in Xbp1fl/fl acinar cells in cultured cells 
with a normal UPR response. This involved treating cell lines with thapsigargin and 
harvesting RNA, protein, and fixed cells for closer analysis. Despite increased Mist1 
transcript levels following thapsigargin treatment in MEFs (Figure 5.04a), no MIST1 
protein could be detected by protein blot or immunohistochemical staining (Figure 
5.04b). Interestingly, a MEF line derived from reporter mice in which β-galactosidase 
was knocked into the Mist1 locus revealed that the Mist1 locus was transcriptionally 
active during ER stress, but only in a minority of cells. This led us to conclude that Mist1 
expression in MEFs may be alternatively regulated, either in a cell cycle-dependent 
fashion or possibly via post-translational silencing of MIST1.  
 
266-6 cells are known to express acinar cell digestive enzyme transcripts and respond to 
some secretagogues, making them among the most “acinar-like” cell lines available. 
Protein analysis performed in the Konieczny lab by Patrick Schweickert confirmed 
MIST1 expression in wild-type cells, making them relatively unique among pancreatic 
cell lines that are usually derived from ductal cancers in which MIST1 is silenced. 
Characterization of the 266-6 cell line following ER stress induction revealed increased 
Mist1 transcripts and MIST1 protein, with strong expression maintained up to 36 hours 
post-thapsigargin treatment (Figure 5.04c-d). Immunohistochemical staining of fixed 
266-6 cells also showed a strong induction of MIST1 protein after ER stress onset 
(Figure 5.04e-f). These data confirmed our hypothesis that Mist1 is indeed expressed 









Figure 5.3 266-6 cells and mouse embryonic fibroblasts splice Xbp1 in response to 
thapsigargin 
RT-qPCR using primers for spliced Xbp1 and BiP transcripts following thapsigargin 
treatment in: (A) Mouse embryonic fibroblasts, high expression of both transcripts. (B) 
266-6 cells, high expression of both transcripts. (C) HEK293, little expression of Xbp1s 
despite BiP induction. (D) MDA231, high levels of BiP induction without associated 
Xbp1s expression. (E) Panc1, high levels of BiP with no Xbp1s. (* = p-value ≤ 0.05 






Figure 5.4 266-6 cells express MIST1 in response to ER stress 
(A,B) RT-qPCR and protein blot on thapsigargin-treated WT MEFs reveals increased 
Mist1 transcripts but no detectable MIST1 protein. (C,D) RT-qPCR/western blot in 
thapsigargin-treated 266-6 cells shows increased Mist1 transcripts and protein. (E,F) 
IHC stain for MIST1 reveals few positively-stained cells (white arrows) in basal-state 
266-6 cells and extensive staining following ER stress induction via thapsigargin. (* = p-
value ≤ 0.05 relative to control samples, normalized to 18s expression)  
109 
 
5.3 Mist1 is specifically targeted by XBP1 under conditions of ER stress 
Following confirmation of increased Mist1 expression during ER stress, we next sought 
to investigate whether XBP1 activity could be correlated with Mist1 expression or its 
activities. Since MIST1 is known to control acinar identity and differentiation, we utilized 
a collagen-based 3D acinar cell culture system to study whether ablation of Xbp1 would 
cause any changes in Mist1 levels or acinar differentiation status.  We harvested 
Xbp1ΔEx2 acinar cells 48 hours post-ablation and embedded them in a 3D collagen 
matrix. As shown in Figure 5.05a, Xbp1ΔEx2 acinar cells are initially deficient in Mist1 and 
become moreso by 48 hrs post-embedding (96 hours post-Xbp1 ablation). We also 
gauged acinar differentiation status by quantifying the degree to which the embedded 
acinar clusters converted to duct-like cysts upon treatment with TGFα, an extracellular 
growth factor receptor agonist that mimics activated KRAS signaling (Figure 5.05b). 
Xbp1ΔEx2 acinar cells showed an increased tendency to undergo ductal cyst 
transdifferentiation when treated with TGFα, a similar phenotype seen in embedded 
Mist1KO acinar cells (Shi et al., 2012). Interestingly, Xbp1ΔEx2 acinar cells also showed a 
marked tendency to spontaneously convert in the absence of TGFα (Figure 5.05c), 
implying an intrinsic differentiation defect that may be related to a lack of Mist1 induction. 
 
We next sought to experimentally determine whether Mist1 was expressed in response 
to UPR and Xbp1 activation. To accomplish this we acquired Xbp1KO MEFs, a generous 
gift from Dr. Ann-Hwee Lee at Harvard University. These cells were derived from Xbp1KO 
embryos, avoiding the problem of post-natal lethality known to occur in Xbp1KO neonates 
and allowing analysis in a mouse cell completely devoid of XBP1 protein. Similar to the 
Xbp1ΔEx2 allele, these mice have a missing second exon, resulting in a truncated, 
nonfunctional protein but still undergoing IRE1-mediated RNA splicing, allowing splice-
specific primers to be used to measure ER stress induction (Lee et al., 2003). We 
repeated our initial characterization studies of MEFs, this time utilizing WT and Xbp1KO 
lines to assay whether Mist1 transcript levels were induced following ER stress in the 
absence of XBP1. Intriguingly, Xbp1KO MEFs failed to upregulate Mist1 gene expression 
upon ER stress induction, indicating that XBP1 was responsible for Mist1 expression 







Figure 5.5 Loss of Xbp1 in vitro results in increases in induced and spontaneous 
ductal cyst formation 
(A) RT-qPCR data on isolated acinar clusters in our collagen-based 3D culture system 
showing a precipitous drop in Mist1 expression in Xbp1ΔEx2 acinar cells relative to 
isolated wild-type acini. (B) Counts of ductal cyst formation in wild-type vs. Xbp1ΔEx2 
acinar cells shows significantly increased cyst generation in Xbp1ΔEx2 acinar cells 
following TGFα treatment. (C) Ductal cysts spontaneously form at a significantly higher 
rate in Xbp1ΔEx2 acinar cells. (* = p-value ≤ 0.05 relative to control samples, Fig. A 




activation by other UPR branches by transfecting MEFs with an Xbp1s-encoding plasmid 
that caused increased Mist1 transcript levels similar to those seen in response to 
thapsigargin (Figure 5.06b). These data indicated that XBP1 activity was directly 
responsible for increased Mist1 expression during ER stress. 
 
We next sought to determine whether the Mist1 gene was a direct transcriptional target 
of XBP1. This initially involved a sequence analysis of both the human (huMist1) and 
mouse (muMist1) promoters, which encode similar proteins but are structurally distinct 
due to the presence of an untranslated first exon in the mouse sequence (Figure 5.07a). 
We scanned the 1000 base pairs preceding the transcriptional start site of msMist1 and 
the corresponding region of huMist1 through to the end of the gene and identified no ER 
stress element (ERSE) consensus sequences, eliminating the possibility of a joint 
ATF6/XBP1 induction of MIST1. Analysis of the same sequence in the msMist1 gene for 
the XBP1-specific unfolded protein response element (UPRE) (Figure 5.07b) revealed 
two candidate sites within the mouse gene, termed site A and site B, both matching 7/8 
nucleotides of the consensus UPRE sequence. Intriguingly, these sites are either 
partially (site A) or fully (site B) conserved in the huMist1 promoter, with the partially 
conserved huMist1 site A (termed A’) actually matching 8/8 nucleotides of the consensus 
UPRE.  
 
In order to determine whether XBP1 could bind to and activate these regions of the 
Mist1 promoter, we utilized luciferase containing fragments of the msMist1 promoter 
through intron 1 sequences. These plasmids were cotransfected into 266-6 cells along 
with an expression plasmid encoding XBP1. As shown in Figure 5.07c, the promoter 
fragment containing both candidate sites was capable of producing a 7-fold increase in 
luciferase expression relative to control, indicating XBP1s could directly bind that region 
of the Mist1 promoter. Intriguingly, when we tested mutated reporter plasmids in which 
either Site A (mutA) or Site B (mutB) had been mutated to remove the UPRE (GACGTG 
-> ACTAGT), it was the partially conserved site A that had reduced luciferase activity 
while mutation of site B had no significant impact on luciferase expression. We thus 













Figure 5.6 XBP1 is directly responsible for inducing Mist1 expression 
(A) RT-qPCR on spliced Xbp1 transcripts in Xbp1KO MEFs indicates ER stress induction 
following thapsigargin treatment but with no increase in Mist1 expression levels. (B) RT-
qPCR analysis of vector (control) or Xbp1s transfected MEFs shows a significant 
increase in Mist1 transcripts in cells expressing XBP1s. (* = p-value ≤ 0.05 relative to 





Figure 5.7 XBP1 activates reporter gene expression in Mist1-promoter region 
constructs 
(A) Schematic of the mouse and human Mist1 genes (msMist1 and huMist1, 
respectively). HuMist1 contains only one exon that consists of mostly the entire coding 
sequence (CDS), although a 87% sequence match exists between msMist1 exon 1 and 
an upstream huMist1 region (green box). (B) Sequence analysis of huMist1 and 
corresponding region of msMist1 showing the location of two conserved putative XBP1s 
binding sites (A/A’, B). (C) Luciferase expression data following XBP1/Mist1pr-Luc 
constructs in 266-6 cells, showing increased expression in the construct containing both 
UPREs. Increased expression is lost by mutating site A but unaffected by mutating site 
B. (* = p-value ≤ 0.05 relative to pGL3p luciferase value after Xbp1 transfection) 
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As a final verification that XBP1-mediated activation of MIST1 was an important 
component of MIST1’s activity, we expanded our sequence analysis to an additional 
eight species to determine whether either of the two candidate UPRE sites were 
conserved. As shown in Table 5.01, site A (found in exon 1) is conserved in human, 
mouse, and rat while site B (found in intron 1) is 100% conserved across five species. 
Interestingly, four of the remaining five species also have putative XBP1 binding sites 
matching the UPRE consensus sequence, indicating that XBP1 binding to the Mist1 
promoter plays an important role across higher eukaryotes. 
 
5.4 Proposed MIST1 targets are induced during ER stress 
We found no published data analyzing pancreatic acinar cells in the context of ER 
stress. Rather than conducting costly microarray or RNA-seq genome-wide expression 
studies, we chose to bioinformatically search for possible MIST1-regulated genes by 
correlating available published microarray data on XBP1 and the Konieczny lab’s own 
data regarding unstressed pancreata. A detailed description of this analysis can be 
found in Chapter 2, and selection criteria are summarized in Figure 5.08. Briefly, we 
generated a list of 184 possible MIST1 effectors based on published microarray data 
utilizing fibroblasts transfected with XBP1 as well as general UPR-associated genes 
gleaned from literature searches and commercially available UPR PCR arrays. We then 
refined this list using data generated previously by the Konieczny lab by selecting only 
genes with significant ChIP-Seq enrichment scores, expression changes following 
induction of a Mist1 transgene in a Mist1KO acinar cells, and the presence of either TA or 
GC E-boxes in the promoter and first two exons and introns of each candidate gene. 
Finally, we cross-checked our remaining candidate effectors against available 
microarray data from Ire1KO liver samples treated with tunicamycin as a final selection 
criteria, selecting for genes with significantly altered expression levels in WT vs. Ire1KO 
samples. This analysis resulted in a short list of 15 high-scoring candidates satisfying all 
criteria, with a further 6 genes with strong scores in most areas but that failed to satisfy 











Table 5.1 Evolutionary conservation of UPRE sites in the Mist1 gene  
Sequence analysis indicates a 100% conservation of the putative UPRE binding site in 
intron 1 across five species. Four additional species have variants on UPRE sites in 
similar locations, with only one species lacking any identified XBP1 binding site. 
 
  Intron 1 (Site 2) Exon 1 (Site 1) 
Species Sequence UPRE Match Sequence UPRE Match 
Human CCACGTGG 7/8 CGACGTGT 8/8 
Mouse CCACGTGG 7/8 CTACGTGT 7/8 
Rat CCACGTGG 7/8 CGACGTGT 8/8 
Chimp CCACGTGG 7/8 N/A N/A 
Wolf CCACGTGG 7/8 N/A N/A 
Killer Whale CGACGTGT 8/8 N/A N/A 
Tasmanian Devil AGACGTGA 6/8 N/A N/A 
Drosophila GGACGTGG 7/8 N/A N/A 
Zebrafish CAACGTGC 6/8 N/A N/A 









Figure 5.8 Summary diagram of candidate gene selection criteria 
Selection criteria for putative MIST1-dependent UPR target genes. Each circle 
represents an additional criteria, with the number of genes possessing that criteria and 






Following the selection of likely MIST1 targets, we next sought to determine if any of the 
purported effectors were upregulated following ER stress induction. Given the previously 
discussed cell context specificity of XBP1’s targets, we determined that an investigation 
of MIST1’s role in the UPR necessitated a viable system for triggering ER stress 
specifically in pancreatic acinar cells at higher levels than normally present under basal 
conditions. However, the available Xbp1fl/fl mouse model generated extensive and  
cumulative ER stress in acinar cells, but removed XBP1, our hypothesized MIST1 
activator. Published reports on targeted deletions of other UPR master regulators in 
mice did not show extensive ER stress as a consequence of their deletion (Reimold et 
al., 2000; Urano et al., 2000; Yamamoto et al., 2007; Zhang et al., 2002). Our own 
efforts at inducing ER stress induction in vivo via intraperitoneal injection of both 
thapsigargin and tunicamycin showed that such agents either resulted in animals that 
became rapidly nonresponsive and ill or a cellular response that was insufficient to 
initiate a UPR. We thus determined that 266-6 cells would be our best system for 
monitoring how MIST1 functions in the UPR. 
 
We conducted a time course on 266-6 cells treated with thapsigargin to induce ER 
stress. These cells were harvested every 12 hours for RNA in order to study expression 
changes of candidate genes. Interestingly, analysis of transcript levels over repeated 
thapsigargin challenges indicated that Xbp1s expression following thapsigargin 
challenge in 266-6 cells rapidly climbs and diminishes, while Mist1 expression increases 
and remains elevated for 36 hours after induction (Figure 5.09a). Because of the 
sustained Mist1 expression levels, we hypothesized that MIST1 targets would follow a 
similar expression pattern, with an initial increase following thapsigargin treatment and 
subsequent prolonged elevation. We proceeded to design primers for each candidate 
target gene to test the expression pattern of each following ER stress in 266-6 cells. 
 
As shown in Figure 5.09c, 14 of the 21 candidate MIST1 target genes behave similarly 
to Mist1, with an initial spike in expression at 12 hours post-ER stress induction followed 
by sustained expression over the following 24 hours. This expression pattern is 
consistent with our hypothesis regarding MIST1 targets being expressed in a similar 







Table 5.2 Summary of candidate effectors of MIST1 within the UPR pathway 
Catalog of 15 highest scoring and 6 highly-scored putative MIST1 targets. Each gene is 
shown with its relative ChIP enrichment score, E-box content at enrichment sites, fold 
change in Mist1WT vs. Mist1KO pancreata, fold change with significance in published 
Ire1KO + tunicamycin liver sample microarray (So et al., 2012), and associated function. 
Commas are used to separate ChIP enrichment and E-box locations when multiple 









Figure 5.9 Candidate MIST1 targets display predicted expression patterns upon ER 
stress induction 
RT-qPCR data from 266-6 cells treated with thapsigargin. (A) Combined Xbp1s and 
Mist1 expression data from multiple experiments showing rapid increase and decrease 
in Xbp1s levels and comparatively long, persistent elevation of Mist1 expression. (B) 
Five of the 19 putative MIST1 targets share a common expression pattern, with high 
expression at 12 hours post-ER stress induction followed by approximately 50% 
expression at 24 hours that remains by 36 hours. (C) Remaining putative MIST1 targets 
all share a similar expression profile to Mist1, with initial elevation and continued, nearly 
constant levels at later time points. (* = p-value ≤ 0.05 relative to control samples, 




in expression at 12 hours followed by a decline to approximately half that level at 24 and 
36 hours, suggesting that they may be targets for direct XBP1 and MIST1 binding, but 
not necessarily MIST1 alone. 
 
5.5 A subset of putative MIST1 targets are expressed in a MIST1-dependent 
fashion following ER stress 
Following our expression analysis, we sought to directly determine whether knock-down 
of Mist1 via expression of a Mist1-targeting shRNA would significantly alter expression 
levels of the putative target genes. We generated both shCtrl (non-targeting control 
shRNA) and shMist1 (targeting the Mist1 CDS) viral constructs and infected 266-6 cells 
to generate stable lines. We then proceeded to challenge these cells with thapsigargin 
and harvested RNA at 12 hours post-ER stress induction to measure expression levels. 
As shown in Figure 5.10, there was no significant difference in Xbp1 activation between 
the two groups, although both were significantly induced vs. DMSO-treated controls 
(data not shown). Interestingly, nine of the previously identified candidate Mist1-effector 
genes had significantly reduced expression following ER stress induction (Figure 
5.10b). This is consistent with a model in which MIST1 is serving as the primary 
regulator of these ER stress-responsive genes in pancreatic acinar cells. 
 
5.6 Discussion 
Molecular mechanisms behind complex cell phenomena are increasingly being utilized 
to design modern therapeutics. As more and more knowledge regarding how cells utilize 
signaling pathways and feedback mechanisms to regulate their survival accumulates, so 
too do the opportunities to target these control circuits more precisely in order to 
manipulate aberrant cell behaviors. The unfolded protein response is an emerging target 
of interest in cancer treatment, as it utilizes unique pathways to regulate gene 
expression and cell survival independent of the more frequently targeted growth 
signaling and developmental gene networks (Koong et al., 2006). Ideally, novel 
therapeutics would modulate expression of downstream components of a pathway, 
making scaling factors such as MIST1 ideal targets as they are not essential for cell 










Figure 5.10 Expression of a subset of Mist1 candidate target genes is significantly 
decreased in shMist1 266-6 cells following thapsigargin treatment 
Expression analysis of transcripts from shCtrl and shMist1 266-6 stable cell lines treated 
with thapsigargin (12 hours post-induction) reveals nine putative MIST1 gene targets 
with significantly reduced expression. Splicing of Xbp1, a measure of ER stress levels, 
was not affected by Mist1 knockdown. Expression values are scaled to shCtrl values for 
illustrative purposes. (* = p-value ≤ 0.05, ** = p-value ≤ 0.01 relative to control samples, 
normalized to 18s expression)  
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this work we set out to establish if and how MIST1 plays a role in the XBP1-mediated 
branch of the unfolded protein response.  
 
Our analysis established that Mist1 is directly upregulated by pancreatic acinar cells 
undergoing ER stress (Figure 5.02). Indeed, stressed acinar cells increased total Mist1 
expression to over 3.5 fold higher than basal levels, a particularly surprising finding as 
this expression took place with less than 10% of the total acinar cell population 
contributing to the result. This data indicates that the actual enrichment of MIST1 protein 
in the zymogenic population may be far higher than shown in transcript analysis, further 
supporting the idea that Mist1 expression is important in regulating acinar cell health 
during periods of heightened stress.  
 
We next proceeded to establish that the 266-6 immortalized acinar cell line has 
increased MIST1 expression in response to ER stress that mimics our in vivo mouse 
findings (Figure 5.03c-d). We also showed that ablation of Xbp1 in cells embedded in a 
collagen-based 3D culture system resulted in a general reduction in Mist1 levels and a 
drastically increased rate of acinar cell transdifferentiation that mimics the phenotype of 
MIST1KO acinar cells (Figure 5.05) (Shi et al., 2012). Furthermore, we established that 
Mist1 expression is directly correlated with expression and binding of XBP1 to the Mist1 
promoter (Figure 5.07), indicating that MIST1 is involved in the UPR via direct 
interaction with one of its primary initiating transcription factors. This provides a link 
between previous research showing that Mist1 is developmentally regulated by XBP1 
(Huh et al., 2010) and our own work showing a connection between Mist1 expression 
and ER stress. Interestingly, we also showed a strong evolutionary conservation 
between possible XBP1-binding sites in the human and mouse Mist1 genes, indicating 
that the regulation of Mist1 by XBP1 may be an important feature of Mist1-expressing 
secretory cells across species. 
 
We lastly sought to identify candidate MIST1 targets that were modulated in response to 
ER stress. Using a number of bioinformatic data sets we were able to identify a suite of 
21 likely MIST1 targets, with eleven of candidates associated with various protein 
transport mechanisms into and out of the ER. This is consistent with recent reports of 
MIST1 regulating the Atp2c2 gene, a sarcoplasmic reticulum calcium ATPase known to 
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be associated with the secretory pathway and involved in shuttling proteins across the 
ER membrane (Garside et al., 2010). In fact, our analysis also independently identified 
HTRA2, a protein involved in ER-associated degradation that has also been 
demonstrated to be a direct target gene of MIST1 (Direnzo et al., 2012). Htra2 also 
shares a similar expression pattern to 13 of the 21 candidate genes upon thapsigargin 
treatment (Figure 5.08c). These data support the validity of our approach, and they also 
add further support to the idea that one of the primary functions of MIST1 is to facilitate 
secretory networks via activation and expression of downstream genes in response to 
stress conditions. Indeed, the previously described constant UPR and XBP1 activity 
present in the pancreas may be the reason why MIST1 is found constitutively expressed 
in exocrine tissue (Iwawaki et al., 2004). 
 
Finally, we validated that nine of our candidate genes have altered expression following 
thapsigargin treatment of 266-6 cells and shRNA-mediated knockdown of Mist1. This 
prompted us to conclude that Mist1, and not Xbp1, was directly responsible for 
expression of this subset of candidate genes, as differences between Xbp1 levels in the 
two cell lines were insignificant. Further testing is planned on this suite of genes 
including anti-MIST1 ChIP experiments to verify direct binding of MIST1 to each 
candidate gene’s respective promoter. Additionally, whole-genome approaches including 
ChiP-Seq and RNA-Seq may be utilized to further investigate MIST1 targets in the UPR. 
 
Based on our data, we propose that MIST1 functions as a scaling factor for the unfolded 
protein response via activation by XBP1. This role as a facilitating influence rather than 
as a critical UPR regulator is also in agreement with published literature showing altered 
ER stress responses in MIST1KO mice, which likely survive despite aberrant UPR 
functioning due to the supportive nature of MIST1’s target genes. This work serves as a 
jumping-off point for possible therapeutic design targeting the UPR and its downstream 
networks. While direct disabling of key molecules, such as XBP1, has been shown by us 
and others be deleterious to cell survival, targeted modulation of MIST1 or its gene 
targets could impair UPR function sufficiently to allow increased cell sensitivity to 
chemotherapeutics. We believe that the MIST1 transcriptional network may present an 









CHAPTER 6. HIGH-LEVEL KRASG12D EXPRESSION IN DEVELOPING PANCREATIC 
ACINAR CELLS LEADS TO ACINAR-DUCTAL METAPLASIA THAT IS MITIGATED 
BY MIST1 
6.1 Introduction 
Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal malignancies, with a 
five-year survival rate of less than 6% (Siegel et al., 2013). The high fatality rate of PDA 
is primarily attributed to a lack of early diagnostic markers and a clear understanding of 
early transformation events. The median survival time following diagnosis plummets 
from a high of 24 months in patients with small, isolated pancreatic tumors to less than 
10 months in patients with local lymph node invasion and less than 5 months in patients 
with detectable metastases (Hidalgo, 2010). As a result, extensive research in humans 
and mouse models has focused on classifying and investigating how PDA develops and 
progresses. 
 
Molecular analysis of pancreatic tumors shows mutations in the RAS proto-oncogene in 
greater than 90% of PDA tumor specimens (Hidalgo, 2010). The RAS protein is a 
molecular switch that couples activation of membrane-embedded receptor tyrosine 
kinases (RTKs) to cytoplasmic and nuclear effectors (Figure 6.01a) (Spaargaren et al., 
1995). RAS binds to activated RTKs via adapter proteins, including growth factor 
receptor-bound protein 2 (GRB2) and Son of Sevenless (SOS), that couple the signal 
generated by activation and phosphorylation of ligand bound receptors to RAS activation 
(McCormick, 1993; Spaargaren et al., 1995). The activation of RAS is governed by GTP 
binding facilitated by guanine nucleotide exchange factors (GEFs) while RAS 
deactivation is accomplished via hydrolysis of the bound GTP, a process that is 
dependent on GTPase activating proteins (GAPs) (Figure 6.01b) (Cox and Der, 2003). 
RAS mutations that prevent GTP hydrolysis (including the previously described 
KRASG12D mutation) are among the most prevalent in pancreatic and other cancers, 







Figure 6.1 Diagram of normal and mutant RAS-based signal transduction 
(A) Receptor tyrosine kinase signaling in which ligand binding promotes dimerization of 
receptors which then auto/transphosphorylate themselves. Adapter proteins bind to 
phosphorylated receptor sites, tethering the RAS molecule and causing it to become 
active and initiate signal cascades promoting growth and proliferation. (B) Diagram of 
normal RAS activity in which activated GTP-bound RAS hydrolyzes the bound GTP with 
the assistance of GTPase activating proteins (GAPs). Reactivation of the molecule 
involves exchange of GDP for a new GTP molecule and is facilitated by guanine 
nucleotide exchange factors (GEFs). (C) RASG12D has a mutant 12th amino acid (GD) 




proliferation events (Figure 6.01c) (Hingorani and Tuveson, 2003). Interestingly, PDA 
progression is believed to require additional genetic insults including deregulation of cell 
death pathways via mutations in the p16Ink4A and p53 proteins (Maitra and Hruban, 
2008). The disease, however, may still be RAS dependent, as recent work has shown 
that inactivation of RAS in a mouse model of RAS-driven pancreatic cancer can cause 
tumor regression (Collins et al., 2012). 
 
Advanced PDA is characterized by extensive stromal infiltration of the pancreas that is 
often seen alongside epithelial structures resembling enlarged and abnormal ductal 
structures termed pancreatic intraepithelial neoplasias (PanINs) (Hruban et al., 2006). A 
proposed model for progression from small PanINs into advanced disease utilized 
findings that the stromal deposition observed in patients is often focused on specific 
pancreatic lobes, termed lobulocentric atrophy (Brune et al., 2006). 
 
The observed fibrous stroma deposition seen in early PDA samples is restricted to lobes 
also containing PanINs (Brune et al., 2006). Further analysis of post-mortem pancreatic 
samples taken from elderly patients with no evidence of pancreatic disease also found 
foci of fibrosis associated with PanIN structures (Detlefsen et al., 2005). These data led 
to a proposed model in which PanIN development obstructs normal ducts, preventing 
normal zymogen secretion and triggering autoactivation of digestive enzymes leading to 
localized tissue damage (Hruban et al., 2008). Localized damage then triggers 
inflammation and regeneration via prolonged mitogenic signaling, suppressing normal 
cellular mechanisms for preserving DNA integrity and suppressing proliferation. This 
allows the expansion of the existing PanIN lesion and development of more extensive 
fibrosis, initiating a feedback loop in which the initial lesion promotes an inflammatory 
environment that gives rise to other lesions. These findings, coupled with the ductal 
expression phenotype and ductal histological appearance prompted many researchers 
to conclude that PDA was derived from ductal cells that acquire an activating KRAS 














Figure 6.2 Acinar cells directly contribute to PanIN lesions 
(A) Proposed model for PanIN development in which duct cells give rise to PanIN 
lesions(Hruban et al., 2008). (B) Schematic of genetic loci in Mist1CreER/+; LSL-Kras; 
R26LacZ reporter mice coupling acinar-specific KRASG12D expression to β-galactosidase. 
(C) PanIN lesions in Mist1CreER/+; LSL-Kras; R26LacZ reporter mice are positive for β-gal 
expression, indicating an that these PanINs are initially derived from acinar cells. Image 




Questions regarding the ductal origin of PDA arose when mouse models in which 
oncogenic KRAS was expressed from the duct-specific cytokeratin 19 (K19) promoter 
failed to produce PanINs or PDA (Brembeck et al., 2003). Other researchers utilized  
lineage tracing models with Cre-mediated acinar-specific activated KRAS expression 
coupled to expression of the β-galactosidase gene (Figure 6.02b) (Habbe et al., 2008; 
Shi et al., 2009b). This construct labels all cells expressing KRAS as well as their 
progeny, allowing tracing of acinar cells that undergo Cre-mediated recombination 
regardless of any transdifferentiation events tied to oncogenic transformation. The 
appearance of β-gal positive PanIN structures following KRASG12D expression allowed 
investigators to conclude that PanIN lesions were being derived from acinar cells via a 
process known as acinar-ductal metaplasia (ADM) (Figure 6.02c) (Habbe et al., 2008; 
De La O et al., 2008). Updated models of PanIN progression that include data from 
mouse studies now include acinar cells as possible sources of PanIN lesions, although 
the exact transcriptional networks that are required for ADM have not been fully 
elucidated. 
 
Acinar-ductal metaplasia is frequently seen associated with PanIN lesions in human and 
mouse models (Brune et al., 2006; Zhu et al., 2007). ADM is accompanied by reduced 
digestive enzyme synthesis, altered acinar morphology resulting in cells resembling duct 
cells, and expression of duct-restricted proteins including mucin and transcription factor 
Sox9 (Figure 6.03) (Kopp et al., 2012). ADM conversion also involves downregulation of 
the acinar cell-specific transcription factor MIST1 (Rooman and Real, 2011), although 
the exact role MIST1 plays in maintaining acinar cell identity is still under investigation. 
 
Loss of MIST1 in transgenic mice is associated with cell disorganization, polarity loss, 
loss of intracellular gap junctions/communication, and increased acinar lumen size 
(Figure 6.04) (Direnzo et al., 2012; Jia et al., 2008; Pin et al., 2000; Rukstalis et al., 
2003; Zhu et al., 2004). These mice, however, show no significant decrease in lifespan. 
Interestingly, Mist1 knockouts have increased ADM and PanIN formation in KRASG12D 
expressing mice (Shi et al., 2009b). However, even in KRAS-expressing, MIST1KO mice, 
PanIN formation is sparse and temporally dispersed with only a small subset of acinar 
cells undergoing ADM at any given time. This has made studies of KRAS-derived ADM 










Figure 6.3 Acinar-ductal metaplasia involves alterations to acinar cell morphology 
and protein expression 
Early PN1 neonatal pancreata have little endoplasmic reticulum staining but still 
abundantly express amylase, the highest-produced zymogen in the pancreas. Mist1Kras/+ 
(discussed later) PN1 mouse pancreata with extensive ADM have multiple open-








Figure 6.4 MIST1 regulates cell polarity, gap junction formation, and lumen size in 
pancreatic acinar cells 
(Left panels) Wildtype adult pancreata with characteristic acinar morphology including 
apical-basal polarity (H&E image), expression of CONNEXIN32 (Cx32), and tight acinar 
lumens marked by ZONA OCCLUDENS 1 (Zo-1). (Middle panels) Mist1KO pancreata 
lack apical-basal polarity and Cx32 expression and have enlarged lumens. (Right 
panels) Mist1KO pancreata expressing a Mist1myc transgene have restored polarity, Cx32 




Correlative studies utilizing human patient samples found that ADM can be observed in 
both stand-alone and PanIN-associated states (Shi et al., 2009a). When isolated for 
genetic analysis via laser capture microdissection, stand-alone ADMs were found to be 
KRASWT while ADM-containing RAS-mutations were exclusively found associated with 
PanINs. This data suggests that ADM is not exclusively derived from KRAS mutants in 
pancreatic cancer patients, necessitating a further investigation of ADM to determine 
how and if RAS governs the ADM process. This has proven to be very difficult in human 
patients and existing mouse models, since mutant RAS expression triggers only limited 
transformation events despite high penetrance in many mouse systems (Guerra et al., 
2003). More recent work has shown that this refractory response to KRASG12D 
expression is due to the need for KRAS activation via initiation of extrinsic mitogenic 
signaling (Huang et al., 2013). Indeed, multiple studies have confirmed that oncogenic 
RAS mutations within the pancreas do not necessarily lead to development of PDA or 
metastatic disease (Lu et al., 2002; Parsons and Meng, 2009; Yan et al., 2005). These 
findings indicate that cellular context must be accounted for in developing systems for 
studying ADM. 
 
Mouse model work studying pancreatic cancer development has shown that even single 
occasions of acute pancreatitis following expression of mutant KRAS can drastically 
accelerate PDA progression (Carrière et al., 2009). Pancreatitis leads to development of 
extensive ADM, however, it also induces extreme damage throughout the pancreas and 
may complicate studies of the KRAS-specific component of ADM development. 
Therefore, it seems that the ideal model for studying ADM should utilize a suitable 
cellular context to allow KRAS-induced ADM formation without chemical or damage-
induced exacerbation. We thus sought to investigate whether high-level expression of 
oncogenic RAS in developing mouse pancreata could be used to study acinar-ductal 
metaplasia. 
 
In this study, we utilized a mouse model in which activated KRASG12D is expressed from 
the acinar cell-specific Mist1 promoter during embryonic development and in the adult 
exocrine pancreas. Herein we demonstrate that high-level, acinar cell-specific 
expression of activated RAS during embryogenesis generates extensive ADM ductal 
structures both during and following development. Furthermore, we show that these 
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ductal structures bear the hallmarks of ADM structures including decreased zymogen 
synthesis and increased proliferative capacity. Finally, we show that the severity of ADM 
formation is mitigated by the MIST1 protein, indicating that MIST1 likely plays a role in 
maintaining the acinar cell phenotype during KRAS-induced ADM formation. 
 
6.2 Generation of Mist1Kras/+ mice 
The Mist1Kras/+ line was generated via collaboration between the Konieczny and the 
Tuveson research group at the University of Pennsylvania. This line expresses 
oncogenic KRASG12D from the Mist1 promoter, previously described in this report as 
restricted to acinar cells in the pancreas. The mouse line was generated via standard 
“knock in” techniques utilizing generation of chimeric mice following homologous 
recombination of the Kras4BG12D cDNA into embryonic stem cells (Figure 6.05a) 
(Tuveson et al., 2006). Median survival time for Mist1Kras/+ mice was decreased by 
approximately 55% (Figure 6.05b). Notably, Mist1Kras/LacZ mice (not included on the plot) 
appear externally normal at birth but are severely undersized and die by three days post-
birth, revealing the importance of MIST1 to normal acinar cell function. 
 
In order to investigate the effects of KRASG12D expression driven by the Mist1 promoter, 
we bred Mist1Kras/+ mice to Mist1LacZ/+ animals (Figure 6.05c). This crossing scheme 
generated control Mist1+/+ and Mist1LacZ/+ animals as well as Mist1Kras/+ and Mist1Kras/LacZ 
experimental mice. This design allowed us to investigate the effects of KRASG12D 
expression both in the presence and absence of MIST1. Of note, Mist1Kras/+ females are 
incapable of nursing their young due to expression of KRASG12D in the lactating 
mammary gland. As a result, only male Mist1Kras/+ mice were used as breeders, however 
female mice were used in embryo studies. 
 
6.3 Mist1Kras/LacZ mice develop extensive ADM that can be rescued by expression of 
a MIST1myc transgene 
Previous work in mouse models had demonstrated that embryonic expression of high 
levels of RAS can lead to development of hyperplasia (Perez-Mancera and Tuveson, 











Figure 6.5 Crosses for generating the Mist1Kras/+ line and relevant controls for 
embryonic studies 
(A) Targeting strategy for generation of the Mist1Kras/+ mouse line. (B) Kaplan-Meier plot 
showing median survival time of 10.8 months for Mist1Kras/+ mice vs. 24.2 months for 
Mist1+/+ mice. (C) Mist1Kras/+ mice were mated to Mist1LacZ/+ mice to generate both control 
(Mist1+/+) animals as well as mice bearing the KrasG12D allele either with or without Mist1 





we first harvested pancreata from post-natal day 1 (PN1) embryos from the previously 
described mouse cross. Histological examination of sections from fixed pancreata 
showed that Mist1+/+ acini have normal apical-basal polarity with basally-localized nuclei 
(Figure 6.06a), but they lack strong staining of the ER, presumably due to decreased 
need for digestive hydrolases during development and while still nursing. Additionally, 
acini in these animals had closed lumens, indicating no basal levels of damage or 
developmentally- associated acinar-ductal metaplasia (Figure 6.06a, blue arrows). In 
contrast, Mist1Kras/+ PN1 pancreata had a pronounced increase in the occurrence of 
ADM-like, open-lumened acini (Figure 6.06b, red outlines and arrows), although 
normal acini with closed lumens were also present (Figure 6.06b, blue outline and 
arrow). Mist1Kras/LacZ mice had no normal acini. Instead, pancreata in Mist1Kras/LacZ mice 
contained a mix of ADM-like open-lumened acini (Figure 6.06c, red outlines and 
arrows) and larger duct-like complexes (Figure 6.06c, D.C.).  
 
The striking difference between Mist1Kras/+ and Mist1Kras/LacZ was confirmed to be due to a 
deficiency in MIST1 following an experiment performed by Dr. Yan Sun in the Konieczny 
lab (Shi et al., 2009b) in which Mist1Kras/LacZ mice were mated to mice expressing a 
Mist1myc transgene from the acinar cell-specific elastase promoter (Elpr-Mist1myc). As 
shown in Figure 6.07b,c, expression of MIST1myc rescues the Mist1Kras/LacZ phenotype, 
eliminating the appearance of large ductal complexes and returning the pancreas to a 
Mist1Kras/+ appearance. We next sought to determine whether we could observe the 
earliest stages of ADM development via analysis of embryonic pancreata from Mist1Kras/+ 
and Mist1Kras/LacZ animals.  
 
6.4 Mist1Kras/+ pancreata develop increasing numbers of proliferative ductal 
structures during embryogenesis 
Embryos were obtained via timed pregnancies at three specific ages; E13.5, E 16.5, and 
E18.5. MIST1 expression (and thus KRASG12D expression) was first detected at day 
E13.5 and was only present in cells coexpressing amylase (Figure 6.08b, c). However, 
no phenotypic difference could be observed between Mist1+/+, Mist1Kras/+, and 














Figure 6.6 Mist1Kras/+ and Mist1Kras/LacZ animals have disrupted pancreata at birth 
(A) Mist1+/+ neonatal pancreata at post-natal day 1 (PN1) have acini (blue dotted lines) 
with normal, basal-localized nuclei and closed apical lumens (blue arrows). (B) Mist1Kras/+ 
PN1 pancreata have both normal acini (blue outline, arrow) and abnormal acini (red 
outlines) with open lumens (red arrow) resembling acinar-ductal metaplasia. (C) 
Mist1Kras/LacZ PN1 pancreata have predominantly abnormal acini with open lumens (red 














Figure 6.7 ADM formation in Mist1Kras/LacZ mice can be rescued via expression of a 
Mist1myc transgene 
(A) Protein blots on neonatal (PN1) pancreatic isolates for β-galactosidase (β-gal), 
MIST1, and MYC. Mist1Kras/LacZ mice lack expression of MIST1 while Mist1Kras/LacZ/Elpr-
Mist1myc mice regain expression of MIST1. (B) Mist1Kras/LacZ PN1 pancreata have large 
ductal complexes. (C) Mist1Kras/LacZ/Elpr-Mist1myc PN1 pancreata do not have predominant 













Figure 6.8 E13.5 pancreata express MIST1 in cells coexpressing AMYLASE 
(A) Low-magnification of E13.5 embryo. Red box indicates location of the developing 
pancreas. (B) H&E and anti-MIST1 IHC images of pancreatic sections from E13.5 
embryo. MIST1 is expressed in the terminal buds of the developing pancreas (black 
arrows). (C) High magnification image of a pancreatic terminal bud showing 
coexpression of MIST1 and AMYLASE, both markers exclusive to acinar cells.  
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ADM/open-lumened acini were first observed at E16.5 in all three genotypes (Figure 
6.09b). However, the majority of Mist1+/+ acini exhibited normal polarity and closed 
lumens with a scant minority of open-lumened structures (Figure 6.09b, left panel 
insets). In contrast, acini from Mist1Kras/+ and Mist1Kras/LacZ pancreata were largely of the 
open lumen variety (figure 6.09b, center and right panels). This difference in the 
KRASG12D-expressing mice was drastically increased by E18.5 (Figure 6.09a). Mist1Kras/+ 
pancreata, however, had a marked increase in both open-lumened acini and ductal 
complexes (Figure 6.09a, middle). Interestingly, Mist1Kras/LacZ pancreata were even 
more severe, with the pancreas consisting almost entirely of ductal complexes with few 
surviving normal acini (Figure 6.09a, right).  
 
In order to confirm that the ADM/open-lumened acini had decreased acinar properties 
we quantified amylase expression via serial section fluorescence imaging on isolated 
pancreata. As shown in Figure 6.10a,b, the diffuse amylase content throughout the 
exocrine compartment in Mist1+/+ pancreata was vastly diminished in Mist1Kras/+ and 
Mist1Kras/LacZ animals, with the majority of zymogen content present in the lumens of the 
large ductal complexes (to be discussed later). Quantification of relative amylase 
intensity of non-lumenal areas via pixel analysis showed a significant reduction in 
amylase content in both KRASG12D-expressing groups relative to control, with no 
significant difference between either of the KRAS groups. 
 
Finally, we sought to determine whether the ADM/open-lumened acini were more highly 
proliferative, a common observation in ADM and PanIN lesions in human patients. We 
stained embryonic sections for the proliferation marker Ki67 and quantified the numbers 
of positive nuclei per field as a percentage of total nuclei. As shown in Figure 6.11b, 
Mist1Kras/+ and Mist1Kras/LacZ pancreata have a significantly higher proliferative index 
during embryonic development relative to Mist1+/+. Both also remain elevated at birth, 














Figure 6.9 ADM and ductal lesion formation precede birth in Mist1Kras/+ and 
Mist1Kras/LacZ animals 
(A) Low magnification images of whole pancreata isolated from E18.5 mice. Mist1+/+ 
pancreata appear normal, while Mist1Kras/+ pancreata have extensive open lumen acinar 
structures and Mist1Kras/LacZ mice have almost entirely large ductal complexes. (B) 
Pancreatic sections from E16.5 animals reveal that Mist1+/+ acinar cells have 
predominantly closed lumens (inset, white box) with occasional open lumened acini 
(inset, red box). Mist1Kras/+ acinar cells are predominantly open lumened (inset, red box), 







Figure 6.10 Zymogen production is reduced in Mist1Kras/+ and Mist1Kras/LacZ pancreata 
throughout development 
(A, B) Confocal microscopy of PN1 and E18.5 pancreata reveal diffuse amylase staining 
in Mist1+/+ acinar cells (Ac) with little amylase content outside of duct-like complex 
lumens (white arrows) in Mist1Kras/+ and Mist1Kras/LacZ animals. (C) Quantification of 
relative intensity of amylase staining in acinar areas shows significantly reduced 
expression in both Mist1Kras/+ and Mist1Kras/LacZ animals by E18.5. (* = significantly 










Figure 6.11 Mist1Kras/LacZ pancreata have significantly increased proliferative capacity 
throughout development 
(A) Immunofluorescence staining for the proliferation marker Ki67 in PN1 pancreatic 
sections. (B) Counts of Ki67-positive nuclei per 10X field in E16.5, E18.5, and PN1 
pancreatic sections as a percentage of total nuclei. Mist1Kras/LacZ pancreata have 
significantly increased proliferative capacity relative to Mist1+/+ throughout development 
while Mist1Kras/+ pancreata are significantly increased until birth when they remain 




6.5 Ductal complex size is correlated with expression of MIST1 
Since MIST1 appeared to have a substantial effect on phenotype severity between 
Mist1Kras/+ and Mist1Kras/LacZ mice, we sought to determine if the previously stated link 
between ADM formation and downregulation of MIST1 could be observed in our 
embryonic mice. We first stained E16.5 Mist1Kras/+ pancreatic sections for MIST1, as they 
previously had been seen to have large numbers of ADM/open-lumened acini. 
Surprisingly, the open-lumened acinar structures in E16.5 pancreata were all MIST1 
positive (Figure 6.12a, black outlines and arrows). We proceeded to stain E18.5 
Mist1Kras/+ pancreatic sections and found extensive MIST1 expression in the ADM 
structures (Figure 6.12b, black stars). Interestingly, upon closer examination we 
determined that while small ADMs were MIST1 positive, larger ductal complexes were 
almost uniformly MIST1 negative (Figure 6.12c). This expression pattern was consistent 
in ductal complexes that were larger than their acinar cell counterparts, however smaller 
open-lumened acini consistently expressed MIST1. 
 
In order to determine if the downregulation of MIST1 in ductal complexes was 
associated with any secretory phenotypes, we stained E18.5 pancreatic sections for the 
zymogens amylase and carboxypeptidase A. As shown in Figure 6.13a-c, the lumens of 
the ductal cysts in Mist1Kras/+ and Mist1Kras/LacZ pancreata were positive for both amylase 
and CPA but negative for a non-zymogen control (α-MIST1, unretrieved). This is unique 
as normal ducts in Mist1+/+ pancreata have no zymogen staining. This may be a 
byproduct of the ductal complexes being forced to expel the remaining zymogen 
granules before completing the conversion from acinar to duct-like cells, although further 
analysis is required. 
 
6.6 Adult Mist1Kras/+ acinar cells are predisposed to ductal complex and cyst 
formation 
In order to determine whether the observed ADM and ductal cysts seen in embryonic 
sections from Mist1Kras/+ mice would give rise to ductal lesions in adult mice, we 
performed ex vivo and in vivo analyses of mature Mist1Kras/+ pancreata. We first utilized 











Figure 6.12 Ductal complexes in Mist1Kras/+ mice have a correlation between 
expression of Mist1 and reduced size 
(A) Immunohistochemical (IHC) stain for MIST1 in Mist1Kras/+ mice at E16.5 shows open-
lumened acini (black outlines) with MIST1-positive nuclei (black arrows). MIST1-negative 
islet nuclei (red arrows) shown for reference. (B) IHC for MIST1 in Mist1Kras/+ E18.5 
pancreata shows the presence of both ADM (black stars) and large ductal complexes 
(red stars). (C) High magnification image of black boxed area from image B showing 
ADM lesions with MIST1-positive nuclei (black outlines, arrows) while ductal complexes 











Figure 6.13 Ductal structures aberrantly secrete zymogens into their lumens in 
Mist1Kras/+ and Mist1Kras/LacZ pancreata 
(A) High-magnification confocal immunofluorescence image of representative ductal 
lumen in E18.5 Mist1Kras/+ pancreata. Amylase is largely absent from the cells but is 
present in the ductal lumen. White outlines represent boundaries of the ductal structures. 
(B) Low-magnification stain for carboxypeptidase A (CPA), another zymogen, also 
shows strong staining in the ductal lumens. White outlines represent boundaries of the 
ductal structures.  (C) Non-zymogenic antibody control (α-MIST1, unretrieved) does not 




isolated acinar cells from 3 month-old Mist1Kras/+ mice via collagenase digestion and 
subsequent size exclusion filtering before embedding the resulting clusters in a collagen 
matrix. As shown in Figure 6.14, Mist1Kras/+ acinar clusters begin forming ductal cysts 
(Figure 6.14, red boxes) within 24 hours of embedding. These clusters subsequently 
grew and merged, becoming a large cluster of duct-like cysts with no remaining acinar 
clusters by day 5 in culture. Interestingly, this conversion to ductal cysts was 
accompanied by a pronounced degradation of the collagen matrix, seen in Figure 6.14 
as a pronounced transparency in the collagen by day 5. Mist1+/+ acinar clusters 
remained quiescent over the duration of the experiment with a minimum of ductal cyst 
conversion. 
 
In order to see whether the pronounced tendency of Mist1Kras/+ acinar clusters to convert 
to ductal cysts would lead to in vivo disease, we isolated pancreata from 3-9 month old 
Mist1Kras/+ animals. These animals all had palpable masses in the pancreas area of the 
gut, although the size of the masses was highly variable. Pancreata were isolated and 
sectioned, and representative images are shown in Figure 6.15. Pancreata from 
Mist1Kras/+ mice were deficient in acinar tissue (Figure 6.15, right panel - labeled Ac), 
with most of the pancreatic bulk being composed of small ductal complexes (Figure 6.15 
- black stars) and larger, encapsulated mucinous structures. Following analysis of the 
sections conducted with the assistance of Dr. Michael Logan, a certified pathologist, we 
concluded that the large encapsulated complexes most closely resembled mucinous 
cystic neoplasms (MCNs), a less common oncogenic lesion that progresses slowly and 
does not generally give rise to pancreatic ductal adenocarcinoma. 
 
6.7 Discussion 
PDA remains a highly lethal human cancer due primarily to insufficient methods of early 
diagnosis and understanding of early disease. Mouse models utilizing inducible 
expression of oncogenic KRAS variants can give rise to ADM and PanIN precursor 
lesions, but typically do so in a wide spatial and temporal window, making analysis of 
early events in ADM formation difficult to observe. We sought to determine whether the 
Mist1Kras/+ mouse model expressing high levels of acinar-cell specific oncogenic 












Figure 6.14 Mist1Kras/+ acinar cells rapidly develop into duct-like cysts in 3D culture 
(Top panel) Mist1+/+ acinar clusters grown in a collagen 3D-culture model remain largely 
quiescent over five days. (Lower panel) Mist1Kras/+ acinar clusters begin forming duct-like 
cysts (red boxes) in culture within 24 hours of collagen embedding. These clusters grow 













Figure 6.15 Mist1Kras/+ mice develop extensive mucinous neoplasms but not PanINs 
(A) Low-magnification image of pancreatic section from a 6 month old Mist1Kras/+ mouse. 
The vast majority of acinar tissue has been replaced by ductal complexes (black stars) 
and other ductal tissues of mixed pathology. (B) High-magnification image of boxed area 
from 6.13a shows small pockets of acinar tissue (Ac) as well as well-encapsulated ductal 
structures (black outlines). Analysis by a certified pathologist identified these structures 




As demonstrated in Figure 6.05b, Mist1Kras/+ mice have a drastically shortened lifespan 
compared to Mist1+/+ littermates. This decreased lifespan was hypothesized to be due to 
advanced pancreatic cancer, although hepatocellular carcinomas resulting from either 
metastasis or transient MIST1 (and thus KRASG12D) expression in hepatic stem cells 
were also observed (Tuveson et al., 2006). Importantly, Mist1Kras/+ mice develop large 
ADM and ductal cyst populations at least as early as E18.5 (Figure 6.09), indicating that 
use of the model to observe ADM development would necessitate embryonic tissue 
isolation.  
 
ADM and ductal cyst development in both Mist1Kras/+ and Mist1Kras/LacZ animals was 
accompanied by a significant decrease in amylase expression (Figure 6.10) and a 
significant increase in proliferative capacity (Figure 6.11). Interestingly, the decrease in 
amylase expression was observed alongside an aberrant depositing of zymogens into 
the ductal lumens of the large complexes (Figure 6.13). This was surprising as ductal 
lesions in vivo are frequently disconnected from established ductal networks. This could 
indicate that early conversion to ductal cysts is accompanied by aberrant secretion of 
digestive enzymes into the periacinar space, providing an alternative reason as to why 
ductal cyst formation is closely associated with fibrous stromal deposition (Brune et al., 
2006; Detlefsen et al., 2005).  
 
Reduced MIST1 expression is a hallmark of early ADM and PanIN development, as well 
as a general response to damage in acinar cells (Rooman and Real, 2011). Here, we 
showed that the absence of MIST1 drastically enhances the effects of embryonic 
expression of KRASG12D (Figures 6.07, 6.09). Indeed, recent work by the Konieczny 
group utilizing acinar cells isolated from LSL-KrasG12D transgenic mouse showed that 
forced overexpression of MIST1 in 3D cultured acinar cells attenuated ductal cyst 
formation (Shi et al., 2012). This further establishes that MIST1 serves as a critical 
regulator of acinar cell transdifferentiation, either via direct interaction with KRAS 
downstream signaling pathways or through enforcement of acinar cell differentiation 
programs. 
Isolation of acinar clusters from adult Mist1Kras/+ mice indicated a predisposition for these 
cells to spontaneously convert to duct-like cysts in culture (Figure 6.14). This finding is 
likely due to the high level of RAS expression driven by the MIST1 promoter prompting a 
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more rapid damage response following dissociation of the acinar clusters. This is in 
agreement with recent work indicating that normal levels of oncogenic RAS are 
insufficient to generate substantial lesion development but that high levels of RAS 
expression can lead to a pancreatitis-like phenotype and development of cystic 
carcinomas and metastatic PDA (Ji et al., 2009). This work is also consistent with our 
finding of cystic neoplasm development in adult Mist1Kras/+ mice. 
 
Future directions involving the Mist1Kras/+ line are complicated due to the numerous 
pitfalls of high-level RAS expression in MIST1-expressing tissues. The previously 
described inability of Mist1Kras/+ females to nurse pups either necessitates the use of 
foster mothers for rearing or reduces the available breeding pool to only males. 
Additionally, the occurrence of pancreatic malformations as early as PN1 (Figure 6.06) 
leads to often severe pancreatic disease by breeding age onset. Anecdotal observations 
indicate a reduced drive in Mist1Kras/+ males, making breeding of sufficient numbers of 
mice difficult. Nevertheless, the Mist1Kras/+ line does develop extensive ADM throughout 
the pancreas, making it ideal for future studies of molecular mechanisms of ADM 
conversion using whole pancreatic isolates. Additionally, the correlation of ductal cyst 
size with lack of MIST1 expression in E18.5 Mist1Kras/+ pancreata would allow for 
molecular analysis of the role of MIST1 in the two structures via laser capture 
microdissection of embryonic pancreas sections. Finally, the development of non-PDA 
advanced cancer in Mist1Kras/+ mice could be used to investigate the causes and 
molecular characteristics of mucinous cystic neoplasms, a form of pancreatic cancer that 












CHAPTER 7. SUMMARY AND FUTURE DIRECTIONS 
Pancreatic ductal adenocarcinoma (PDA) is the most prevalent form of pancreatic 
cancer, a malignancy that has become the 4th leading cause of national cancer-related 
deaths despite being primarily considered a disease of the elderly (Siegel et al., 2013). 
The astonishingly high mortality rate is due to poor understanding of the mechanisms of 
development, progression, and spread of the disease. While behavioral and genetic 
insults are suspected to be a link between pancreatic cancer and inflammatory 
pancreatitis, few studies have attempted to explore the novel cellular response and 
transcriptional networks that may link the two diseases and provide novel treatment 
options (Farrow and Evers, 2002). This has resulted in a lack of knowledge regarding 
possible overlap between the damage responsive pathways of the pancreas and 
alternative approaches to preventing malignant progression. 
 
Pancreatic cancer and inflammatory pancreatitis both present substantial hurdles for 
researchers and physicians attempting to improve disease understanding and 
management. Scientists researching possible causes and treatments of PDA are 
hampered by a plethora of mouse models that often fail to recapitulate the full spectrum 
of disease conditions (Hruban et al., 2006). Additionally, controversy regarding the 
applicability of data based on mouse model systems to human patients has also delayed 
possible treatment developments (Rooman and Real, 2011). Physicians face a difficult 
problem as well, as patients suffering from either PDA or chronic pancreatitis are 
increasingly turning to surgical resection as the only available treatment for either 
condition (Ho et al., 2005). Despite technical improvements that have reduced the 
exceptionally high mortality rate that once saw over half of patients die from post-
operative complications, surgical intervention still carries a morbidity rate as high as 60% 
(Ho et al., 2005). These data point to a glaring need for increased knowledge of cancer 
development, damage responses, and regenerative mechanisms in the pancreas in 




Recent work in designing targeted cancer therapeutics that are based on a molecular 
understanding of the disease have yielded astonishingly effective pharmaceutical 
treatments, including drugs such as trastuzumab (an antibody to the Her2 receptor 
overexpressed in breast cancer) and imantiinib (an inhibitor to the aberrant Bcr-Abl 
tyrosine kinase expressed in certain forms of chronic myelogenous leukemia). Other 
approaches, however, have proven less successful, including the long history of 
attempted inhibition of the Ras signaling pathway. Ras mutations are among the most 
frequent occurrences in human cancers, but represent a difficult-to-drug pathway due to 
the incredibly high occurrence of off-target effects and the importance of Ras signaling to 
normal cell processes (Chappell et al., 2011). The struggles with Ras have led to new 
approaches to chemotherapeutics, particularly a refocusing on small, downstream 
signaling pathway and pathway components that may allow sensitization of cancer cells 
to broad spectrum chemotherapy options. The unfolded protein response (UPR) is an 
emerging pathway of interest for design of new drugs to weaken transformed cancer 
cells (Wang et al., 2010). 
 
Transforming cells must initially acquire mutations or genetic insults that promote their 
aberrant growth and proliferation. Once acquired, however, cells must then meet the 
challenge of increased need for nutrients and oxygen, requiring extensive use of protein 
folding in the ER (Ma and Hendershot, 2004). The UPR can initiate adaptive or apoptotic 
signaling cascades in transformed cells, making it an ideal target for pharmacological 
intervention (Li et al., 2011). Indeed, recent drugs taking advantage of ER stress 
induction, coupled with UPR inhibition (Mimura et al., 2012) or novel small molecules 
that specifically activate the apoptotic arm of the UPR (Flaherty et al., 2010), have 
shown promise in treating various malignancies. These approaches necessitate 
advances in understanding how the UPR maintains cell homeostasis as well as the 
downstream targets that may be viable options as drugable targets.  
 
Several recent investigations have turned to mouse models in order to investigate the 
inner workings of the UPR. While yeast studies have long established that the 
IRE1/XBP1 branch of the UPR is the most prevalent and conserved of the three master 
regulatory arms (Kimmig et al., 2012), higher eukaryotes have evolved a more complex 
interacting response utilizing downstream signaling from the ATF6 and PERK embedded 
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ER sensors (Chakrabarti et al., 2011). This finding prompted numerous groups to 
generate developmental knock-out mouse lines of each of the respective UPR master 
regulators, producing a wide range of effects from no observable phenotypic differences 
at birth (ATF6) to embryonic or neonatal lethality (IRE1) (Reimold et al., 2000; Urano et 
al., 2000; Yamamoto et al., 2007; Zhang et al., 2002). The lethality associated with either 
IRE1 or XBP1 germline knockouts made investigations of this particular UPR branch 
difficult, a problem that was addressed via generation of a Cre-inducible knockout line by 
Drs. Ann-Hwee Lee and Laurie Glimcher at Harvard University (Hetz et al., 2008). This 
line, termed the Xbp1fl/fl mouse line, has been used by multiple groups to investigate 
XBP1’s role in both the UPR and development. 
 
Early investigations of XBP1 revealed that its expression was required for normal liver 
development and survival of developing mouse embryos (Reimold et al., 2000). When 
XBP1 expression was rescued in the liver, a key observation was made that secretory 
machinery in a number of exocrine tissues was disrupted, demonstrating that XBP1 was 
required for generating normal protein synthetic organelles (Lee et al., 2005). This 
prompted the Mills group at Washington University to use the Xbp1fl/fl mouse line to 
generate an inducible adult knock-out line lacking XBP1 expression in the constantly 
renewing zymogenic chief (ZC) cells of the stomach (Huh et al., 2010). This research 
revealed a deficiency in newly generated ZCs following Xbp1 ablation that was attributed 
to failure of these cells to express MIST1, a bHLH transcription factor associated with 
maintenance of secretory function in serous secretory cells throughout the body (Huh et 
al., 2010). Interestingly, no observable changes in levels of ER stress were observed 
despite a lack of XBP1, the primary effector of IRE1 in the UPR. This prompted us to ask 
whether XBP1 was essential for UPR functioning and, if so, whether Mist1 was itself a 
downstream target of XBP1 playing a previously uncharacterized role in the unfolded 
protein response. 
 
In order to better study XBP1 in the context of a highly secretory cell type, our research 
utilized pancreatic acinar cells (PACs) that produce more protein than any other cell type 
in the human body (Case, 1978). PACs have low-level, constitutive expression of 
XBP1s, indicating a basal level of ER stress (Iwawaki et al., 2004). PACs also 
constitutively express MIST1, previously shown to be essential for acinar cell 
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organization and identity (Direnzo et al., 2012; Pin et al., 2001; Shi et al., 2012). We thus 
sought to generate a PAC-specific, Cre-inducible line in which we could ablate Xbp1 in 
adult pancreata. These mice (Mist1CreER/+;Xbp1fl/fl) were then utilized to conduct timed 
observations of the effects of Xbp1 ablation on PACs. 
 
Our data revealed that PACs are entirely dependent on the IRE1/XBP1 branch of the 
UPR, with strong activation of the other two UPR master regulators failing to ameliorate 
basal levels of ER stress. This resulted in an apparent cumulative effect, with PACs 
developing increasing signs of zymogen deficit, damage, and ER structural changes 
consistent with ER stress, ultimately culminating in expression of CHOP, a key mediator 
of the apoptotic component of the UPR, and cell death. This gradual stress accumulation 
shows promise for XBP1-mediated therapeutic development, as acinar cells can tolerate 
Xbp1 ablation for an extended period of time. While our own studies attempting to 
combine Xbp1 ablation with activated KRAS expression were hampered by the 
simultaneous ablation/activation necessitated by our Cre-mediated model system, future 
investigations utilizing shRNA or small molecule inhibitors of XBP1 in the context of 
transformed cells may reveal a novel solution to sensitizing these growing, highly 
proliferative masses to chemotherapeutics in a way that spares normal acinar cells. This 
could represent an ideal system for preventing expansion of tumors in a way that spares 
the organ-devastating effects of pancreatic resection. 
 
Existing models of damage often produce sub-optimal results, requiring either extensive 
chemical treatment or genetic “second hits” in order to generate physiologically relevant 
levels of exocrine damage and regeneration (Lerch and Adler, 1994). Additionally, these 
model systems often produce conflicting results regarding the cell of origin for 
regenerated exocrine cells, with some studies implicating pre-existing acinar cells 
(Strobel et al., 2007) and others suggesting that the centroacinar/ductal compartment 
(Criscimanna et al., 2011) serves as a source of new cells. Inflammatory cells also likely 
play a role in exacerbating pancreatic damage, as recent studies have shown a 
substantial role for stromal cells in contributing to damage (Guerra et al., 2011). We thus 
sought to determine whether ER stress-induced loss of a large portion of the exocrine 




Our studies have shown that acinar cell regeneration following Cre-mediated Xbp1 
ablation and subsequent loss of acinar cells is accompanied by cell cycle reentry and 
proliferation of both the acinar and centroacinar compartments. This proliferation results 
in a substantial recovery of the acinar lineage from a minority of acinar cells that failed to 
delete both Xbp1 alleles. Importantly, this system leads to large-scale acinar destruction 
accompanied by a mixed inflammatory response that is reminiscent of human patient 
samples. We thus believe that this model represents a preferred alternative to standard 
damage systems, combining the inflammatory environment seen in weaker, chemically-
induced models with the intrinsic, massive acinar cell loss observed in transgenic 
models that fail to generate inflammation. Further follow-up studies may also take 
advantage of the generous window of opportunity for studying regenerative signaling 
events, as the prolonged recovery time (several weeks) is a distinct advantage over the 
rapid regeneration observed following chemical treatments. Indeed, the use of ER stress 
as a means of inducing extensive damage may more accuratly represent a chronic 
damage state than existing methods requiring frequent hourly treatments inducing 
supramaximal levels of aberrant zymogen secretion.  
 
While both the demonstration of XBP1 as an element of acinar cell homeostasis and the 
establishment of a novel model of pancreatic damage and regeneration are important 
aspects of our work, we believe the most promising use of our data lies in the 
establishment of MIST1 as a new component of the unfolded protein response. This is 
because tumor cells often overcome regulatory mechanisms mediated by intrinsic stress 
pathways as a necessary component of tumor initiation and promotion (Li et al., 2011). 
Indeed, recent work has shown that restoration/induction of the UPR in cancer cells can 
restore the ability of certain chemotherapeutics to kill previously resistant cell types 
(Martins et al., 2011). Thus, increased knowledge regarding downstream targets of 
major UPR components may aid in the discovery of new compounds to facilitate current 
treatments for pancreatic and other secretory malignancies. 
 
We have shown that Mist1 expression is correlated both in vivo and in vitro with ER 
stress, indicating a physiological response suggesting a role in the UPR. We furthermore 
demonstrated that this activation was directly due to Xbp1 expression, and XBP1 was 
capable of binding to elements of the Mist1 promoter in order to activate transcription. 
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Finally, we revealed that a number of putative MIST1 gene targets, determined via 
bioinformatic analysis of genome-wide expression data, are expressed in a pattern 
suggesting a correlation with MIST1 protein, indicating that these targets may be the 
means by which MIST1 exerts an influence on the unfolded protein response. These 
data may allow the targeting of specific MIST1 effectors, or MIST1 itself, as a means of 
compromising normal UPR function in transformed cells. This, in turn, could provide an 
approach to switching cellular ER stress responses from the adaptive to the apoptotic 
phases of the UPR. Such a treatment could be combined with other cytotoxic and 
chemotherapeutic treatment options in order to provide an extra “push” to cells that may 
be responsive to standard drug and radiation therapy, but only submaximally initiating 
damage/apoptotic cascades. 
 
In summary, our work has generated a more complete understanding of how the UPR, 
and specifically XBP1, play a role in maintaining and sustaining the homeostatic balance 
in highly secretory pancreatic acinar cells. We show that XBP1 is an indispensable part 
of the mammalian UPR in cells with high demand for secreted products, and that the ER 
stress imparted by loss of Xbp1 can be used as a means to study pancreatic disease in 
vivo. We furthermore show that XBP1 may exert influence on cell processes both within 
and outside the canonical UPR via its direct interaction with MIST1. We believe that 
exploring the molecular events mediated by the XBP1/MIST1 interaction should be an 
important goal of future work focused on understanding and manipulating exocrine cell 
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Locations Fold GC TA 
Alg12 asparagine-linked glycosylation 12 Promoter 2.3 1 0 
Alg2 asparagine-linked glycosylation 2 Promoter 3.0 2 2 
Amfr Autocrine motility factor receptor Intron 4 7.0 1 1 
Arcn1 archain 1 Intron 1 5.0 0 1 
Arfgap3 ADP-ribosylation factor GTPase 
activating protein 3 
In 1, Ex 2 5.8, 3.8 1, 2 0 
Atf4 Activating transcription factor 4 Upstream 3.0 2 0 
Atf6 Activating transcription factor 6 Intron 1 5.0 0 2 
Atp2a2 ATPase, Ca++ transporting, cardiac 
muscle, slow twitch 2 
Intron 1 8.0 1 0 
Atxn3 Ataxin 3 Upstream (-
900) 
2.0 1 1 
Bet1 blocked early in transport 1 Promoter 2.8 1 0 
Cct7 Chaperonin containing Tcp1, subunit 
7 (eta) 
Promoter 9.0 1 0 
Cebpb CCAAT/enhancer binding protein 
(C/EBP), beta 
Exon 1 3.7 2 0 
Copz1 coatomer protein complex, subunit 
zeta 1 
Intron 1 23.0 0 1 
Creb3I3 CAMP responsive element binding 
protein 3-like 3 
Intron 3 4.0 1 0 
Creb3l1 cAMP responsive element binding 
protein 3-like 1 
Promoter 10.0 2 0 
Derl1 Der1-like domain family, member 1 Promoter 2.0 1 0 
Dnajb11 DnaJ (Hsp40) homolog, subfamily B, 
member 9 
Exon 1/TSS 4.0 1 0 
Dnajb9 DnaJ (Hsp40) homolog, subfamily B, 
member 11 
-2.5K 3.0 0 1 
Dnajc1 DnaJ (Hsp40) homolog, subfamily C, 
member 1 
Prom, In 1 7.8, 8.0 0, 2 1, 0 










Dnajc3 DnaJ (Hsp40) homolog, subfamily C, 
member 3 
Intron 1 3.5 0 2 
Dnajc4 DnaJ (Hsp40) homolog, subfamily C, 
member 4 
Exon 1 2.7 1 0 
Edem1 ER degradation enhancer, 
mannosidase alpha-like 1 
Intron 1 (2) 17, 4.5 0, 1 1, 1 
Edem3 ER degradation enhancer, 
mannosidase alpha-like 3 
Prom, In 1 7, 4.5 1, 1 0, 1 
Eif2a eukaryotic translation initiation factor 
2A 
Intron 1 3.5 0 0 
Eif2ak3 Eukaryotic translation initiation factor 
2 alpha kinase 3 
Intron 2 2.7 0 0 
Ern1 Endoplasmic reticulum (ER) to 
nucleus signalling 1 
Intron 1 (2) 5.7, 21 1, 1 0 
Ero1L ERO1-like (S. cerevisiae) Promoter, In 
1, In 2 
6, 6, 10 0,0,1 1,0,0 
Ero1Lb ERO1-like beta (S. cerevisiae) Promoter NO CTRL 0 0 
Erp44 Endoplasmic reticulum protein 44 Intron 1 2.5 0 2 
Fbxo6 F-box protein 6 Intron 1 8.0 0 0 
Fkbp10 FK506 binding protein 10 Upstream -1K 2.1 1 0 
Fkbp11 FK506 binding protein 11 Exon 1/TSS 2.4 1 0 
Fkbp14 FK506 binding protein 14 Promoter 7.0 2 0 
Gcc1 golgi coiled coil 1 Promoter 7.0 0 1 
Golga3 golgi autoantigen, golgin subfamily a, 
3 
Intron 1 6.0 1 0 
Golga4 golgi autoantigen, golgin subfamily a, 
4 
Intron 1 4.0 1 0 
Golgb1 golgi autoantigen, golgin subfamily b, 
macrogolgin 1 
Upstream -4K 9.0 1 0 
Golph3 golgi phosphoprotein 3 Intron 2 10.0 0 2 
Gopc golgi associated PDZ and coiled-coil 
motif containing 
Intron 1 7.0 0 1 
Gorasp2 golgi reassembly stacking protein 2 Promoter 3.0 2 2 
H13 histocompatibility 13 Intron 1 2.3 4 0 
H47 Histocompatibility 47 Ex 1, In 2 2, 10 2, 1 0, 0 
Herpud1 Homocysteine-inducible, 
endoplasmic reticulum stress-
inducible, ubiquitin-like domain 
member 1 
Intron 1 2.3 0 0 
Hmox1 heme oxygenase (decycling) 1 Exon 1/TSS 3.3 2 1 
Hsp90b1 heat shock protein 90 alpha 
(cytosolic), class B member 1 
Intron 4 4.0 1 0 
Hspa13 Heat shock protein 2 Upstream -1k 8.0 1 1 
Hspa2 heat shock protein 70 family, 
member 13 
Promoter 4.0 0 0 
Hsph1 Heat shock 105kDa/110kDa protein 
1 
Intron 1 5.0 2 0 
Htra2 HtrA serine peptidase 2 Intron 2 2.1 4 0 
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Htra4 HtrA serine peptidase 4 Intron 8 2.7 0 0 
Hyou1 hypoxia up-regulated 1 Exon 1/Intron 
1 
7.0 1 0 
Kdelr2 KDEL (Lys-Asp-Glu-Leu) 
endoplasmic reticulum protein 
retention receptor 2 
Upstream -2K 23.0 1 0 
Lman1 lectin, mannose-binding, 1 Exon 1 9.0 0 0 
Manf Mesencephalic astrocyte-derived 
neurotrophic factor 
Exon 1 3.7 1 1 
Mapk10 Mitogen-activated protein kinase 10 Intron 1 10.0 0 0 
Mapk9 Mitogen-activated protein kinase 9 Intron 1 10.0 2 0 
Mbtps1 Membrane-bound transcription factor 
peptidase, site 1 
Exon 1/TSS 11.0 1 0 
Mbtps2 Membrane-bound transcription factor 
peptidase, site 2 
Upstream (-
3K) 
6.0 1 0 
Mcfd2 multiple coagulation factor deficiency 
2 
Intron 1 4.0 0 1 
Mgat2 mannoside 
acetylglucosaminyltransferase 2 
Promoter 5.5 0 0 
Mogs mannosyl-oligosaccharide 
glucosidase 
Exon 4 10.0 1 0 
Nploc4 Nuclear protein localization 4 
homolog (S. cerevisiae) 
Intron 1 12.5 0 1 
Nucb1 Nucleobindin 1 Intron 1 4.7 1 0 
Ormdl3 ORM1-like 3 (S. cerevisiae) Upstream (-
3K), Ex 1 
10, 5 1, 1 0 
Os9 Amplified in osteosarcoma Prom, In 3 10, 4 1, 0 0, 2 
PDI/Pdia3 Protein disulfide isomerase 
associated 3 
Promoter 14.0 2 0 
Pdia4 protein disulfide isomerase 
associated 4 




Pfdn2 Prefoldin 2 Exon 1/TSS 3.0 0 0 
Pfdn5 Prefoldin 5 Intron 2 3.0 0 0 
Piga phosphatidylinositol glycan anchor 
biosynthesis, class A 
Intron 4 8.0 1 0 
Ppib peptidylprolyl isomerase B Intron 1 3.5 2 0 
Ppp1r15b Protein phosphatase 1, regulatory 
(inhibitor) subunit 15b 
Intron 1 7.7 2 0 
Rab33b RAB33B, member of RAS oncogene 
family 
Exon 1/TSS 2.3 1 0 
Rnf139 Ring finger protein 139 Ex 1, In 1 5, 3.7 0, 1 0, 0 
Rnf5 Ring finger protein 5 Intron 1 2.5 0 1 
Rpn1 Ribophorin I Intron 1 (2) 3, 3 1, 0 0, 0 
Rrbp1 ribosome binding protein 1 Intron 1 7.0 1 0 
Sdf2l1 stromal cell-derived factor 2-like 1 Exon 1/TSS, 
In 1 
7, 7 1, 1 0, 0 
Sec11a SEC11 homolog A (S. cerevisiae) Upstream -1K 5.0 1 0 
Sec11c SEC11 homolog C (S. cerevisiae) Intron 1 4.5 1 1 
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Sec31a Sec31 homolog A (S. cerevisiae) Intron 1 4.0 0 0 
Sec61a1 Sec61 alpha 1 subunit (S. cerevisiae) Intron 1 3.0 0 0 
Sec61b Sec61 beta subunit Intron 2 3.8 2 1 
Sec61g SEC61, gamma subunit -1K, In 1 6, 4 1, 0 0, 0 
Sec62 SEC62 homolog (S. cerevisiae) Intron 1 3.0 1 0 
Sec63 SEC63-like (S. cerevisiae) Intron 1 (2) 5, 4.3 1, 2 1, 0 
Sel1I Sel-1 suppressor of lin-12-like (C. 
elegans) 
Upstream (-
1.5K), In 1 
8, 5.5 0, 1 0, 0 
Selm selenoprotein M Exon 1/TSS 3.0 0 0 
Serp1 signal peptidase complex subunit 3 
homolog (S. cerevisiae) 
Intron 2 2.7 1 0 
Sil1 Endoplasmic reticulum chaperone 
SIL1 homolog (S. cerevisiae) 
Intron 1 12.0 1 1 
Spcs2 signal peptidase complex subunit 2 
homolog (S. cerevisiae) 
Intron 1 6.0 1 0 




Srebf1 Sterol regulatory element binding 
transcription factor 1 
Intron 1 3.5 0 0 




10.0 1 0 
Srp19 signal recognition particle 19 Intron 2 3.7 1 0 
Srp54a signal recognition particle 54A Exon 1/TSS 11.0 1 0 
srp68 signal recognition particle receptor Intron 1 6.0 2 1 
Srpr signal sequence receptor, gamma Intron 1 4.8 1 0 
Srprb signal recognition particle receptor, B 
subunit 
Intron 1 7.0 0 0 
Ssr1 signal sequence receptor, alpha Promoter  1 0 
Ssr3 translocating chain-associating 
membrane protein 1 
Intron 1 3.5 0 2 




Surf4 surfeit gene 4 Exon 1/TSS 3.7 1 0 




8.0 0 1 
Tor1a Torsin family 1, member A (torsin A)     
Tram1 Stress-associated endoplasmic 
reticulum protein 1 






Txndc11 thioredoxin domain containing 11 Intron 1 (2) 4, 5 0, 0 0, 0 
Txndc5 thioredoxin domain containing 5 Intron 1  1 0 
Ube2g2 Ubiquitin-conjugating enzyme E2G 2 Intron 1 2.7 0 0 
Ubxn4 UBX domain protein 4 Exon 1 2.0 0 0 




2, 2.3 1, 0 0, 0 
Uso1 USO1 vesicle docking factor Intron 1 3.7 2 0 
Usp14 Ubiquitin specific peptidase 14 Promoter 3.0 1 0 
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Vamp2 vesicle-associated membrane protein 
2 
Upstream (-
1K), In 1 
2.5, 5.0 4, 0 0, 0 
Vamp4 vesicle-associated membrane protein 
4 
Promoter 6.0 0 0 
Vamp7 vesicle-associated membrane protein 
7 
NO DATA    
Vcp Valosin containing protein Promoter, In 
1, In 2 




Xbp1 X-box binding protein 1 Promoter 3.5 1 0 















Locations Fold GC TA 
Atf5 Activating transcription factor 5 N/A N/A N/A N/A 
Atf6b Activating transcription factor 6 
beta 
N/A N/A N/A N/A 
Bax Bcl2-associated X protein N/A N/A N/A N/A 
Bet1l blocked early in transport 1-like N/A N/A N/A N/A 
Bfar bifunctional apoptosis regulator N/A N/A N/A N/A 
Blzf1 basic leucine zipper nuclear 
factor 1 
N/A N/A N/A N/A 
Calr Calreticulin N/A N/A N/A N/A 
Canx Calnexin N/A N/A N/A N/A 
Cct4 Chaperonin containing Tcp1, 
subunit 4 (delta) 
N/A N/A N/A N/A 
CHOP/D
dit3 
component of oligomeric golgi 
complex 3 
N/A N/A N/A N/A 
Cog3 component of oligomeric golgi 
complex 6 
N/A N/A N/A N/A 
Cog6 coatomer protein complex, 
subunit beta 1 
N/A N/A N/A N/A 
Copb1 coatomer protein complex, 
subunit beta 2 (beta prime) 
N/A N/A N/A N/A 
Copb2 coatomer protein complex, 
subunit epsilon 
N/A N/A N/A N/A 
Cope coatomer protein complex, 
subunit gamma 1 
N/A N/A N/A N/A 
Copg CAMP responsive element 
binding protein 3 
N/A N/A N/A N/A 
Creb3 DNA-damage inducible transcript 
3 
N/A N/A N/A N/A 




N/A N/A N/A N/A 
Derl2 Der1-like domain family, member 
2 
N/A N/A N/A N/A 
Dnajb2 DnaJ (Hsp40) homolog, 
subfamily B, member 2 
N/A N/A N/A N/A 
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Dolpp1 dolichyl pyrophosphate 
phosphatase 1 
N/A N/A N/A N/A 
Ern2 Endoplasmic reticulum (ER) to 
nucleus signalling 2 
N/A N/A N/A N/A 
Erp29 endoplasmic reticulum protein 29 N/A N/A N/A N/A 
Fkbp1b FK506 binding protein 1b N/A N/A N/A N/A 
Fkbp2 FK506 binding protein 2 N/A N/A N/A N/A 
Fkbp7 FK506 binding protein 7 N/A N/A N/A N/A 
Ganab Alpha glucosidase 2 alpha neutral 
subunit 
N/A N/A N/A N/A 
Ganc Glucosidase, alpha; neutral C N/A N/A N/A N/A 
Ggcx gamma-glutamyl carboxylase N/A N/A N/A N/A 
Golph3l golgi phosphoprotein 3-like N/A N/A N/A N/A 
Gosr2 golgi SNAP receptor complex 
member 2 
N/A N/A N/A N/A 
Hspa1L Heat shock protein 1-like N/A N/A N/A N/A 
Hspa4 Heat shock protein 4 N/A N/A N/A N/A 
Hspa4L Heat shock protein 4 like N/A N/A N/A N/A 
Hspa5 Heat shock protein 5 N/A N/A N/A N/A 
Hspb9 Heat shock protein, alpha-
crystallin-related, B9 
N/A N/A N/A N/A 
Insig1 Insulin induced gene 1 N/A N/A N/A N/A 
Insig2 Insulin induced gene 2 N/A N/A N/A N/A 
Kdelr3 KDEL (Lys-Asp-Glu-Leu) 
endoplasmic reticulum protein 
retention receptor 3 
N/A N/A N/A N/A 
Lepre1 leprecan 1 N/A N/A N/A N/A 
Lman2 lectin, mannose-binding 2 N/A N/A N/A N/A 
Mapk8 Mitogen-activated protein kinase 
8 
N/A N/A N/A N/A 
Pdia6 protein disulfide isomerase 
associated 6 
N/A N/A N/A N/A 
Ppia Peptidylprolyl isomerase A N/A N/A N/A N/A 
Prkcsh Protein kinase C substrate 80K-H N/A N/A N/A N/A 
Rab3a RAB3A, member RAS oncogene 
family 
N/A N/A N/A N/A 
Rabac1 Rab acceptor 1 (prenylated) N/A N/A N/A N/A 
Rcn3 reticulocalbin 3, EF-hand calcium 
binding domain 
N/A N/A N/A N/A 
Rpn2 ribophorin II N/A N/A N/A N/A 
Scap SREBF chaperone N/A N/A N/A N/A 
Sec22b SEC22 vesicle trafficking protein 
homolog B (S. cerevisiae) 
N/A N/A N/A N/A 
Sec23a SEC23A (S. cerevisiae) N/A N/A N/A N/A 
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Sec23b SEC23B (S. cerevisiae) N/A N/A N/A N/A 
Sec24d Sec24 related gene family, 
member D 
N/A N/A N/A N/A 
Srp9 signal recognition particle 9 N/A N/A N/A N/A 
Ssr2 signal sequence receptor, beta N/A N/A N/A N/A 
Ssr4 signal sequence receptor, delta N/A N/A N/A N/A 
Stx5a syntaxin 5A N/A N/A N/A N/A 
Tcp1 T-complex protein 1 N/A N/A N/A N/A 
Ube2j2 Ubiquitin-conjugating enzyme E2, 
J2 homolog (yeast) 
N/A N/A N/A N/A 
Ufd1I Ubiquitin fusion degradation 1 like N/A N/A N/A N/A 
Uggt2 UDP-glucose glycoprotein 
glucosyltransferase 2 
N/A N/A N/A N/A 
Wfs1 Wolfram syndrome 1 homolog N/A N/A N/A N/A 
Yif1a Yip1 interacting factor homolog A 
(S. cerevisiae) 








































Appendix C: Relative Fold Change in MIST1WT, MIST1KO, and MIST1KO;LSL-
MIST1MYC for MIST1 Candidate Effectors With ChIP Enrichment and Significant 
Expression Differences in MIST1WT vs. MIST1KO 
 
Identification Array Data 
Gene abbr. Name 




WT KO Rescue 
Alg12 asparagine-linked 
glycosylation 12 
1 1.20 1.01 0.0260 Full 
Arcn1 archain 1 1 -1.21 -1.16 0.0400 Partial 
Arfgap3 ADP-ribosylation factor 
GTPase activating protein 3 
1 -2.23 -1.35 0.0001 Partial 
Atp2a2 ATPase, Ca++ transporting, 
cardiac muscle, slow twitch 2 
1 -1.34 -1.04 0.0460 Full 
Copz1 coatomer protein complex, 
subunit zeta 1 
1 -3.19 -1.07 0.0000 Full 
Creb3l1 cAMP responsive element 
binding protein 3-like 1 
1 1.32 1.11 0.0070 Partial 
Dnajb11 DnaJ (Hsp40) homolog, 
subfamily B, member 9 
1 1.26 1.22 0.0560 None 
Dnajb9 DnaJ (Hsp40) homolog, 
subfamily B, member 11 
1 1.19 1.14 0.0880 None 
Dnajc1 DnaJ (Hsp40) homolog, 
subfamily C, member 1 
1 -1.82 -1.12 0.0001 Partial  
Dnajc3 DnaJ (Hsp40) homolog, 
subfamily C, member 3 
1 -1.216 1.077 0.0370 Partial  
Dnajc4 DnaJ (Hsp40) homolog, 
subfamily C, member 4 
1 1.334 1.05 0.0005 Partial  
Edem3 ER degradation enhancer, 
mannosidase alpha-like 3 
1 -1.75 -1.11 0.0003 Partial  
Eif2a eukaryotic translation initiation 
factor 2A 
1 -1.16 -1.2 0.0670 None 
Ero1Lb ERO1-like beta (S. cerevisiae) 1 -1.27 -1.33 0.0130 None 
Erp44 Endoplasmic reticulum protein 
44 
1 -1.24 -1.18 0.0040 None 
Fbxo6 F-box protein 6 1 -1.22 1.07 0.0600 Partial 
H13 histocompatibility 13 1 -1.28 1.01 0.0490 Full 
H47 Histocompatibility 47 1 -1.16 -1.11 0.0880 Partial 
Htra2 HtrA serine peptidase 2 1 -2.78 -1.48 0.0000 Partial  
Mapk9 Mitogen-activated protein 
kinase 9 
1 -1.24 1.01 0.0197 Full  
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Mcfd2 multiple coagulation factor 
deficiency 2 
1 -1.20 -1.04 0.0650 Full 
Mogs mannosyl-oligosaccharide 
glucosidase 
1 -1.56 -1.20 0.0056 Partial 
Os9 Amplified in osteosarcoma 1 -1.77 -1.24 0.0001 Partial  
PDI/Pdia3 Protein disulfide isomerase 
associated 3 
1 1.24 1.2 0.0890 None 
Pdia4 protein disulfide isomerase 
associated 4 
1 1.40 1.36 0.0630 None 
Pfdn2 Prefoldin 2 1 1.17 1.08 0.0320 Partial  
Pfdn5 Prefoldin 5 1 1.17 1 0.0010 Full  
Piga phosphatidylinositol glycan 
anchor biosynthesis, class A 
1 2.56 1.34 0.0003 Partial 
Ppib peptidylprolyl isomerase B 1 1.13 1.04 0.0061 Full 
Ppp1r15b Protein phosphatase 1, 
regulatory (inhibitor) subunit 
15b 
1 -1.22 1 0.0530 Full  
Rnf139 Ring finger protein 139 1 -1.264 -1.11 0.0410 Partial  
Rrbp1 ribosome binding protein 1 1 1.21 1.18 0.0040 None 
Sec11a SEC11 homolog A (S. 
cerevisiae) 
1 1.21 1.08 0.0240 Partial 
Sec11c SEC11 homolog C (S. 
cerevisiae) 
1 -2.62 -1.74 0.0000 Partial 
Sec31a Sec31 homolog A (S. 
cerevisiae) 
1 -1.20 -1.05 0.0630 Partial 
Sec61b Sec61 beta subunit 1 -1.33 -1.16 0.0148 Partial 
Sec61g SEC61, gamma subunit 1 1.18 1.12 0.0990 Partial 
Sec62 SEC62 homolog (S. 
cerevisiae) 
1 1.15 1.16 0.0560 None 
Selm selenoprotein M 1 -1.17 -1.20 0.0810 None 
Serp1 signal peptidase complex 
subunit 3 homolog (S. 
cerevisiae) 
1 -1.567 -1.19 0.0001 Partial  
Spcs2 signal peptidase complex 
subunit 2 homolog (S. 
cerevisiae) 
1 -1.16 -1.03 0.0450 None 
Spcs3 signal recognition particle 68 1 -1.61 -1.29 0.0004 Partial 
srp68 signal recognition particle 
receptor 
1 -1.45 -1.13 0.0019 Partial 
Srpr signal sequence receptor, 
gamma 
1 -1.35 -1.14 0.0010 Partial 
Ssr3 translocating chain-associating 
membrane protein 1 
1 -1.16 -1.04 0.0305 Full 
Stx18 syntaxin 18 1 -1.19 -1.10 0.0630 Partial 
Surf4 surfeit gene 4 1 1.20 -1.02 0.0730 Full 
Syvn1 Synovial apoptosis inhibitor 1, 
synoviolin 




endoplasmic reticulum protein 
1 
1 -1.80 -1.19 0.0000 Partial 
Ube2g2 Ubiquitin-conjugating enzyme 
E2G 2 
1 -1.2 -1.02 0.0750 Full  
Ubxn4 UBX domain protein 4 1 -1.301 -1.032 0.0450 Full  
Uso1 USO1 vesicle docking factor 1 -1.18 -1.11 0.0710 Partial 
Xbp1 X-box binding protein 1 1 1.16 1.21 0.0640 None 


































Appendix D: Relative Fold Change In MIST1WT, MIST1KO, and MIST1KO;LSL-
MIST1MYC For MIST1 Candidate Effectors With ChIP Enrichment But no Significant 
Expression Changes Between MIST1WT vs. MIST1KO 
 
Identification Array Data 
Gene 
abbr. Name 
Expression fold change P-value 
(WT vs. 
KO) 
WT KO Rescue 
Alg2 asparagine-linked glycosylation 
2 
1 -1.22 -1.09 >0.1 
Amfr Autocrine motility factor receptor 1 1.1 -1.07 >0.1 
Atf4 Activating transcription factor 4 1 -1.12 -1.23 >0.1 
Atf6 Activating transcription factor 6 1 -1.01 1.08 >0.1 
Atxn3 Ataxin 3 1 1.12 -1.09 >0.1 
Bet1 blocked early in transport 1 1 1.04 -1.09 >0.1 
Cct7 Chaperonin containing Tcp1, 
subunit 7 (eta) 
1 -1.05 0.93 >0.1 
Cebpb CCAAT/enhancer binding 
protein (C/EBP), beta 
1 1.06 -1.1 >0.1 
Creb3I3 CAMP responsive element 
binding protein 3-like 3 
1 -1.02 1.02 >0.1 
Derl1 Der1-like domain family, 
member 1 
1 1.09 -1.09 >0.1 
Dnajc10 DnaJ (Hsp40) homolog, 
subfamily C, member 10 
1 1.11 -1.67 >0.1 
Edem1 ER degradation enhancer, 
mannosidase alpha-like 1 
1 -1.12 -1.05 >0.1 
Eif2ak3 Eukaryotic translation initiation 
factor 2 alpha kinase 3 
1 1.05 -1.11 >0.1 
Ern1 Endoplasmic reticulum (ER) to 
nucleus signalling 1 
1 -1.02 1.05 >0.1 
Ero1L ERO1-like (S. cerevisiae) 1 -1.14 1.21 >0.1 
Fkbp10 FK506 binding protein 10 1 1.24 1.19 >0.1 
Fkbp11 FK506 binding protein 11 1 1.05 -1.07 >0.1 
Fkbp14 FK506 binding protein 14 1 1.08 1.26 >0.1 
Gcc1 golgi coiled coil 1 1 -1.14 -1.16 >0.1 
Golga3 golgi autoantigen, golgin 
subfamily a, 3 
1 1.14 -1.03 >0.1 
Golga4 golgi autoantigen, golgin 
subfamily a, 4 
1 -1.16 1.01 >0.1 
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Golgb1 golgi autoantigen, golgin 
subfamily b, macrogolgin 1 
1 1.19 1.14 >0.1 
Golph3 golgi phosphoprotein 3 1 -1.13 -1.02 >0.1 
Gopc golgi associated PDZ and 
coiled-coil motif containing 
1 1.16 -1.13 >0.1 
Gorasp2 golgi reassembly stacking 
protein 2 
1 1.05 -1.13 >0.1 
Herpud1 Homocysteine-inducible, 
endoplasmic reticulum stress-
inducible, ubiquitin-like domain 
member 1 
1 1.08 -1.15 >0.1 
Hmox1 heme oxygenase (decycling) 1 1 1.15 1.09 >0.1 
Hsp90b1 heat shock protein 90 alpha 
(cytosolic), class B member 1 
1 1.16 1.23 >0.1 
Hspa13 Heat shock protein 2 1 -1.20 -1.39 .0.1 
Hspa2 heat shock protein 70 family, 
member 13 
1 -1.02 -1.04 >0.1 
Hsph1 Heat shock 105kDa/110kDa 
protein 1 
1 -1.03 1.003 >0.1 
Htra4 HtrA serine peptidase 4 1 -1.04 1.14 >0.1 
Hyou1 hypoxia up-regulated 1 1 1.16 1.12 >0.1 
Kdelr2 KDEL (Lys-Asp-Glu-Leu) 
endoplasmic reticulum protein 
retention receptor 2 
NO DATA     
Lman1 lectin, mannose-binding, 1 1 -1.20 1.00 >0.1 
Manf Mesencephalic astrocyte-
derived neurotrophic factor 
1 1.07 -1.02 >0.1 
Mapk10 Mitogen-activated protein kinase 
10 
1 1.05 1.33 >0.1 
Mbtps1 Membrane-bound transcription 
factor peptidase, site 1 
1 1.09 1.13 >0.1 
Mbtps2 Membrane-bound transcription 
factor peptidase, site 2 
1 1 1.03 >0.1 
Mgat2 mannoside 
acetylglucosaminyltransferase 2 
1 1.06 -1.33 >0.1 
Nploc4 Nuclear protein localization 4 
homolog (S. cerevisiae) 
1 -1.11 -1.03 >0.1 
Nucb1 Nucleobindin 1 1 1.075 -1.07 >0.1 
Ormdl3 ORM1-like 3 (S. cerevisiae) 1 1.04 1.17 >0.1 
Rab33b RAB33B, member of RAS 
oncogene family 
1 1.13 -1.04 >0.1 
Rnf5 Ring finger protein 5 1 -1.11 -1.24 >0.1 
Rpn1 Ribophorin I 1 1.08 1.115 >0.1 
Sdf2l1 stromal cell-derived factor 2-like 
1 
1 1.01 -1.02 >0.1 
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Sec61a1 Sec61 alpha 1 subunit (S. 
cerevisiae) 
1 -1.07 1.07 >0.1 
Sec63 SEC63-like (S. cerevisiae) 1 -1.12 1.06 >0.1 
Sel1I Sel-1 suppressor of lin-12-like 
(C. elegans) 
1 -1.12 -1.13 >0.1 
Sil1 Endoplasmic reticulum 
chaperone SIL1 homolog (S. 
cerevisiae) 
1 1.12 1.13 >0.1 
Srebf1 Sterol regulatory element 
binding transcription factor 1 
1 -1.2 1.08 >0.1 
Srebf2 Sterol regulatory element 
binding factor 2 
1 1 1.14 >0.1 
Srp19 signal recognition particle 19 1 1.00 -1.23 >0.1 
Srp54a signal recognition particle 54A NO 
DATA 
      
Srprb signal recognition particle 
receptor, B subunit 
1 -1.25 -1.12 >0.1 
Ssr1 signal sequence receptor, alpha 1 1.01 1.01 >0.1 
Tor1a Torsin family 1, member A 
(torsin A) 
1 1.12 1.07 >0.1 
Txndc11 thioredoxin domain containing 
11 
1 -1.03 -1.34 >0.1 
Txndc5 thioredoxin domain containing 5 1 1.15 1.14 >0.1 
Uggt1 UDP-glucose glycoprotein 
glucosyltransferase 1 
1 -1.01 1.13 >0.1 
Usp14 Ubiquitin specific peptidase 14 1 1.16 1.03 >0.1 
Vamp2 vesicle-associated membrane 
protein 2 
1 -1.02 -1.01 >0.1 
Vamp4 vesicle-associated membrane 
protein 4 
1 -1.07 -1.03 >0.1 
Vamp7 vesicle-associated membrane 
protein 7 
1 1.01 -1.35 >0.1 
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